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Abstract 
Abstract 
 
 
The importance of crystals to the pharmaceutical industry is evident - over 90% of 
pharmaceutical products contain a drug in crystalline form. However, the 
crystallization phenomena of drug compounds are poorly understood. An increased 
understanding of these processes may allow a greater degree of control over the 
crystallization outcomes, such as morphology, purity, or stability. In these studies, 
we have applied Atomic Force Microscopy (AFM) to the in situ investigations of 
drug crystal growth.  
We utilized AFM to assess the growth on the (001) face of aspirin crystals at 
two supersaturations, elucidating both the growth mechanisms and kinetics at each 
supersaturation. 
We also investigated the nucleation of aspirin crystals, using microcontact 
printing to arrange aspirin-binding and non-binding self-assembled monolayers 
(SAMs) onto surfaces. This facilitated the visualization, using AFM, of the growth of 
aspirin crystals adhered to the surface. Additionally, secondary nucleation was 
observed on the growing crystals.  
The effect of the additives acetanilide and metacetamol on the morphology 
and growth on the (001) face of paracetamol was investigated. The presence of 
metacetamol significantly reduced the growth rate on the face, with respect to pure 
paracetamol solutions. The growing steps exhibited a pinned appearance, consistent 
with the Cabrera and Vermilyea model. Conversely, acetanilide caused dissolution to 
occur.  
Finally, we assessed the capabilities of AFM in following the structural 
transformations of crystals, which can occur in unstable pharmaceutical compounds. 
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We employed AFM to determine the process by which anion exchange, and the 
subsequent structural transformations, of the co-ordination polymers {[Ag(4,4-
bipy)]BF4}f and {[Ag(4,4-bipy)]NO3}f occur. AFM data verified that the anion 
exchange process is solvent-mediated. The mechanisms underlying this process are 
discussed herein.  
 
These results reiterate the capability of AFM to monitor dynamic events on crystal 
surfaces. Analogous studies could be applied to numerous pharmaceutical 
compounds, thus facilitating the optimization of their crystallization parameters. In 
essence, future experiments using AFM may afford greater control over 
crystallization, and prevent the production of unwanted or unstable pharmaceutical 
compounds. 
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Chapter 1 
Chapter 
1 
Introduction 
 
 
 
1.1 Nucleation and crystallization processes, and their importance 
in the production of pharmaceutical compounds. 
 
1.1.1 Nucleation. 
 
The process of creating a new solid phase from a supersaturated mother phase is 
known as nucleation, and is central to all types of crystallization [1]. Crystallization 
begins with the aggregation of molecules, typically solute molecules in solution, 
leading to the formation of a nucleus. If the nucleus attains a certain critical size, it 
will grow into a macroscopic crystal, whereas subcritical sized nuclei redissolve. 
In general, nucleation mechanisms  can be divided into three main categories: 
homogeneous, heterogeneous, and secondary nucleation [2-7]. The thermodynamic 
considerations for these nucleation mechanisms are based on the works of Gibbs [8] 
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and Volmer [9], and are discussed extensively in a review by Rodríguez-Hornedo 
and Murphy [7]. 
Homogenous nucleation is the spontaneous nucleation of crystals, in a 
supersaturated solution, in the absence of any impurities or nucleation-promoting 
substrates. This type of nucleation rarely occurs in volumes larger than 100 µl, since 
real solutions tend to contain random impurities which may induce nucleation [10, 
11]. 
Heterogeneous nucleation occurs when a surface or interface of different 
composition to that of the crystallizing solute, acts as a nucleation substrate [12, 13]. 
Heterogeneous nucleation can occur in the presence of impurities, or on ordered 
substrates, such as monolayers or micelles. The promotion of nucleation by self-
assembled monolayers is detailed in Chapter 3.  
The presence of impurities or nucleation-promoting surfaces can induce 
nucleation at supersaturations lower than those required for homogeneous nucleation. 
The extent of this reduction depends on the degree to which the nucleation-
promoting substance mimics the structure of the crystallizing material [1]. In some 
instances, this process occurs by the non-oriented adsorption of solute molecules  
onto an existing surface until it resembles a crystal. In other cases, a specific 
structural relationship exists between the surface and the crystallizing solute, 
allowing the crystal to nucleate and grow epitaxially [1]. A number of researchers 
have applied the concepts of heterogeneous nucleation to the directed nucleation of 
specific polymorphs [14-18]. These studies provide us with the attractive possibility 
that a library of organic seeds can be used to control polymorphism, or to search for 
unknown polymorphs [13].  
 -  - 12
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The best match between a substrate and a crystallizing solute exists when the 
substrate is in fact a seed crystal of the solute. Nucleation that occurs on, or is 
promoted by, seed crystals of the crystallizing solute is known as secondary 
nucleation [7]. This nucleation mechanism generally occurs at much lower 
supersaturations than homogeneous or heterogeneous nucleation [1].  
Nucleation processes are of practical importance in production of 
pharmaceutical compounds, for example, in instances where crystallization is 
observed at times shorter than the desired product shelf-life, or where precipitation 
occurs upon injection. In these cases, the kinetic stability of supersaturated solutions 
is regulated by the nucleation mechanisms and kinetics. As previously mentioned, 
nucleation phenomena are equally important in the selective crystallization of a 
particular polymorphic form [15, 17]. It is also of great interest to understand the 
efficiency of crystal seeding in pharmaceutical crystallization.  
 
1.1.2 Crystal growth. 
 
Once the nucleation step has been overcome, nuclei grow into macroscopic crystals. 
The nucleation and growth processes compete for solute molecules in terms of their 
respective dependence on supersaturation, and their relative rates will determine the 
crystal size distribution [7]. 
 Crystal growth is governed by both internal and external factors. Internal 
factors, such as the three-dimensional crystal structure and crystal defects, will 
determine the nature and strength of the intermolecular interactions between the 
crystal surface and the solution. On the other hand, external factors, such as the 
temperature, supersaturation, solvent, pH, stirring rate, and the presence of 
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impurities, will affect the type of interactions at the solid-liquid interface [7]. The 
mechanisms of growth of crystals are well characterized, and are described in detail 
in Chapter 2. 
The dependence of nucleation and growth mechanisms of crystalline drugs  
upon the aforementioned crystallization parameters are ill defined [19-25]. The 
reproducibility of crystallization techniques requires the identification of the 
crystallization mechanisms and kinetics under well defined conditions [7]. In order to 
attain this information, in depth research must be performed on the in situ 
mechanisms of nucleation and growth of drug crystals, and the influences of 
crystallization parameters on these factors must be realized. 
 
1.1.3 The importance of crystals to the pharmaceutical industry. 
 
Crystallization from solution is a critical stage in the chemical production of 
pharmaceutical materials. Over 90% of all pharmaceutical products, such as tablets, 
aerosols, capsules, suspensions, and suppositories contain a drug in crystalline form 
[26]. The crystallization processes of such compounds are principally responsible for 
their chemical purity and physical properties, such as particle shape and size, crystal 
structure, and degree of crystal imperfection [27-29]. Crystalline variations or 
interbatch anomalies in these properties are associated with a wide range of industrial 
formulation problems, such as bioinequivalence (variable dissolution rate), tabletting 
failure, and chemical and physical instability of the solid drug in its final dosage 
form [28, 30-32]. 
Table 1. 1 summarizes the most important solid-state characteristics which 
are affected by crystallization, and the influence these properties have on the 
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stability, and downstream processing of pharmaceutical compounds. Some of the 
problematic properties of crystalline drugs highlighted in Table 1. 1 will be discussed 
in more detail in the following sections. 
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Crystal properties Effect on drug substance and/or drug 
product 
Structural 
Crystallinity (existence of 
amorphous and semi-crystalline 
forms) 
 
Polymorphs 
Solvates (hydrates) 
Salts 
Crystal defects 
 
Physical and chemical stability 
 
 
 
% relative humidity (RH) profile 
Solubility profile and dissolution rate 
All aspects of processing 
Dimensional 
Particle size distribution 
 
 
Particle surface structure 
 
Processing behaviour: bulk density, 
agglomeration, flow, compaction 
 
Particle permeability (i.e. particle 
adsorption) 
Bioavailability (drug absorption) 
Consistency and uniformity of the dosage 
form 
Chemical 
Presence of impurities, residual 
solvent, and decomposition 
products 
 
Chiral forms and chiral separation 
 
Toxicity 
 
 
 
Chemical, physical, and enantiomeric 
stability 
Mechanical 
Brittle/ductile transitions, fracture 
stress, indentation hardness, 
stress/strain relaxation, Youngs 
modulus 
 
Milling and tabletting behaviour 
Electrical 
Electrostatic charge distribution 
 
Agglomeration and flow properties 
 
  
Table 1. 1 The most important solid-state characteristics which are affected by 
crystallization, and the influence these properties have on the stability and 
downstream processing of pharmaceutical materials. Adapted from [28].  
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It should be noted that, besides the crystalline drug component of 
pharmaceutical formulations, other crystalline components, such as excipients, may 
also be present in the formulation. These excipients may be bulking or binding 
agents, lubricants, or plasticizers. The physical properties of the crystalline excipient 
components are also of importance to the overall stability and efficacy of the drug 
formulation [28]. For example, tablets are by far the most widely used and 
convenient solid dosage form. In addition to the active drug component of the dosage 
form, a number of different solids, mostly crystalline excipients, may be included in 
the tablets. The overall success of any direct tabletting procedure, and the resulting 
mechanical properties of the tablets, are strongly dependent on the quality of the 
crystals used in the process [28]. It is apparent that both the properties of the drug 
and excipient compounds are of great importance during formulation.  
Two-thirds of the currently marketed tablets contain less than 100 mg of drug 
[33] and, hence, the mechanical properties of the excipient compounds will dominate 
within these formulations. Conversely, in the remaining one-third of tablet 
formulations, the mechanical characteristics of the drug compound will prevail [28]. 
However, for the purposes of this thesis, only the effects of crystallization on drug 
compounds shall be discussed.  
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1.2 The influence of crystallization conditions on the physical 
properties and stability of pharmaceutical drugs. 
 
Crystallization processes in pharmaceutical science affect both the solid-state 
properties of the drug substances, and the drug product stability and performance. It 
should be emphasized that even minor changes in crystallization conditions, for 
example, supersaturation, temperature, cooling or evaporation rate, and impurity 
concentration can induce significant changes in the crystal properties, in particular, 
particle size, shape, purity, and defect structure [19-21, 34]. These alterations in 
crystallization parameters can, in turn, induce significant variations in the 
thermodynamic and mechanical properties [28]. These effects have been recognized 
as the major batch-to-batch variation problems, leading to inconsistency in the final 
drug formulation properties.  
Variations in crystallization conditions may also confer instability upon the 
product, leading to disordered and amorphous states, polymorphism, chiral 
separation, or the occurrence of solid-state reactions [35].  
In order to apply the concepts of crystal engineering to pharmaceutical 
substances, the reproducibility of the solid-state properties and stability must, first of 
all, be attained. It is apparent that, in order to achieve full control over the 
characteristics of drug compounds, we must gain a greater insight into their 
crystallization procedures, and design more advanced crystallization methods. The 
complexity and variety of crystallization problems warrant investigations of the more 
fundamental aspects of crystal growth.  
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In the following section, a description is given of some of the crystallization 
parameters which affect the properties of drug crystals. It should be noted that the list 
of parameters discussed is not intended to be exhaustive. 
 
1.2.1 Supersaturation: its effect on the growth and properties of drug crystals. 
 
The supersaturation of a solution may be created by various methods that regulate the 
solute concentration. These include solvent removal by evaporation or freezing, 
addition of salts with ions that participate in precipitation, and the dissolution of 
metastable solid phases. Supersaturation can also be created by methods that regulate 
the solute solubility, such as temperature change, pH change, and addition of a 
solvent that lowers the solubility of the solute [7].  
Supersaturation can have a profound affect on crystal growth, resulting in 
morphological changes in the crystallizing compound over a range of 
supersaturations [24, 27, 29, 36-38]. It is also known to affect many of the physical 
properties of crystals including, the solvent content, melting point, enthalpy and 
entropy of fusion, and the dissolution rate [21].  
In general, the number of crystals produced increases with the 
supersaturation, whilst the size of crystals decreases [39]. This is due to the fact that 
the number of molecules necessary to achieve an effective nucleating cluster is 
inversely proportional to the level of supersaturation. Therefore, as the 
supersaturation is increased, the probability of nucleation increases. The much larger 
number of nuclei produced per unit of time is detrimental to growth, so that smaller 
crystals are obtained [40]. On the contrary, large crystals are most often produced by 
using low supersaturations [39].  
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All of the above properties are very important in pharmaceutical systems, 
with particular emphasis on the dissolution rate, size, and morphology of crystals. 
The bioavailability of a drug crystal is, evidently, dependent upon its dissolution rate. 
Hence, the supersaturation of a growth medium must be controlled in order that the 
bioavailability of a drug is maintained. In addition, the size and morphology (habit) 
of drug crystals have downstream effects on their processing.  
Processing factors such as separation, flow, compaction, dissolution, and 
packing all depend to a considerable extent on the crystal shape and size distribution 
[37]. Variations in crystal habit also present serious problems in pharmaceutical 
manufacturing, influencing the uniformity of tablet weight [37], and causing 
difficulty in tabletting [31]. These problems may be overcome by grinding or milling 
the materials to provide more acceptable and reproducible properties. However, these 
treatments may promote changes in crystal structure [41] and crystal perfection [35].  
Two specific examples of drug formulations which require crystals of a 
defined size and morphology are described below. 
 
1.2.1.1 Crystalline particles for inhalation devices. 
 
Dry powder inhalers (DPI) and metered dose inhalers (MDI) are types of delivery 
systems for inhalation drugs. These contain crystalline particles in the form of a 
drug/excipient mixture or a particle suspension respectively. Currently, these devices  
have a relatively low efficiency of delivering drugs to the alveoli region, mainly 
because of problems with the particle size distribution and particle morphology [28]. 
Only particles with a diameter below 5 µm are able to reach the deep lung alveoli 
region, which contain the majority of the blood vessels. Submicron particles are 
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likely to be exhaled and, therefore, a narrow particle size distribution of between 1 
µm and 5 µm is required for efficient drug delivery [28]. In addition, the crystal 
morphology dictates its effective aerodynamic diameter, and defines the mechanism 
by which the particle clouds are intercepted by the airways [42].  
 Novel crystallization methods which can afford the production of crystals 
with a narrow size distribution are, therefore, required [28]. 
 
1.2.1.2 Solid drug nanoparticles. 
 
Polymer-drug nanoparticle systems have attracted much attention over the past 
decade as they can be designed for the targeted delivery of drugs to specific organs  
or tissues [43]. The particle size and crystalline structure of nanoparticles define, 
most importantly, the dissolution rate of these drugs. Nanoparticles are crystallized at 
high supersaturation or, alternatively, are formed under harsh conditions of 
mechanical processing [28]. At high supersaturation, the crystallization of 
nanoparticles occurs at a very fast nucleation rate. Coupled with intensive mixing, 
this can lead to problems related to the agglomeration of particles [28]. Harsh 
mechanical processing can result in the formation of crystal defects, less stable 
crystalline forms, or partially amorphous material,  all of which lead to an increase in 
solubility and dissolution rate. Thus, the development of alternative crystallization 
methods is necessary.  
 
It is clear that a better understanding of the underlying crystallization 
processes, such as the effect of supersaturation on the process, could lead to the 
optimization and control of drug crystal size and morphology. 
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1.2.2 Recrystallizing solvent: its effect on the growth and properties of drug 
crystals. 
 
The manufacture of pharmaceuticals often involves crystallization from organic 
solvents or mixtures of solvents. The solvent composition influences the nucleation 
rate, as well as the relative growth rate of each crystal face, and, thus, affects the 
shape of the product crystals and the size distribution of the crystallized mass [44-
46]. For example, changing the solvent polarity during crystallization of 
nitrofurantoin and ibuprofen [47, 48] provided crystals with an elongated 
morphology, and enhanced compression behaviour. The solvent composition may 
also influence the aggregation properties, as well as the solvent incorporation of the 
crystals [49]. 
Although the role played by the solvent at the molecular level is still unclear, 
two theories have been proposed regarding the influence of the solvent on nucleation 
and growth [50]. One theory postulates that favourable interactions between solute 
and solvent molecules on specific faces lead to a reduction in the solid-liquid 
interface energy. Hence, the activation energy for nucleation on the crystal is reduced 
and the crystal becomes rougher, leading to enhanced crystal growth.  
Alternatively, it has been proposed that, for solvent molecules that can be 
strongly bound to the crystallizing compound, the solute-solvent dissociation can 
determine the nucleation and growth rates [46]. To determine which of these theories  
is accurate, in situ studies must be carried out on the nucleation and growth of drug 
crystals in a wide range of solvents.  
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1.2.3 Impurities/Additives: their effect on the growth and properties of drug 
crystals. 
 
The effects of impurities or additives on pharmaceutical crystals are described, in 
depth, in Chapter 4. In summary, impurities can have a substantial effect on the 
kinetics of nucleation and growth, and, hence, the resulting morphology [23, 29, 34, 
39, 49-60] and polymorphic form [14, 16, 18, 61]. These molecules induce their 
effects by interacting with the crystal faces during growth. Some impurities can 
completely suppress growth, some enhance growth, whilst others act selectively or to 
varying degrees on each crystal face, consequently modifying the crystal morphology 
[4].  
Additives are frequently used in pharmaceutical technology to modify the 
habit of crystals. It has also been found that additives, such as polymers or 
surfactants, prevent undesirable polymorphic changes in pharmaceutical preparations 
[62]. The modes by which additives induce habit alterations and stabilize 
polymorphs lie in their mechanisms of interaction at the crystal surface during 
growth. It is clear, therefore, that more information on the incorporation of additives 
into crystals at the molecular level is required.  
 
Fundamental to understanding the influence of these factors on the physical 
properties of the product crystal, is defining their role in both the structural and 
mechanistic aspects of the growth process. Hence, their role in the macro- and 
micromorphological development of the crystal must be determined [37]. 
The macromorphology of a crystal depends on the relative growth rates of the 
different crystal faces. Those which grow rapidly have little or no effect on the 
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crystal shape, whilst the slow growing faces have the most influence [37]. The 
growth of a particular face is defined by the crystal structure, the density of active 
growth sites, and by the crystallization conditions. 
 The micromorphology of crystal surfaces, that is their structure on the 
nanometre to micrometre scale, is the governing factor in the process of crystal 
growth. One means of developing a quantitative understanding of growth under a 
variety of conditions, is to study the microtopography of the crystal surfaces. This 
would provide direct evidence for the mechanisms governing the growth of each 
crystal face which, in turn, can be related to the macromorphological behaviour of 
the crystal [37]. The techniques which allow the acquisition of such 
microtopographical information shall be discussed later in the chapter.  
 
1.3 Unstable forms of pharmaceutical crystals. 
 
In the subsequent sections, the potentially unstable forms of pharmaceutical crystals, 
and the transformations they undergo to enhance their stability, are highlighted. An 
excellent, comprehensive review of the properties of potentially unstable 
pharmaceutical compounds, and the effects these have on drug formulation, is given 
by Shekunov and York [28]. 
 
1.3.1 Polymorphism. 
 
Polymorphism occurs when a molecule can pack in more than one stable orientation, 
giving two or more different crystal structures. Thus, polymorphs have divergent 
physical properties. Most important of these characteristics are the differing 
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solubilities and dissolution rates, as they can significantly alter important 
pharmacokinetic factors, such as rates of absorption, drug availability, and the 
resulting physiological concentrations [62].  
Polymorphism is notably common for certain groups of drugs, for example, 
barbiturates, sulphonamides, and steroids. In fact, it is rare when a medicinally active 
substance exhibits only one crystalline structure [30, 62-66]. 
  Polymorphs may grow under the same set of environmental conditions, or 
may be dependent upon specific crystallization parameters, such as the crystallizing 
solvent. For example, two polymorphs of the drug sulphathiazole (II and III) can be 
crystallized from water, two other polymorphs (I and IV) are obtained from acetone, 
and only one (I) can be recrystallized from n-propanol [67]. The proposed 
mechanism for this polymorphic selectivity involves the selective adsorption of 
solvent molecules onto the crystal faces, followed by the inhibition of nucleation and 
growth of particular polymorphic forms [28]. Factors, such as temperature and 
supersaturation, can also influence the polymorphic selection [28]. 
  In some cases, solid-state transformations of one polymorph to another may 
take place [68, 69]. The time periods of these reactions range from seconds to years 
[28]. This occurrence is particularly worrying for drug compounds. One such 
example occurred in 1998, when a shortage in the supply of capsules of Norvir, an 
HIV protease inhibitor, was caused by the sudden formation of a crystalline structure 
different from the one harvested for months [70]. These transformations must be 
suppressed in order to maintain the integrity of the drug product during its shelf-life. 
If a mixture of polymorphs occurs in a pharmaceutical formulation, quantitative 
control over crystallization is necessary in order to ensure a fixed proportion of each 
form. 
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  The disappearing or elusive polymorphs described by Dunitz and 
Bernstein [71], provide further evidence for the consequences of poor process control 
in the crystallization of polymorphic systems. It is, therefore, imperative to achieve a 
greater understanding of the kinetic mechanisms of polymorphism, and an enhanced 
degree of control over the crystallization techniques of drug substances.  
It should also be noted that processing techniques, such as milling, drying, 
and compression, can also introduce polymorphic modifications and transformations 
[28]. Thus, further investigation of the effects of processing on crystal structure is 
also required.  
 
1.3.2 Amorphous solids. 
 
Partially crystalline and amorphous drugs are more soluble than their crystalline 
counterparts and can, therefore, be used to promote therapeutic activity. The classic 
example of such an application is the formulation of insulin consisting of various  
proportions of amorphous, crystalline, and complexed forms of insulin to achieve 
short, intermediate, and long acting therapeutic effects [28].  
However, formulations containing amorphous forms are less stable than 
purely crystalline forms, and are at a significant risk to crystallize at a later stage 
during their product shelf-life [72]. These materials are often reactive and unstable to 
mechanical and thermal stresses [73]. These instabilities are the major factors 
impeding the more widespread use of amorphous solids. Thus, one of the basic 
questions of pharmaceutical formulation is to define what conditions make the solid 
form unstable [28]. An understanding of the crystallization kinetics of amorphous 
solids would provide a considerable advantage in the formulation of such drugs [28]. 
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1.3.3 Solvates. 
 
The presence of solvent molecules in a crystal lattice provides another opportunity 
for the modification of the crystal structure, which affects the thermodynamic 
activity, and the corresponding physicochemical characteristics [28]. Hence, such 
compounds are often referred to as pseudopolymorphs. The incorporation of solvent 
into the crystal structure can modify a variety of crystal properties, such as 
flowability, compaction, chemical stability, bioavailability, and dissolution rate [30, 
31, 74]. 
Dosage forms such as creams, gels, and suspensions are formulated with 
water, which may, therefore, facilitate the formation of different hydrates. Hydrates 
may be stable within a wide range of relative humidity (RH), or may transform into 
higher or lower solvates, or anhydrous desolvated forms. Consequently, partially 
solvated forms with different degrees of crystallinity and, thus, stability can be 
obtained [28]. 
 
1.3.4 Chiral drugs. 
 
More than half of all marketed drugs are chiral and exist in at least two enantiomeric 
forms [75]. The most important pharmaceutical problems associated with chiral 
drugs are related to the purity of their crystalline form. The undesirable enantiomers, 
if present in the crystallization medium, can become incorporated into the crystal 
lattice. The similarity of their molecular structure ensures that these enantiomeric 
impurities are very difficult to remove completely. A chiral impurity which is 
incorporated into the crystal will give rise to a variation in the solid-state properties 
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of the crystalline substance [28]. Uncontrollable impurity content may cause the 
unpredictable and erratic performance of the drug, leading to interbatch variations.  
In most cases, crystallization yields either a mixture of enantiomorphous 
crystals (a racemic conglomerate), or a racemic crystalline material (a racemic 
compound) [28]. As a result, drug substances are often administered as a mixture of 
enantiomeric forms [76]. In addition, a metastable racemic compound or 
conglomerate in the dosage form will be inclined to convert into a more stable form, 
thus causing significant formulation problems [28]. 
 The mechanisms and kinetics of enantiomeric drug crystallization and 
metastable enantiomeric conversion have not been sufficiently studied. Hence, the 
resolution of chiral drugs currently relies on methods of trial and error [28]. It is, 
therefore, necessary to provide a means of promoting the nucleation and growth of 
specific enantiomers, and to increase the stability of metastable enantiomers. 
 
1.3.5 Solid-state transformations. 
 
During the shelf-life of a drug compound, it may undergo a solid-state transformation 
to a more stable form. The transformations may be photochemically-induced, 
thermally-induced, or a result of solid-gas reactions [35]. These transformations can 
involve restructuring of the compound into another polymorphic form, or may result 
from internal chemical reorganization, such as dimerization, polymerization, 
cyclization, or decomposition [35].  
It has been proposed that solid-state reactions are initiated at nucleation sites, 
such as defects in the crystal surface [35]. Clearly, more investigations must be 
conducted to enable greater stability of these crystalline compounds. 
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1.3.6 Solvent-mediated transformations. 
 
Similarly, drug compounds may undergo solvent-mediated transformations to attain 
a more stable form. Knowledge of the stability of a crystal in a solvent is crucial in 
many of the stages of pharmaceutical development because pharmaceutical solids are 
designed to be dissolved in, and to come into contact with, solvents from the early 
stages of their development (during crystallization) and during processing (wet 
granulation, spray drying, and freeze drying) [7]. Given that the sudden 
disappearance or appearance of a crystalline modification can threaten the 
development process, the characterization of the kinetics and mechanisms of solvent-
mediated transformations is of practical importance [7].  
 
 
All of the aforementioned examples illustrate the instability of pharmaceutical 
compounds under certain conditions, the transformations they undergo to enhance 
their stability, and the consequences of such transformations on drug formulations. 
Transformations of crystalline structures may have a dramatic effect on the 
properties of the drug substance, in particular the toxicity, dissolution rate, and 
bioavailability. It is, therefore, imperative to not only increase the stability of 
pharmaceutical compounds, but to increase the understanding of the crystallization 
processes and the parameters which confer stability upon these compounds and 
produce the desired characteristics, such as size, shape, or polymorphic form. In 
order to accomplish these objectives, we must investigate the fundamental 
mechanisms of nucleation and growth of drug compounds, and the effects that 
crystallization parameters have on these mechanisms. 
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The resolution of many of the crystallization problems encountered during 
the production of drug crystals lie in the development of more advanced 
crystallization processes. Crystallization techniques using supercritical fluids (SCF) 
have been suggested as a novel method of production of pharmaceutical compounds 
[28]. The flexible conditions used during SCF crystallization have been shown to 
provide control over particle size, morphology, and water content [28]. Nonetheless, 
the methods of crystallization currently used during the production of pharmaceutical 
compounds require in-depth investigation. This fact has become apparent to 
regulatory bodies, whose guidelines on the control of crystallization are outlined in 
the following section. 
 
1.4 Regulations governing the control over crystallization of 
pharmaceutical compounds. 
 
The critical role of crystallization mechanisms and kinetics in determining the 
appearance of crystallization modifications has been recognized by many regulatory 
bodies, including the United States Food and Drug Administration (FDA). Their 
guidelines for the manufacture of drug substances state that [77]:  
Appropriate manufacturing and control procedures (including in-process 
testing when needed) should be established for the production of the desired solid-
state form(s). It should be emphasized that the manufacturing process (or storage 
condition) is responsible for producing particular polymorphs or solvates; the control 
methods merely determine the outcome. 
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The potential impact of modifications in crystal properties during the late 
stages of drug development, in terms of both cost and product delay, has led to the 
proposal of specific guidelines on the control of physicochemical properties. The 
guidelines are in the form of a New Drug Application (NDA), which must be 
submitted to a government regulatory body when a new drug product has completed 
its series of clinical trials [28]. These guidelines have been developed as a result of 
collaboration between regulators, industry, and academia [72, 78, 79]. The above 
regulations, in conjunction with internationally accepted rules governing current 
good manufacturing practices (cGMP) [80], make the crystallization process one of 
the most widely recognized issues in pharmaceutical development [28]. 
 
1.5 Techniques used to investigate nucleation and crystal growth. 
 
1.5.1 Molecular simulations. 
 
Recently, a structural approach has been taken to investigate crystal growth, due to 
the availability of commercial software for the prediction of crystal structures from 
molecular structures (ab initio predictions) [7]. Desiraju [81, 82] and Gavezzotti [66, 
83-86], amongst others [45, 87-89], have demonstrated the methods used for the 
prediction of crystal structure, polymorphism, and molecular aggregation processes. 
They have also illustrated how molecular dynamics calculations can simulate the 
effects of solvents on molecular aggregation. 
These studies, although very useful, must be complemented by in situ 
experimental studies to ascertain fully the processes occurring during nucleation and 
growth. 
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1.5.2 Experimental techniques used to investigate nucleation. 
 
Nucleation phenomena are often described in terms of macroscopic properties, due to 
the scarcity of experimental techniques that allow for monitoring events at the 
molecular level.  The current approach to detecting nucleation events is to measure, 
continuously, an appropriate property of the system as nucleation proceeds. A 
number of properties can be measured, including: 
i) Temperature. Since nucleation reduces the free energy of a system, 
heat is frequently evolved. This may be detected either by the direct 
measurement of temperature change, or by differential scanning 
calorimetry (DSC). DSC measures the heat flow into and out of a 
sample as its temperature is raised and lowered in tandem with a 
reference sample. The corresponding exo- and endotherms relate to 
the crystallization and melting of the sample [1]. 
ii)  Volume. Solid phases have different densities from their mother 
phases, and, hence, dilatometry is used to measure the volume of the 
crystallizing system with time [1]. 
iii)  Optical transmittance. Nucleation produces a dispersion of fine 
crystals. Consequently, the optical properties of a solution change at 
the point of nucleation. This allows the use of laser light scattering or 
Raman spectroscopy for the detection of nucleation [1]. 
iv) Concentration measurement. Nucleation of the solute results in a 
decrease in the solution concentration. This can be monitored by 
following the change in a concentration-dependent physical property, 
such as conductivity, density, or refractive index [1]. Alternatively, 
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the concentration itself can be monitored, using techniques such as  
spectrophotometry chromatography [7]. 
 
1.5.3 Experimental techniques used to investigate crystal growth. 
 
The experimental techniques which are commonly used to study crystallization, and 
the information they provide on crystallization mechanisms and kinetics are given in 
Table 1. 2 [7]. 
Until recent years, knowledge of crystal surface dynamics and morphology 
has been based principally on data acquired using optical microscopy [62, 90-92], 
electron microscopy [93-95] and in situ optical interferometry [27, 96, 97] and 
supported by the theories of Burton, Cabrera and Frank [98], Bennema [99-101], 
Gilmer et al.  [102], and Chernov [103]. These techniques are described in the 
following sections. 
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Technique Information that the technique provides about 
crystal growth 
Optical Microscopy - Study crystallization processes in situ 
- Monitor transformations in suspensions 
- Characterize additive or solvent interactions with 
specific crystal faces 
- Identify nucleation mechanisms 
- Measure crystal growth rates 
Electron Microscopy - Characterize additive or solvent interactions with 
specific crystal faces 
- Identify nucleation and growth mechanisms 
- Measure crystal growth rates 
Interferometery - Examine surface topography 
- Identify nucleation and growth mechanisms 
- Measure crystal growth rates 
Atomic Force Microscopy - Examine surface topography 
- Study crystallization processes in situ at high 
resolution, and in real-time 
- Characterize additive or solvent interactions with 
crystal faces 
- Identify nucleation and growth mechanisms 
- Measure crystal growth rates 
 
 
Table 1. 2 The experimental techniques which are commonly used to study 
crystallization, and the information they provide on crystallization mechanisms and 
kinetics. Adapted from [7].   
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1.5.3.1 Optical microscopy. 
 
A detailed account of the mechanical description of optical microscopes has been 
reported by Needham [104]. Optical microscopy, in its simplest form, employs a 
series of lenses to focus a beam of visible light, after it has interacted with a sample. 
This provides an image of the sample which is usually observed through an eyepiece. 
However, due to the relatively long wavelength of visible light, the resolution of an 
optical microscope is limited (working beyond 600X is difficult when observing 
microcrystalline materials) [105]. A diagram illustrating the basic components of an 
optical microscope is shown in Figure 1. 1. 
The application of optical microscopy with the use of a flow cell system has 
facilitated the acquisition of growth rates of individual crystal faces of many crystal 
systems [106-108], including sulphathiazole [62, 90], methylprednisolone [90], and 
phenytoin [91, 92]. 
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Figure 1. 1 A schematic illustration of a conventional optical microscope [105]. 
 
 
 
 
 
 
 
 
 
 
 
 -  - 36
Chapter 1 
1.5.3.2 Electron microscopy. 
 
The short wavelength attainable for a beam of high energy electrons allows the 
resolution of an electron microscope to be several hundred-fold higher than that of a 
light microscope. A wide variety of electron microscopes exist, each of which, as the 
name suggests, employ a source of electrons to provide information about a sample. 
A full technical description of these techniques are given in references [109, 110].  
A diagrammatic representation of one of these techniques, scanning electron 
microscopy (SEM), is given in Figure 1. 2. In SEM, electrons from a source (usually 
a hot tungsten filament) are accelerated using an electric field to give the required 
wavelength. After acceleration, the electrons are initially focused by a lens to give a 
very small spot, typically 2 - 50 nm in diameter. The focused spot is then raster 
scanned across the sample. The detected signal is displayed on an oscilloscope in 
unison with the movement of the focused spot.  
The spatial resolution of SEM is limited by the diameter of the focused beam, 
which is related to the voltage used to generate the electron beams. Higher voltage 
operation results in a smaller spot and better resolution, but this can also lead to an 
increase in heat generation and radiation damage. Both of these factors can cause 
sample damage. In addition to these limitations, non-conducting samples may need 
to be gold coated prior to analysis [111].  
It should be noted that the majority of electron microscopy techniques require 
the analysis of a sample to be carried out in a vacuum. This, therefore, precludes 
these techniques for the in situ  study of wet samples, such as crystals in their growth 
media.  
However, the more recent development of environmental SEM (ESEM) has 
enabled the application of these techniques to biological and wet samples [112, 113]. 
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This technique allows the investigation of samples in their natural state, under 
environmental conditions. Magnifications of up to 50,000X, with a resolution of 10 
nm, are possible in such environments. ESEM operates without coating the sample, 
and is non-destructive. It is thought that ESEM may facilitate the examination of 
swelling, dissolution, and growth of pharmaceutical compounds. 
Electron microscopy techniques have been utilized to determine the growth 
mechanisms of crystals, such as calcite [114] and lysozyme [93], and have also been 
applied to characterize the aggregation properties of nanoparticulate drugs [115], and 
the stability of crystalline drugs [116, 117]. 
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Figure 1. 2 Schematic illustration of a scanning electron microscope [105].  
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1.5.3.3 Interferometry. 
 
In interferometers, an illuminating coherent light beam is split into two beams, one of 
which is reflected by a mirror, and the other is reflected by the sample. The reflected 
beams recombine in a detector and interfere with each other. The basic set-up of an 
interferometer is shown in Figure 1. 3. The resulting interferometric patterns provide 
topographic information on a growing crystal surface [97]. 
 This technique allows the acquisition of growth data by exploiting the light 
interference phenomena which take place on a flat or curved mirror-like surface. If a 
flat, dislocation-free face is observed, the interference patterns will be parallel,  
straight fringes. In contrast, a growth hillock developing on such an atomically flat 
face will produce concentric interference fringes. Each of these fringes passes 
through points located at the same height from a reference single plane, and plays the 
role of a contour line on a topographic map. This allows the gradient of the surface, 
p, to be measured.  
During growth, the concentric fringes increase in size, spreading outwards 
from the hillock centre. The tangential velocity, v, of the growing hillock is the 
frequency at which the fringes are passing through a given point on the pattern. 
Movement of the fringes gives additional information about the normal growth rate, 
R, which can be calculated using the equation: 
   v = R/p     Equation 1.1 
Such microtopographic observations can reveal the growth mechanisms and 
kinetics of crystal faces under a variety of growth conditions. Interferometric studies 
have been performed on paracetamol crystals to probe the growth kinetics, crystal 
defects, solvent-crystal interactions, and the influence of additives [27, 37, 96]. 
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Figure 1. 3 A diagram illustrating the basic set-up of an interferometer. A beam of 
laser light is sent to a beam splitter, where it is split into two separate beams. One of 
the beams is focused on a mirror (green arrows), and the other is focused on the 
sample (blue arrows). The direction of the beams are indicated by the coloured 
arrows. The reflected beams from both the mirror and the sample are transmitted to 
the detector, where they recombine and interfere with each other. These interference 
patterns reveal information about the sample surface. Adapted from [97]. 
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The above techniques evidently have drawbacks. Both optical and electron 
microscopies have limited resolution, and electron microscopy techniques, with the 
exception of ESEM, must be performed in a vacuum. Interferometry also possesses 
limited x and y resolution and, although it allows the analysis of crystal growth in 
solution, it does not enable the direct observation of the growing features on crystal 
surfaces. 
Over the past decade, a powerful technique, known as Atomic Force 
Microscopy or AFM, has come to the fore in the study of crystals and their growth, 
and has considerably advanced our appreciation of their detailed physical properties. 
In contrast to the above techniques, AFM allows the direct observation of crystal 
surfaces in solution, at near molecular resolution. A description of the principles of 
this technique, and its now almost ubiquitous use in the study of crystal growth, are 
presented below. 
 
1.6 Atomic Force Microscopy. 
 
Since its inception, atomic force microscopy (AFM) has established itself as a 
leading technique in the nanoscale investigation of mechanisms and rates of crystal 
growth. It was first reported, in 1986, to image material surfaces with high resolution 
in aqueous solutions, thus enabling the study of a wide range of solid-liquid 
interfaces [118].  
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1.6.1 The principles and methodology of AFM. 
 
The theory behind AFM and its methodology are well documented [119-126] and, 
hence, shall be only briefly described here. Most modern instruments can be operated 
in both contact and tapping mode. Contact mode has been used throughout the 
experiments described in this thesis, and hence will be focused upon in this section.  
In contact mode, an AFM probe, typically made of silicon nitride, is  
impressed on the surface of interest and then raster scanned over the surface. The 
AFM probe is a sharp stylus, analogous to a minute record player needle, which has a 
tip of radius approximately 5 - 40 nm. Probes which incorporate carbon nanotubes as  
their tips, and thus are much sharper than conventional tips, are currently under 
development [127]. The probe is mounted at the end of a short, flexible cantilever, 
typically 100  250 µm in length, and having a low spring constant (< 1 Nm-1) to 
minimize the force between the sample during imaging [127].  
Scanning is performed by translating the probe over the sample along a 
continuous sequence of raster lines. As the probe tip passes over the surface, it 
interacts, through aggregate atomic forces, with the structural features on the surface. 
These interactions cause the probe to be deflected. These extremely small deflections 
are amplified by the deflections of a laser beam, which is reflected from the upper 
side of the cantilever. These deflections are subsequently detected by a position-
sensitive split photodiode. Photoelectric circuitry converts the laser beam deflections 
into height information [118]. The resulting data, recorded as a topological image, 
can then be presented in a number of visual forms [127]. A diagram depicting the 
experimental set-up of AFM is shown in Figure 1. 4. 
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Figure 1. 4 Diagram a) depicts the experimental set-up of AFM. A sharp probe 
attached to a flexible cantilever is scanned across a sample surface. Any deflections 
of the cantilever, induced by the structural features of the sample, are amplified by 
the laser beam which is reflected from the upper side of the cantilever. The reflected 
laser beams are detected by a photodiode, and converted by the circuitry of 
instrument into a topographical image of the sample surface. b) shows an SEM 
image of an AFM probe [128]. 
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AFM can be operated in both height and deflection modes. In the former, a 
feedback mechanism raises and lowers the tip, and maintains the cantilever 
deflection at a nearly constant level. The system monitors the piezo height and 
produces a corresponding image. In deflection mode, the piezo remains stationary 
and the actual cantilever deflection data are recorded [127].  
When the AFM is operated in height mode, quantitatively accurate 
information on the surface morphology is obtained. The deflection mode of 
operation can be particularly useful for imaging surface features which vary widely 
in height over the field of observation [127]. Indeed, some of the images depicted in 
the forthcoming chapters are shown as deflection images, as their features can vary 
from a few nanometres to hundreds of nanometres in height.  
 In contact mode, AFM probes can exert a significant amount of pressure on 
the surface of a sample. The quality of an image depends on the degree of force 
exerted by the tip on the surface. The greater the force between the tip and the 
surface, the more sensitive the probe is to variations in height [127]. Conversely, too 
large a force can perturb or damage a sample surface. Although this may not be a 
severe limitation for robust materials such as crystals, it must be a major 
consideration when imaging relatively soft biological materials. 
 The development of tapping mode has overcome some of the problems which 
arise through unfavourable probe-surface interactions. During tapping mode, the 
probe is in intermittent contact with the sample surface, that is, it oscillates up and 
down as it is scanned over the surface, essentially tapping its way across the 
surface. The vertical position of the probe is continually adjusted by the feedback 
mechanism in order to maintain its amplitude. Tapping mode, thus, minimizes the 
contact between the probe and the sample surface, and greatly reduces lateral forces. 
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This technique has allowed the visualization of materials which would otherwise be 
too fragile to tolerate contact mode imaging [129-133]. 
 
1.6.2 Advantages of AFM over conventional techniques. 
 
 AFM can yield images of crystal surfaces having exceptional clarity and detail. Scan 
fields range in size from less than 20 nm to around 150 µm, with a lateral resolution 
of around 1 nm, and a vertical resolution of 0.1 nm. Thus, it provides precise visual 
detail over a size range that exceeds most other techniques [127]. Its application 
extends over the range lying between individual macromolecules, which are 
accessible by X-ray crystallography, macromolecular assemblies amenable to 
electron microscopy, and living cells, which can just be seen using optical 
microscopy [120, 123].  
As AFM has the capacity to image in a liquid environment, samples do not 
undergo dehydration, as is generally the case with electron microscopy [127], and 
capillary forces between the tip and sample are eliminated. In addition, no fixing or 
staining is required, and the image contrast depends only on the relative height of the 
features in the image. 
 The benefits of AFM lie not only in its imaging capability, but also in the 
non-perturbing nature of the probe on interaction with the sample surface [127]. As 
the sample is virtually unaware of the presence of the probe, process such as  
dissolution and growth appear to be minimally affected [134]. Thus, a sequence of 
consecutive images allows the visualization of steps dissolving or growing on a 
crystal surface, and kinetic information to be obtained.  
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1.6.3 The application of AFM to the study of crystal growth. 
 
AFM was first introduced to the field of crystal growth by Durbin and Carlson in 
1992 [135], who observed the growth of steps on the surface of lysozyme crystals in 
mother liquor. Its subsequent application has substantially changed the way we view 
protein, virus, and simple molecular crystals [127]. A vast number of researchers  
have taken advantage of AFM to investigate the mechanisms of crystal growth. 
Crystalline materials whose growth has been probed using AFM range from 
inorganic systems, such as calcite [136, 137], potassium sulphate [138, 139], and 
potassium hydrogen phthalate [140], to complex macromolecules, such as insulin 
[130], lysozyme [38, 135, 141, 142], canavalin [143-145], catalase [141, 144], 
hydroxyapatite [146-148], and amylase [149].  
 An excellent review of the applications of AFM to the visualization of crystal 
growth is given by McPherson et al. [127].  
AFM allows crystals to be observed over long periods (hours to days). Hence, 
it is possible to obtain precise quantitative measures of the kinetic parameters of 
growth to supplement the topographical data obtained through imaging [127].  
In addition to exposing the crystallization process to direct visualization, 
AFM has provided an insight into many of the complex phenomena on which 
crystallization relies. It has increased the emphasis on the importance of impurities 
and their consequences [150], provided new information on defect structures [150], 
and revealed some of the mechanisms which regulate crystal growth [151]. In the 
case of protein crystals, these are all factors which affect their ultimate resolution and 
diffraction quality [36, 127, 130]. Similarly, these factors may affect the purity, 
morphology, and stability of drug crystals.  
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Although the growth of drug crystals, such as sulphathiazole [62, 90], 
methylprednisolone [90], ibuprofen [45] and paracetamol [24, 27, 37, 96, 97] have 
been investigated previously using traditional imaging techniques, such as 
interferometry and optical microscopy, this has not been achieved through the use of 
the AFM.  
As previously mentioned, the optimization of drug crystallization would be 
aided significantly by the direct, real-time visualization of nucleation and growth, 
particularly with regard to observing critical nucleation events, identifying 
polymorphs, and examining the role of factors such as the recrystallizing solvent, 
supersaturation, and impurities on growth. These needs  have prompted us to study 
the nucleation and growth of drug crystals using in situ AFM. 
We also wish to further assess the capabilities of AFM to follow dynamic 
events on crystal surfaces, in particular, structural transformations. For this we have 
used crystalline compounds known as co-ordination polymers, which undergo anion 
exchange when in a solution of non-host anions. This anion exchange process is 
accompanied by a significant structural transformation within the crystal. Significant 
controversy currently surrounds the mechanism by which this anion exchange 
process, and its consequent structural transformation, occurs. One theory suggests 
that the process is solvent-mediated, whereas another hypothesizes that a solid-state 
transformation takes place. To date, there have been no detailed microscopic 
investigations of the anion exchange reactions of co-ordination polymers. We are 
optimistic that AFM will provide an insight into the true mechanism occurring 
during this process, and that these studies may pave the way for future investigations 
on drug crystal transformations. 
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1.7 Aims of the project. 
 
The importance of crystallization processes to the pharmaceutical industry is, 
evidently, profound. However, despite the significant role that crystallization plays in 
the manufacture of drug compounds, process control, and determination of solid 
phase outcome, crystallization phenomena are often neglected and are, hence, poorly 
understood. In this project we, therefore, apply AFM to the investigation of 
nucleation and growth mechanisms of drug crystals. 
In Chapter 2, AFM is employed to probe the growth on the (001) face of 
aspirin crystals at two levels of supersaturation, to assess whether the mode of 
growth changes with increasing supersaturation, or the kinetics of growth simply 
increase with supersaturation. Aspirin has been chosen for these initial studies as it 
has previously been imaged using AFM (its dissolution and molecular structure have 
been probed using AFM). 
In Chapter 3, we investigate the nucleation and early stages of crystal growth 
by nucleating aspirin crystals on various self-assembled monolayer (SAM) surfaces. 
Recent findings have demonstrated the superiority of SAMs over other surfaces, such 
as Langmuir monolayers and functionalized polymer interfaces, in promoting 
nucleation and growth of oriented crystals in predetermined areas. Microcontact 
printing is used to pattern aspirin-binding and non-binding SAMs onto gold surfaces. 
The resulting templates are used to study the nucleation and fundamental growth 
mechanisms of aspirin crystals. AFM and SEM are utilized throughout to visualize 
and quantify these processes. 
The studies detailed in Chapter 4 focus on the effects of impurity molecules  
on the morphology and growth of paracetamol crystals. We investigate the 
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morphology and kinetics of growth on the (001) face of paracetamol crystals in the 
presence and absence of two of its known structurally related additives, namely 
acetanilide and metacetamol. The influence of acetanilide and metacetamol on the 
morphology and growth of entire paracetamol crystals has previously been studied. 
However, there have been no investigations into the effects of these additives on the 
growth of individual faces of paracetamol crystals. In this chapter, we utilize both 
AFM and SEM to characterize the morphology of pure paracetamol crystals and 
those crystallized in the presence of an additive. In addition, we employ AFM to 
envisage and quantify the effects of these additives on growth on the crystal surface. 
Finally, we employ AFM to probe the anion exchange mechanisms of two 
crystalline co-ordination polymers, namely {[Ag(4,4-bipy)]BF4}f and {[Ag(4,4-
bipy)]NO3}f, in Chapter 5. As previously mentioned, there is, currently, significant 
controversy surrounding the mechanism by which this anion exchange process, and 
its consequent structural transformation, occurs. The acquisition of in situ  AFM data 
may reveal the true mechanism occurring during this process. 
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Chapter 
2 
 
An in situ study of the effects of supersaturation on 
aspirin crystal growth. 
 
 
 
AFM has been extensively used in the investigation of growth of a plethora of 
crystalline compounds. However, to date, it has not been used to probe the growth 
dynamics of any pharmaceutical drug crystal. In this chapter, we use AFM to assess 
the mechanisms and kinetics of growth on the (001) face of aspirin crystals at two 
levels of supersaturation. Supersaturation is known to have profound effects on both 
the morphology and, at the molecular level, the growth mechanisms of crystals. We 
envisage that these experiments will pave the way for future studies on the other 
parameters which affect drug crystal growth, such as temperature, pH, and impurity 
concentration. Such studies would provide essential, fundamental information, to the 
pharmaceutical industry on the growth of drug compounds, and would facilitate the 
optimization of drug crystallization. 
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2.1 Introduction 
 
2.1.1 The effects of supersaturation on crystal growth. 
 
Significant uncertainty still remains over many fundamental aspects of 
crystallization, including the evolution and activity of growth modes  as a function of 
supersaturation, the effect of defects on nucleation and step motion and, perhaps 
most importantly, the pathway by which ions or molecules leave the solution and 
become units within the crystal lattice [143]. Increased understanding of these events 
would potentially lead to a greater degree of control over the rate of crystallization, 
resulting crystal size, habit, and polymorphic form. 
As highlighted in Chapter 1, supersaturation (ı) can have a profound affect 
on crystal growth, resulting in morphological changes in the crystallizing compound 
over a range of supersaturations [24, 27, 29, 36-38]. Supersaturation induces these 
effects by altering the modes of growth on the faces of crystals, as a function of the ı 
of the growth medium [143, 145, 152].  
There are three main mechanisms by which growth can occur on a crystal 
surface, each of which may be favoured within a particular ı range. These are: 
i) The Dislocation mechanism, 
ii) Two-dimensional (2D) nucleation, and 
iii) Three-dimensional (3D) nucleation. 
The ı ranges over which each of these modes of growth are prevalent are specific to 
individual compounds, however, in general, the dislocation mechanism is favoured at 
low ı, with 2D and 3D nucleation favoured at moderate and high ı respectively 
[152, 153]. Low ı is defined as the concentration of the solute just above its 
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solubility in the solvent; i.e. slightly above equilibrium. High ı is defined as the 
concentration slightly below that which allows the formation of visible microcrystals 
in the growth medium. The three modes of growth are described and illustrated in the 
following sections. 
 
2.1.2 The dislocation mechanism of growth. 
 
A dislocation on the crystal surface results from stresses which occur during crystal 
growth. These induce sections of the crystal to become misaligned with respect to 
their neighbouring areas [1, 98]. The origin of a dislocation and the growth pattern 
which emerges from it are illustrated in Figure 2. 1. The arrows shown on Figure 2. 
1a) represent the displacement of the two sections of the crystal. As a result, a ledge 
is formed onto which molecules can absorb and continue growth. However, as the 
ledge is of non-uniform height, growth occurs in a spiral pattern around the 
dislocation, and the growth mechanism is often referred to as screw dislocation [98, 
103]. The features which arise from growth around such a dislocation are growth 
hillocks, illustrated in Figure 2. 1b) and c). A screw dislocation hillock is shown 
from above and from the side, with the corresponding layers indicated by dashed red 
lines. Dislocations may be simple or complex in nature, that is, they may consist of 
only one misaligned section, or may be composed of a series of dislocation sites 
within the same area. When two or more dislocations emerge onto a crystal face in 
close proximity, the resulting spirals may co-operate to produce a step source with an 
activity greater than that of a single dislocation spiral [98]. For such co-operation to 
take place, the separation of the spiral centres must be less than half of the step 
spacing of an isolated spiral. In these instances, dislocations grow around each other, 
 -  - 53
Chapter 2 
leading to a more complex structure than that depicted in Figure 2. 1b) and c). More 
widely separated spirals exhibit an activity that is no greater than that of an isolated 
spiral [140]. The presence of simple or complex dislocations ensures the permanent 
existence of steps on the surface during growth [98]. As the steps grow away from 
their dislocation source, they progressively lose the curved appearance they 
possessed when they originated from the dislocation, becoming straighter and 
forming step trains [143]. 
This dislocation mechanism is favoured at low ı because the dislocations 
provide an inherent source for growth, and render it unnecessary to produce further 
growth sources, such as required for 2D and 3D nucleation, which are energetically 
more expensive.  
Growth via the dislocation mechanism has been observed, using AFM, at low 
ı on crystals of amylase [149], canavalin [143, 145, 154, 155], thaumatin [141], 
lysozyme [38, 141], xylanase [141], and tRNA [152].  
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a) 
 
b) 
c) 
 
Figure 2. 1 Diagram demonstrating the origin and growth of a dislocation. a) 
illustrates the displacement of the two sections of the crystal, indicated by the arrows. 
The resulting dislocation facilitates the attachment of molecules to the surface, and 
promotes a spiral growth pattern around the dislocation. The features which arise 
from such growth are hillocks, illustrated in b) and c). A dislocation hillock is shown 
from above (b) and from the side (c), with the corresponding layers indicated by 
dashed red lines. 
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2.1.3 2D nucleation. 
 
2D nucleation occurs when an island of molecules adsorb onto the crystal face, thus 
providing the basis  for a new crystalline layer. Attachment of further molecules to 
the newly formed step edges of the nucleus allows the new layer to spread across the 
entire crystal face [103]. It is clear that the formation of 2D nuclei on the surface of a 
crystal would require more energy than the simple attachment of molecules to 
existing growth sites, such as dislocations [103]. 2D nuclei can form at moderate ı 
because the greater concentration of solute in the growth medium induces a larger 
degree of solute-solute collisions and, therefore, solute-solute interactions. The 
formation of a two-dimensional layer of solute molecules is, thus, more feasible at 
moderate than at low ı. Hence, 2D nucleation typically occurs at higher ı values  
than dislocation facilitated growth, or on surfaces which lack dislocations.  
The first successful observation of dislocation-free growth from aqueous  
solution by Kuznetsov et al. [156] paved the way for studies on growth by 2D 
nucleation. These studies lead to the proposal of the model of multiple 2D nucleation 
[103]. This model suggests that 2D nuclei appear independently at various points on 
a crystal faces and, upon reaching each other, they merge to complete the next lattice 
layer on this face [103]. This process has been observed using AFM [135]. A 
diagram illustrating the formation and growth of 2D nuclei is shown in Figure 2. 2. 
Growth via 2D nucleation at moderate ı has been observed, using AFM, on 
crystals of amylase [149], canavalin [143], thaumatin [141], lysozyme [38, 141], 
catalase [141], xylanase [141], and tRNA [152]. 
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c) 
b) 
a) 
 
Figure 2. 2 Diagram illustrating the formation and growth of two-dimensional (2D) 
nuclei on a crystal face. In a) the 2D nuclei deposit onto the surface. Growth of these 
nuclei occurs via attachment of molecules to their edges, allowing them to spread 
across the face (b) and coalesce when they meet (c).  
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2.1.4 3D nucleation. 
 
3D nucleation is an unusual growth phenomenon, and one that appears to be unique 
to macromolecular protein and virus crystals [127]. At high ı, three-dimensional 
aggregates, composed of hundreds to thousands of molecules, form in the growth 
medium. These aggregates exhibit short-range order, maintained by non-specific 
hydrophobic interactions and random arrangements of hydrogen bonds [127, 144]. 
Upon sedimentation on the crystal surface, these aggregates develop in one of two 
ways. They either restructure immediately to form crystalline, multilayer stacks, 
known as 3D nuclei, or form faceted microcrystals on the surface of the crystal.  
The formation of 3D aggregates is analogous with that of 2D nuclei. As the 
concentration of solute molecules in the growth medium increases, the number of 
solute-solute collisions and interactions increases further. Therefore, at high ı values  
3D solute structures can form in solution and adsorb to crystal surfaces, providing 
potential 3D nuclei or microcrystals.  
Kuznetsov et al. [144] proposed that the degree of conformity between the 
underlying crystal surface and the depositing aggregate, is likely to be the 
determining factor in whether the aggregate develops as a 3D nucleus, or a 
microcrystal. In the former case, the conformations are virtually exact, so that bonds 
between the substrate crystal and the aggregate interface align in a periodic manner. 
The aggregate then becomes an ordered extension of the substrate crystal. In the case 
of microcrystal formation, the underlying crystal promotes the formation of a 
crystalline state in the aggregate, but there remains physical or mechanical 
discontinuity, or misalignment between the two. Hence, they do not grow as a single 
entity, but as two individuals.  
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3D nuclei restructure on crystal surfaces, forming plateaus with step bunches. 
3D nuclei grow epitaxially on the crystal, without introducing defects, and their step 
trains merge with those of the growing crystal, and other 3D nuclei [127, 141, 145]. 
Growth in the normal direction occurs due to the deposition of 2D nuclei on the 
terraces of the 3D nuclei [141].  
The deposition and growth of 3D nuclei on a surface are illustrated in Figure 
2. 3a). Growth via 3D nucleation at high ı has been observed, using AFM, on 
crystals of canavalin [143, 145, 157], tRNA [152], lysozyme [157], lipase [157], 
satellite tobacco mosaic virus (STMV) [151, 157-159] and thaumatin [157, 160]. 
The lack of continuity between the underlying crystal and the microcrystal 
results in it becoming incorporated into the growing crystal. The incorporation of 
microcrystals that have become embedded into the growing crystal surface, has been 
observed to generate defects such as complex dislocation sources, areas with 
misaligned lattices, and stacking faults [145]. All of these defects degrade the quality 
of the crystal, but provide sources for addition of further solute molecules, and 
growth on the surface. The deposition and incorporation of microcrystals are 
depicted in Figure 2. 3b). The incorporation of microcrystals into catalase [141, 161], 
lysozyme [38], and STMV crystals [159], at high ı, has been visualized using AFM. 
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i) i) 
 
iii) iii) 
2D nucleation 
ii) ii) 
Figure 2. 3 Diagrammatic illustration of the deposition of 3D aggregates on the 
surface of a crystal, their and development into 3D nuclei (a) or microcrystals (b). In 
a) i) the aggregate restructures immediately to form a crystalline, multilayer stack, 
known as a 3D nucleus. The layers of steps within the 3D nucleus grow tangentially 
(ii), and growth in the normal direction occurs due to the deposition of 2D nuclei on 
the terraces of the 3D nucleus (iii). In b) i) the aggregate is misoriented with respect 
to the underlying crystal, and hence forms a microcrystal. Its lack of congruence with 
the crystal renders it unable to grow on the surface, and it progressively becomes 
incorporated into the growing crystal, as shown in ii) and iii). 
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In general, an individual crystal does not grow exclusively by a single mechanism. It 
may employ different mechanisms on different crystal faces, and these may vary at 
different ı values [127]. Although the mechanisms of growth described in the 
preceding sections are typical at their respective ı, some compounds do not alter 
their growth mode with increasing ı. For example, the growth on the (001) face of 
K2Cr2O7 crystals occurs solely via the dislocation mechanism at all the ı values  
investigated [162]. Similarly, the growth of the (001) face of catalase crystals 
proceeds exclusively by 2D nucleation at all ı ranges [141], as does growth on the 
(110) face of lysozyme crystals [142]. 
Conversely, some crystals grow via more than one mechanism at a particular 
ı. This is the case for cadmium mercury thiocyanate crystals, upon which growth 
proceeds via the dislocation mechanism and 2D nucleation simultaneously [163]. 
 
2.1.5 Terrace-Ledge-Kink (TLK) model. 
 
All of the growth sources described above provide growth steps in either a 
continuous (dislocation mechanism) or discontinuous (2D and 3D nucleation) 
manner, and then proceed tangentially over the face of the crystal by addition of 
molecules to their step edges [127]. The attachment of molecules to each of these 
growth sources is hypothesized to occur via the Terrace-Ledge-Kink (TLK) model 
[98]. Although step edges may appear to be smooth, on an atomic scale they are 
blurred by thermal fluctuations, giving rise to kinks. The TLK model, which is 
illustrated in Figure 2. 4, proposes that a solute molecule (Į) adsorbs to the terrace 
regions of the crystal surface and migrates across the surface (ȕ) to the ledge of a 
step (Ȗ). Here it can occupy a vacant kink site (į) which exists in the ledge. The 
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subsequent adsorption, migration, and attachment of further solute molecules to 
crystal surfaces in this manner, facilitates the growth of steps across the terraces, and 
consequently the growth of the crystal faces. 
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Figure 2. 4 A schematic diagram of the Terrace-Ledge-Kink (TLK) model of crystal 
growth. In this model, a solute molecule adsorbs to the crystal terrace (adatom, Į) 
and migrates across the terrace (ȕ) to the ledge of a step (Ȗ). Here it can occupy a 
vacant kink site (į). The further addition of such adatoms to kink sites results in the 
progression of a step across a terrace. 
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As mentioned in Chapter 1, the growth of drug crystals such as sulphathiazole [62, 
90], methylprednisolone [90], ibuprofen [45] and paracetamol [24, 27, 37, 96, 97] 
have been investigated previously using traditional imaging techniques, for example, 
in situ interferometry and optical microscopy. The observation of drug crystal growth 
has not, to date, been achieved through the use of AFM. This technique has, 
however, been utilized to probe aspirin crystals in order to obtain molecular 
resolution images of their surfaces [164, 165], to identify specific faces [166], and to 
investigate the relative dissolution behaviour of its (100) and (001) faces [134].  
AFM has proved its capabilities in following the growth of many crystalline 
compounds [38, 130, 135-149] and has, in addition, revealed how their growth 
mechanisms and growth kinetics change as a function of ı [38, 143, 152]. In this 
chapter, we propose to use AFM to study the effects of ı on the growth of the (001) 
face of aspirin crystals. 
 
2.1.6 Aspirin: a brief history. 
 
Aspirin, the trade name for the compound acetylsalicylic acid, has roots which can be 
traced back to the fifth century B.C., when the Greek physician Hippocrates used a 
bitter powder obtained from the bark of willow trees to treat pain and fever [167]. 
The pain-relieving constituent of the willow bark was salicin, the parent of the 
salicylate drug family of which aspirin is the best known. The predecessor of aspirin 
was sodium salicylate, which was developed in 1875 and used as a general pain 
reliever. However, it had one serious side effect in that it induced severe stomach 
irritation. This made sodium salicylate intolerable to many patients, including the 
father of Bayer chemist Felix Hoffmann. In 1897, Hoffmann endeavoured to develop 
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a drug which would ease his fathers arthritis without causing such stomach 
discomfort. His search led him to synthesize acetylsalicylic acid, a compound which 
shares the therapeutic properties of sodium salicylate, but causes less irritation [168]. 
Acetylsalicylic acid was first synthesized by Bayer in 1897, and was given the name 
Aspirin in 1899 [169]. Needless to say, it quickly became the preferential pain 
reliever of physicians. 
Aspirin is a non-steroidal anti-inflammatory drug (NSAID) which is 
commonly used to alleviate headaches, muscle pain, arthritis, and fever. It is 
estimated that around 80 billion aspirin tablets are consumed in America every year 
[169]. In 1971, Vane [170] discovered the mechanisms underlying the therapeutic 
effects of aspirin. Vane found that aspirin interferes with the biosynthesis of 
prostaglandins, and in 1982, he was awarded the Nobel Prize in medicine in 
recognition of his work. The elucidation of the mode of action of aspirin paved the 
way for its use in the prevention of heart attacks and strokes.  
Aspirin was chosen for the current study because it is easily and reproducibly 
crystallized, its crystal structure is well characterized [44, 171-176], and it has  
previously been imaged using AFM [134, 164-166]. 
 
2.1.7 Aims of chapter. 
 
The modes of growth of drug crystals have, as yet, only been studied using the 
traditional imaging techniques of optical microscopy and interferometry. AFM has 
been widely applied to investigations into the effects of supersaturation on the 
growth of protein and virus crystals, as the growth of these substances is slower than 
that of molecular crystals, and, hence, is easier to observe. In this chapter we will use 
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AFM to probe the mechanisms of growth on the (001) face of aspirin crystals at two 
levels of ı. From these data, we will assess whether the growth mode changes with 
increasing supersaturation, as seen with tRNA [152] and canavalin [143, 145] 
crystals, or whether it remains the same, but the kinetics of growth increase, as 
observed with K2Cr2O7 [162], catalase [141], and lysozyme crystals [142].  
 
2.2 Methods and Materials 
 
2.2.1 Preparation of aspirin crystals and growth media. 
 
Aspirin crystals were prepared using the method described by Tawashi [177]. U.S.P. 
grade aspirin (Sigma Aldrich, Dorset, U.K.) was dissolved to saturation in 100ml of 
95 % ethanol (Sigma Aldrich, Dorset, U.K.). This solution was maintained at 37°C 
with a stirring rate of 238 rpm until all of the solute had dissolved. It was then slowly 
cooled over a period of hours to room temperature. Typically after 24 hours 
crystallization was complete and crystals were filtered, washed with cold ethanol, 
air-dried and stored in a desiccator. Crystals were immobilized on AFM sample 
stubs, and then onto a suitable liquid cell using Tempfix (Agar, Stansted, U.K.).  
Growth solutions were prepared by dissolving 0.054g and 0.057g of U.S.P. 
grade aspirin (Sigma Aldrich, Dorset, U.K.) in 10 ml HPLC grade water, which had 
been filtered once. These solutions were heated to approximately 40°C, with a 
stirring rate of 238 rpm, until all of the solute had dissolved. They were then allowed 
to cool to room temperature, before being placed in the AFM liquid cell with an 
aspirin crystal sample. Approximately 2.5 ml of supersaturated aspirin solution was 
 -  - 66
Chapter 2 
placed in the liquid cell as a growth medium in each experiment. The ı values of the 
solutions used as growth media were calculated using the following equation [7, 24, 
27, 29, 132, 142]:  
ı = ln (c/c0)      Equation 2.1 
where c0 is the concentration of aspirin in a saturated solution, i.e.  the solubility of 
aspirin at a given temperature, and c is the concentration of aspirin dissolved in the 
growth medium. All experiments were carried out at 23.5qC: the solubility of aspirin 
in water (c0) at this temperature is 0.022 mol. kg
-1 [178]. The ı values of the two 
growth media used were calculated as 0.31 and 0.36, respectively. These solutions 
were chosen as the growth media as they were in the range of ı values where growth 
occurred on the surface. Solutions with ı  0.15 were observed, with AFM, to induce 
dissolution on the surface of the crystals. Conversely, solutions of ı  0.48 allowed 
the formation of visible microcrystals in the growth medium. Thus, at this ı, the 
nucleation of new crystals was more favourable than growth on the existing crystal. 
Similar observations have been made during studies on paracetamol crystal growth 
[37].  
 
2.2.2 AFM analysis. 
 
Contact mode imaging was employed throughout, using a ThermoMicroscopes 
Explorer AFM (Veeco, Bicester, Oxon, U.K.). V-shaped silicon nitride cantilevers  
(200µm length) with integrated pyramidal tips (Nanoprobes, Veeco, Santa Barbara, 
CA) and spring constant ranging from k = 0.01  0.064 Nm-1 were used. When 
scanning, care was taken to continually adjust the set point voltage to the lowest 
value for which tip-crystal contact could be maintained, in order to minimize the 
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force applied to the crystal surface. The utilization of minimal force has allowed the 
crystal surfaces of various compounds to be imaged during growth without 
degradation of their growing steps [135, 143, 145]. 
The speed of acquisition of the images was determined by the rate of change 
of the features on the crystal surface. The employed scan rate was typically 10 Hz. 
Both topography and deflection images were acquired in all experiments. The 
topography images are a result of the deflections of the laser beam, and thus the 
cantilever, upon interaction with the underlying sample surface. These deflections 
are converted, by the photoelectric circuitry of the instrument, into height data. 
Deflection images emphasize areas of rapid topography changes, such as steps, but 
do not give any information about relative heights of features on the surface.  
A video clip of growth in a ı =  0.36 solution, composed of over one hundred 
AFM topography images, was compiled using Take One software (Rainer Doele, 
Tuttlingen, Germany) and is available on the attached disk.  
The possibility of instrumental drift during or between scans was considered. 
An AFM calibration grid (Veeco, Bicester, Oxon, U.K.) was imaged sequentially, in 
HPLC grade water, at the same scan rates as those used in each experimental set up. 
The grid was composed of SiO2 raised features on a silicon surface. The grid was  
affixed to an AFM sample stub, and then onto a suitable liquid cell using Tempfix 
(Agar, Stansted, U.K.). A typical image of the AFM calibration grid is shown in 
Figure 2. 5. The dimensions of the repeating components within the calibration grid 
are 2.4 µm x 1.5 µm. We utilized the software available on the AFM, which allowed 
each image to be subtracted from the previous image in the sequence, to assess 
whether any drifting had occurred during scanning. Our measurements on the 
subtracted images indicated that negligible drift occurred in both x and y directions.  
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The steps observed in the image sequences seldom grew in the x or y 
directions and, therefore, trigonometry had to be used in order to calculate the actual 
distance moved by the step in the time period between images. Figure 2. 6 is a 
schematic illustration of the method used to calculate the growth rate of a step. If we 
consider the growth of a step, within a certain time period, as  the movement from 
point A0 to the point A1, then the actual distance moved by the step is a nm. By 
measuring the horizontal distance moved by the step, x, a can be calculated using the 
equation: 
a  =  x / cosș      Equation 2.2 
As the time of acquisition of each image was known, the rate of growth of steps 
could be calculated in nm/s. 
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5 µm 
 
Figure 2. 5 A typical 20 µm x 20 µm AFM topography image of the calibration grid 
used to assess the extent of instrumental drift occurring during imaging.   
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A1 
A0 
ș 
Distance grown by step = a 
cosș = x / a 
therefore, a = x / cosș   
Direction of growth 
 
Figure 2. 6 A schematic illustration of the method used to calculate the growth rate 
of steps. The point A0 on the dashed line is the initial position of the growing step, 
and A1 on the solid line is the final position of the growing step over a certain time 
period. The actual distance moved by the step is a nm. Both x and ș can be measured 
directly and, hence, a can be deduced from the equation above. 
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2.3 Results and Discussion 
 
2.3.1 Growth on the (001) face at ı = 0.31. 
  
A diagrammatic representation of a single aspirin crystal which has been 
recrystallized from a saturated ethanolic solution is displayed in Figure 2. 7. The 
Miller indices are depicted on each face, the most prominent of these is the (001) 
face upon which all experiments are carried out. Typical images of this face exposed 
to a solution with ı = 0.31 are shown in Figure 2. 8.  The actual number of 
experiments from which this data is calculated is six. This sequence of images  
displays the movement of steps, varying from 1 nm in height, which corresponds to 
the unit cell height of aspirin of 1.14 nm [172], to macrosteps which are 85 nm in 
height. The development of macrosteps occurs as the growing steps merge. As the 
distance from the growth centre increases, the height and mutual separation of the 
macrosteps is known to increase [162]. On K2Cr2O7 crystals, steps which had 
originated at dislocations were observed to exceed hundreds of nanometres in height 
[162]. 
  The speed of acquisition of the images is determined by the rate of change of 
the features on the crystal surface. In this instance, the raster image time is  
approximately 87 secs. The time of acquisition of each image is indicated in the 
figure legend. The growth of one particular step across the surface is indicated by a 
black arrow on each image in Figure 2. 8. Growth occurs predominantly in the [100] 
direction, with negligible growth occurring in the [010] direction. The observed steps 
have growth rates ranging from 4.6 nm/s  10.8 nm/s, with an average of 7.2 nm/s, 
and show no correlation between step height and growth rate. This lack of 
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congruency between step height and growth rate has also been observed on 
hydroxyapatite crystals [146]. The mode of growth of steps at this level of ı follows 
that of the dislocation mechanism. Although the dislocation centre is not visible, the 
steps are rounded in appearance, indicating that they have spiralled around a 
dislocation source. 
 It is important to note that aspirin can undergo ester hydrolysis to salicylic 
acid and acetic acid [134, 179] as shown in Figure 2. 9, and that these impurities may 
potentially influence the growth mechanisms or kinetics of the aspirin crystal. The 
molecular structure of the growing face is illustrated in Figure 3. 15 and indicates 
that the ester group of the aspirin molecule is exposed at the (001) surface. The 
expression of the ester groups at the surface provides a potentially reactive site for 
hydrolysis by the growth medium. The lack of correlation between the height and 
velocity of the growing steps may indicate that acid catalysed hydrolysis is 
occurring. However, the pH of the growth solutions used here is approximately 2. 
Figure 2. 10 illustrates the dependence of the rate of aspirin hydrolysis on pH, at 
17°C [180]. From Figure 2. 10, it is evident that the rate constant (k) for the 
hydrolysis of aspirin at this pH is merely 0.05 day -1 [180]. Although our experiments 
are carried out at 25°C, we assume that a similarly low rate of hydrolysis occurs. In 
addition, growth solutions are freshly prepared immediately prior to each 
experiment, and crystal samples are exposed to the growth media for a matter of 
hours, thus reducing the potential for hydrolysis to take place. It is therefore unlikely 
that the trace amounts of the products of hydrolysis, salicylic acid and acetic acid, 
would have a significant effect on the growth mechanisms and kinetics observed in 
these experiments.   
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Figure 2. 7 A diagrammatic representation of an aspirin crystal recrystallized from a 
saturated ethanolic solution. The respective Miller indices are depicted on each face 
Adapted from [44].  
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[010] 
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f) e) 
c) b) a) 
d) 
Figure 2. 8 A sequence of 10 µm x 10 µm AFM images of the (001) face of an 
aspirin crystal during incubation in a solution of supersaturation 0.31. In image a) 
time t = 0 secs, b) t = 102 secs, c) t = 188 secs, d) t = 275 secs, e) t = 361 secs, and f) 
t = 448 secs. All images are deflection images. 
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Figure 2. 9 A schematic illustration of the ester hydrolysis of aspirin. 
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Figure 2. 10 A graph illustrating the dependence of the rate (k day -1) of aspirin 
hydrolysis on pH, at 17°C. Adapted from [180]. 
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Growth via other phenomena, such as 2-dimensional or 3-dimensional nucleation, 
was not observed. However, growth via these methods has been observed only at 
much higher ı on canavalin [145], catalase [161], and thaumatin [160] crystals, and 
therefore the presence of such growth modes for aspirin at higher levels of ı cannot 
be dismissed. 
 
2.3.2 Growth on the (001) face at ı = 0.36. 
 
Figure 2. 11 shows a series of images of the (001) face exposed to a solution with ı = 
0.36. Growth on the crystal surface occurs implicitly via the dislocation mechanism. 
Again no 2D or 3D nuclei are evident, and the dislocation source is not visible in any 
of the images. The morphology of the steps is different to those observed in Figure 2. 
8, which appear rounded. The growing steps visible in Figure 2. 11 are straighter, 
which may infer that they are a greater distance from the source of the dislocation, 
and may thus have formed step trains [143]. The fact that 2D nuclei were not 
observed indicates that the ı = 0.36 solution does not provide enough driving force 
to create 2D islands. This infers that the steps on the surface must emanate from 
dislocation sources and, thus, the dislocations supply all of the new steps on the 
crystal face. 
From the sequence of images in Figure 2. 11, it is apparent that the steps 
grow in both [100] and [010] directions. The growth of two steps, one in the [100] 
and one in the [010] direction, are indicated by a black and a white arrow on the 
images. A video clip, composed of sequential AFM topography images of growth in 
this medium, is available on the attached disk in the file asp_crys.avi. It should be 
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noted that there is no evidence of 2D or 3D nuclei in any of the images which 
comprise the video. 
The steps growing in the [100] direction vary in height from 1 nm to 315 nm, 
and grow at rates ranging from 17.4 nm/s to 34.5 nm/s, showing no correlation 
between step height and growth rate. The average growth rate of these steps is 25.7 
nm/s. The steps which advance in the [010] direction ranging height from 1 nm to 
365 nm, and their growth rates range from 6.0 nm/s to 17.0 nm/s. Again, there is no 
correlation between step height and growth rate, and the average growth rate of the 
steps is 10.7 nm/s.   
  From these data, it is clear that, as ı increases, there is a concurrent increase 
in both the heights and growth rates of steps growing in the [100] direction. Such 
observations have been noted using AFM, as a function of ı, for other crystals 
including lysozyme [38, 142], thaumatin [181], K2Cr2O7 [162], hydroxyapatite [148], 
canavalin [143], and appoferritin [132], and are consistent with theoretical 
implications [103].  
The proposed reason for the observation of larger macrosteps at higher ı is as  
follows. As steps grow, fluctuations in the local temperature or ı can alter their 
growth rate. This leads to the non-uniform growth of steps. As a result, faster-
growing steps merge with slower-growing steps, thus increasing the height of the 
cumulative step. This process is commonly referred to as step bunching. As the step 
height increases, the diffusion fields which surround the individual steps within the 
bunch overlap [103, 143, 182-187]. A greater degree of step bunching leads to a 
more complete overlap of the diffusion fields and, thus, lowers the ı in the direct 
vicinity of the step bunch. This, in turn, decreases the growth rate of the complete 
macrostep [103]. It has been established that the growth rate of steps increases with ı 
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[38, 142, 143, 148, 153, 162, 181] and, hence, more steps bunch per unit time at 
higher ı than at lower ı. As a result, larger macrosteps are formed at higher ı. 
The average growth rate of steps in the [100] direction at ı = 0.31 and ı =  
0.36 is calculated as 7.2 nm/s and 25.7 nm/s respectively. Therefore, at ı = 0.36, the 
growth rate of the steps is a factor of 3.6 times higher than at ı = 0.31, irrespective of 
the larger macrosteps observed at ı = 0.36. 
In addition, this increase in ı from 0.31 to 0.36 promotes the growth of 
monomolecular and macrosteps in the [010] direction. However, the growth rates of 
steps in each direction are not comparable, that is, they are anisotropic. Step 
anisotropy has previously been observed on crystals of thaumatin, catalase, 
lysozyme, xylanase [141], and potassium hydrogen phthalate [140], and was shown 
to depend on ı [141]. Under identical ı conditions, the growth rates of steps on 
thaumatin and catalase crystals were shown to vary up to five fold [141]. It is 
probable that the step anisotropy arises due to the difference in molecular structure of 
the steps advancing in different crystallographic directions [93, 135, 141]. 
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Figure 2. 11 A sequence of 20 µm x 20 µm AFM images of the (001) face of an 
aspirin crystal during incubation in a solution of supersaturation 0.36. In image a) 
time t = 0 secs, b) t = 288 secs, c) t = 576 secs, d) t = 864 secs, e) t = 1152 secs, and 
f) t = 1440 secs. All images are deflection images. 
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These data may suggest that growth on the (001) face of aspirin crystals occurs 
solely via the dislocation mechanism at all values of ı. Similar observations have 
been made using AFM on the (001) face of K2Cr2O7 crystals [162]. However, as 
dissolution was observed at ı d 0.15, and at ı  0.48 microcrystals were visible in 
the growth medium, the range of ı values over which growth on the surface occurs is  
relatively narrow. The two ı values investigated in this chapter are, according to this 
range, moderate to high. As the dislocation mechanism is the most energetically 
favourable at low ı, due to the fact that they provide an intrinsic source of growth 
steps, we assume that at ı values lower than those studied here, growth would again 
progress via the dislocation mechanism. 
It is therefore necessary to conduct similar experiments on the crystal face at 
higher ı to assess whether 2D or 3D nucleation become the prevalent growth 
mechanism at any level of ı.     
It would also be beneficial to carry out experiments on the other faces of 
aspirin crystals. The (001) face is the largest of the crystal faces and, hence, it has the 
slowest growth rate. Therefore, at the ı values used here, alternative growth 
mechanisms could be taking place [127], allowing the remaining faces to advance 
faster.  
 
2.4 Conclusion 
 
We have used AFM to directly visualize, in situ, the mechanisms of growth which 
occurred on the (001) face of aspirin crystals at two levels of ı. AFM also allowed 
the acquisition of kinetic information at each ı. Although AFM has previously been 
used to probe the molecular structure of aspirin crystals, neither the growth dynamics 
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of aspirin nor that of any other pharmaceutical drug crystal have been investigated 
using this technique. 
 Surface features were monitored in solutions with ı = 0.31 and ı = 0.36. At 
both ı values, the mechanism of growth observed was consistent with that of the 
dislocation mechanism. Other growth modes, such as 2-dimensional or 3-
dimensional nucleation, were not observed. However, it is thought that 3D nucleation 
is unique to macromolecular protein and virus crystals [127]. At ı = 0.31, the step 
heights ranged from 1 nm to 85 nm. The rate of growth of steps ranged from 4.6 
nm/s to 10.8 nm/s, and showed no correlation between step height and growth rate. 
All steps were observed to grow in the [100] direction. 
 At ı = 0.36, the steps growing in the [100] direction varied in height from 1 
nm to 315 nm, and grew at rates ranging from 17.4 nm/s to 34.5 nm/s. Again there 
was no relation between step height and growth rate. The average growth rate of 
steps in the [100] direction at ı = 0.31 and ı = 0.36 was calculated as 7.2 nm/s and 
25.7 nm/s respectively. Therefore, at ı = 0.36, the growth rate of the steps was a 
factor of 3.6 times higher than at ı = 0.31, irrespective of the larger macrosteps 
observed at ı = 0.36.  
At ı = 0.36, growth was also initiated in the [010] direction, with steps 
ranging in height from 1 nm to 365 nm. In this direction the growth rates ranged 
from 6.0 nm/s to 17.0 nm/s, with no relation between step height and growth rate. 
However, the growth rates of steps in the [100] and [010] direction are not 
comparable, that is, they are anisotropic. It is probable that the step anisotropy arises 
due to the difference in molecular structure of the steps advancing in different 
crystallographic directions [93, 135, 141]. 
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These data may suggest that growth on the (001) face of aspirin crystals 
occurs solely via the dislocation mechanism at all values of ı. However, as  
dissolution was observed at ı d 0.15, and at ı  0.48 microcrystals were visible in 
the growth medium, the range of ı values over which growth on the surface occurs is  
narrow. Hence, the two ı values investigated in this chapter were moderate to high. 
As the dislocation mechanism is the most energetically favourable at low ı, we 
assume that at ı values lower than those studied here, growth would again progress 
via the dislocation mechanism. It is therefore necessary to conduct similar 
experiments on the (001) crystal face at higher ı to assess whether 2D or 3D 
nucleation occur at any level of ı.  
The (001) face is the most prominent, and therefore the slowest growing, face 
of the crystal. It would, hence, be of great interest to carry out such experiments on 
the remaining faces of the crystal, as the faster growing faces may employ other 
modes of growth at these levels of ı.  
  These results reiterate the capability of AFM to monitor dynamic events at 
the nanoscale, such as in situ growth on crystal faces, and can be used to deduce the 
mechanisms and rates as a function of ı. Similar experiments could be conducted on 
crystalline drugs varying not only the ı, but also other parameters which affect 
crystal growth, such as temperature, pH, or impurity concentration of the growth 
medium.  
This study emphasizes the fact AFM can provide essential fundamental 
information on the growth of drug compounds to the pharmaceutical industry. Such 
knowledge may facilitate the optimization of crystallization parameters of these 
compounds. 
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Chapter 
3 
 
Using self-assembled monolayers to investigate the 
nucleation and growth kinetics of aspirin crystals. 
 
In recent years self-assembled monolayers (SAMs) have proved their ability to 
promote and control the growth of crystals at interfaces. In this chapter, an 
assessment is made of the capability of SAMs to promote the growth of aspirin 
crystals. Microcontact printing of SAMs allowed face-selective nucleation, 
patterning of crystal growth into predetermined areas, and facilitated the observation 
of secondary nucleation. This technique enabled the fabrication of a large number of 
nucleation sites in controlled microenvironments. Hence, these experiments should 
allow the study of fundamental aspects of crystallization and may pave the way for 
future investigations into the parameters governing drug crystal growth, including the 
factors controlling polymorphism. 
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3.1 Introduction 
 
3.1.1 Overview of the current techniques used to promote and investigate 
crystallization. 
 
The significance of crystallization processes in the manufacture of drug compounds, 
during process control, and in the overall determination of the solid-phase outcome is  
unquestionable. However, crystallization phenomena are often neglected by the 
pharmaceutical industry until a problem, such as an undesired polymorph, emerges  
[7]. The overwhelming need to provide information on the crystallization process of 
drug molecules has been discussed extensively in Chapter 1. In particular, detailed 
knowledge of nucleation and fundamental growth mechanisms is essential in order to 
understand, predict, and potentially control crystallization.  
The successful control of nucleation and crystal growth is possible, assuming 
that all the required information on these processes is available. Research in this area 
has seen the exploration of a range of strategies which seek to control the nucleation 
and growth of crystals based on molecular recognition at interfaces [188]. These 
techniques promote heterogeneous nucleation, where nucleation and crystallization 
are initiated on a surface or interface of different composition to that of the 
crystallizing substance. The substrates used for these investigations vary from crystal 
surfaces to synthetically engineered templates. Organic crystal surfaces have been 
shown to control the nucleation and growth of small organic crystals and polymer 
crystals [12, 13], and to direct the nucleation of particular polymorphs [15, 17].  
In some of natures biomaterials, such as bone, macromolecules are used to 
control the nucleation and growth of crystalline phases and thus manipulate the 
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structure and physical properties of the resulting crystal [189-192]. Consequently, 
over the past twenty years a biomimetic approach to crystal engineering has been 
developed, employing synthetic substrates which exhibit specific functional groups 
at their surface. Substrates such as Langmuir monolayers [193, 194], surface-
adsorbed biological macromolecules [195-199], functionalized polymer surfaces 
[190, 200-203], and organic thin films [204] have successfully promoted oriented 
growth of inorganic and organic crystals. One advantage of using these substrates is 
that their functionality and packing can be readily modified, allowing the affect of 
these factors on growth to be investigated. However, these surfaces are, in general,  
neither homogeneous nor well defined, and as a result the nucleation and growth 
processes cannot be easily controlled [205].  
Currently, a group of compounds which are capable of forming self-
assembled monolayers (SAMs) are emerging as potential substrates for not only 
orienting, but also controlling and patterning nucleation and crystal growth. A 
plethora of SAMs exist with a diverse variety of functional groups. In addition, they 
possess long-range order and have been extensively characterized. All of these 
properties make SAMs ideal surfaces upon which to investigate the processes and 
parameters involved in crystal growth, and are discussed below. 
 
3.1.2 Formation of self-assembled monolayers (SAMs) on surfaces.  
 
SAMs are produced when alkanethiols, HS(CH2)nX, chemisorb from solution or 
vapour, onto surfaces of gold, silver or copper, giving complete, highly compact 
coverage of the surface. As gold is the substrate we have chosen to use for our 
studies, we shall concentrate only on SAMs on gold surfaces. Alkanethiols attach to 
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the surface via their thiol head-group. The nature of the gold-sulphur bond is still the 
subject of considerable debate, however current opinion is  that the species present at 
the surface is a gold(I) thiolate. The mechanism of this reaction is not yet fully 
understood, but is believed to occur via Equation 3.1 [206]: 
X  R  SH  +  Au(0)n  ĺ  X  R  S-Au(I).Au(0)n-1  +  ½H2      Equation 3.1  
Once formed, SAM-covered gold surfaces are stable in air or liquid, but SAMs will 
desorb when irradiated with ultraviolet light in an oxygen atmosphere, when exposed 
to ozone, or when heated above 70ºC [206].     
Substrates used to initiate SAM formation are usually gold-coated mica, 
glass, or silicon. A layer of gold as thin as 12 nm is sufficient for the formation of 
continuous, well-structured SAMs [206]. The thermal evaporation of gold on these 
substrates produces films of gold with (111) crystallographic orientation and gold 
molecules arranged in a hexagonal relationship [207]. On binding to the gold, 
sulphur atoms are believed to be localized in three-fold hollow sites of the Au (111) 
surface [208]. Alkyl chains of SAMs reside at an angle of 30º to the normal of the 
gold surface in order to minimize the free volume and maximize van der Waals  
interactions between the chains [206]. As a result, SAMs of alkanethiolates on gold 
pack at densities that approach those of a crystalline solid [206, 209-211]. A 
diagrammatic representation of a SAM on gold is shown in Figure 3. 1. 
  The ability to present a variety of functional groups, X, including structurally 
complex groups, at the terminal position of the alkanethiol makes it possible to 
control the surface chemistry at the molecular level,  and thus to control the 
interfacial properties of these surfaces.  
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Figure 3. 1 Diagrammatic representation of alkanethiols arranged into a self-
assembled monolayer (SAM) on gold-coated mica. Alkanethiols attach to the gold 
surface via their thiol head-groups and their alkyl chains protrude from the surface at 
an angle șû to the normal, where șû is approximately 30û. Thus, their variable 
terminating-groups, X, are exposed to the surrounding environment and govern the 
chemical nature of the SAM. 
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The additional use of soft lithographic techniques [212, 213] make it possible 
to pattern SAMs with different functionalities onto surfaces. The key to soft 
lithography is the use of an elastomeric polymer, with a pattern in bas-relief on its 
surface, as a means of transferring alkanethiols to a surface in desired formations. 
These stamps or moulds are fabricated by casting and curing 
poly(dimethylsiloxane), PDMS, against a master silicon substrate. Soft lithographic 
techniques allow the patterning of surfaces with features ranging from 200 nm [214] 
to 50 µm in diameter [206] and provide a method in which the spacing, ordering, and 
orientation of terminal groups can be accurately and reproducibly determined [188].  
Microcontact printing is one such technique, and is illustrated in Figure 3. 2 
The procedure involves wetting the PDMS stamps with an ethanolic solution of 
alkanethiol, allowing excess solvent to evaporate, and placing the stamp on the gold 
substrate. As PDMS is an elastomer, it contacts the substrate conformally resulting in 
a pattern of SAMs complementary to the features of the stamp. Exposure of the 
remaining bare gold substrate to a second alkanethiol permits the formation of a 
surface presenting patterned regions of two distinct terminal groups. The flexibility 
of PDMS has also enabled patterning of curved surfaces [206, 215].  
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Incubate in 
another SAM to 
backfill the 
remaining gold 
areas 
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reveal patterned 
areas of SAM 
Patterned SAM areas 
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PDMS stamp 
Figure 3. 2 Diagram illustrating the patterning of SAMs onto a gold-coated mica 
surface using microcontact printing. A PDMS stamp is inked with alkanethiol 
solution and placed onto the gold surface. A SAM is formed on the gold in the areas  
which have contacted the stamp. Incubation of the substrate in a second alkanethiol 
solution allows the bare areas to be filled, generating a SAM-covered surface that 
presents different chemical functionalities in different areas. Adapted from [213]. 
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The two-dimensional distribution of functional groups has previously been 
exploited to control and pattern the adsorption of many biological macromolecules to 
surfaces. These include lipids [216], DNA [216-219], proteins [220-223], and entire 
cells [220, 224-226]. A comprehensive review of the use of SAMs in patterning and 
investigating protein binding, cell attachment, growth and apoptosis is given in 
references [206, 212, 213]. The proficiency of SAMs to arrange proteins or cells on a 
surface without diminishing their activity or specificity has led to their use in 
commercial products such as DNA arrays [227] and biosensors [228, 229]. Further 
applications lie in biocatalytic electrodes, catalysts, high throughput screening [206], 
and in microelectronics [230]. 
This technique has also enabled the direction of nucleation and growth of 
crystals and liquid crystals. SAMs have been used to promote heterogeneous  
nucleation and growth of glycine crystals [231], iron hydroxide crystals [232], 
malonic acid crystals [233], to orient the crystallization of calcite [188, 205, 234], 
and to direct the growth of particular polymorphs of calcium carbonate [235]. 
The structure and size of defects within liquid crystals were also controlled 
by this method [216]. Hence this procedure also has  the capability to produce highly 
oriented crystal samples which may be used for structural analysis via X-ray 
diffraction. 
Both Kang et al.  [231] and Aizenberg et al. [188, 205, 234] have shown that, 
by varying the chemical nature of the SAM, the nucleating face of glycine and calcite 
crystals respectively could be altered. Consequently the morphology of the resulting 
crystals was dictated by the SAM surface to which it adhered. The selective 
nucleation of calcite from six crystallographic faces was observed using these 
methods, whereas the use of Langmuir monolayers and adsorbed biological 
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macromolecules as substrates resulted in growth from only one or two faces [198, 
199, 236-238], indicating the superiority of SAMs. Although nucleation mechanisms  
and kinetics were not studied in any of these investigations, micropatterning of 
SAMs was shown to control the density and pattern of nucleation events, and the 
sizes of the growing crystals [188, 234]. 
These studies have demonstrated that varying the geometry, chemistry, and 
pattern of SAM functional groups provides a means of regulating the orientation of 
crystal growth, allows the formation of high resolution patterns of oriented crystals 
[205], and also provides a template upon which nucleation processes can be 
investigated. 
These factors, combined with the ease of preparation of SAMs, make them an 
ideal surface for investigating the nucleation and growth mechanisms of drug 
crystals.  
 
3.1.3 Aims of chapter. 
 
SAMs have already proven to be a model system for investigating the interactions of 
proteins and cells with surfaces. Recent findings have demonstrated their superiority 
over surfaces such as Langmuir monolayers and functionalized polymer interfaces in 
promoting nucleation and growth of oriented crystals in predetermined areas. Here 
we assess the abilities of three SAMs to bind aspirin molecules, and allow aspirin 
crystals to grow on their surface. Microcontact printing will be employed to pattern 
aspirin-binding and non-binding SAMs onto gold. The resulting templates will be 
used to study the nucleation and fundamental growth mechanisms of aspirin crystals. 
AFM and SEM will be used to visualize and quantify these processes throughout. 
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3.2 Methods and Materials 
 
3.2.1 Preparation of self-assembled monolayers (SAMs) on epitaxial gold. 
 
 
The epitaxial gold on mica substrates, prepared using the method described by 
DeRose et al. [207], was cleaned using a hydrogen flame before incubation in SAM 
solution at room temperature. SAMs utilized were 11-mercapto-1-undecanol (11-
MUD) (Aldrich Chem. Co. Milw. WI, USA), 11-mercaptoundecanoic acid (11-
MUA) (Aldrich Chem Co. Milw. WI, USA), and 1-dodecane-thiol (1-DDT) (Sigma 
Aldrich, Dorset, U.K.). The 11-MUD, 11-MUA, and 1-DDT SAMs have OH, 
COOH, and CH3 as their terminating-groups respectively. 11-MUD and 11-MUA 
SAM solutions were prepared by dissolving 6mg of the compound in 10ml of ethanol 
(Sigma Aldrich, Dorset, U.K.). 1-DDT SAM solution was prepared by mixing 60Pl 
of the compound in 10ml ethanol. The final concentrations of the SAM solutions 
were approximately 2.7mM. 
After cleaning, the gold was incubated in a SAM solution for 24hrs. Controls 
were prepared by incubating the gold in HPLC grade water after cleaning. After 
incubation the gold pieces were removed, dried in a stream of nitrogen, and 
incubated in 0.015M aspirin solution where HPLC grade water is the solvent. Aspirin 
(Sigma Aldrich, Dorset, U.K.) used was U.S.P. grade. Figure 3. 3 shows a schematic 
representation of the incubation of SAM-covered gold in aspirin solution. The SAM-
covered gold substrates were imaged periodically, using AFM, in 1ml aspirin 
solution to assess whether nucleation and growth were occurring on any of the 
surfaces. 
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Figure 3. 3 Schematic of the incubation of SAM-covered gold in aspirin solution. 
Stage 1: SAM on gold with terminating-group exposed. Stage 2: incubation of the 
substrate in aspirin solution. Stage 3: possible conformation of aspirin molecules  
bound to the SAM. 
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A PDMS stamp, to be used for microcontact printing, was cast from a silicon 
microchip. The pre-polymer of PDMS, Silgard 184, was obtained from Dow Corning 
(ISL, W. Midlands, U.K.). The stamp was prepared by pouring the pre-polymer of 
PDMS (Silgard 184), in a 10:1 (W/W) ratio of base:curing agent, onto the silicon 
microchip. The PDMS was cured at 35°C for 24 hours and removed from the 
microchip master, washed in ethanol, deionized water, and hexane before drying 
under a stream of nitrogen. This stamp was stored under a stream of argon prior to 
use. The resulting PDMS stamp was imaged using SEM to show its surface features. 
This PDMS stamp was incubated in a solution of 11-MUA or 1-DDT SAM to 
form an inked stamp which, when applied to a gold substrate, would transfer the 
SAM only to the areas in contact with the gold. The inking solutions were prepared 
by dissolving 12mg 11-MUA or 120µl 1-DDT in 5ml ethanol, resulting in solutions 
with a concentration of approximately 10.8mM. The stamp was incubated in the 
inking solution for 15 minutes. After incubation, the inked PDMS stamp was 
removed from the SAM solution, dried in a stream of nitrogen and carefully placed 
onto the gold substrate. Contact between the stamp and gold was maintained for 30 
seconds, the stamp was then peeled away from the surface. It has been shown that 
using ethanolic solutions of SAMs with concentration greater than 10mM for 
printing generates SAMs which are structurally comparable to high-quality SAMs 
formed from a solution [239, 240]. Prior to each stamping experiment, the PDMS 
stamp was washed in 5ml ethanol, then hexane, and ethanol again to remove any 
residual SAM or impurities. In between each wash it was dried with lens tissue.  
The resulting 11-MUA and 1-DDT patterned gold substrates were incubated 
in 1-DDT and 11-MUA solutions respectively, to backfill the unstamped areas of the 
gold. The backfill solutions were prepared by dissolving 6mg of 11-MUA or 60µl 
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1-DDT in 10ml ethanol. After incubation in the backfill solutions for 24 hours, the 
patterned gold substrates were dried in a stream of nitrogen. The two resulting types 
of gold substrates consist of: 
i) areas of 11-MUA SAM in patterns which are mirror images of the 
PDMS stamp features, surrounded by 1-DDT SAM, and 
ii) patterned areas of 1-DDT SAM surrounded by 11-MUA SAM. 
Both types of patterned gold substrate were incubated in 0.015M aspirin solution to 
assess which areas would promote nucleation and growth of aspirin crystals. After 
incubation in aspirin solution for several days, the substrates were imaged using 
AFM and SEM. The 11-MUA stamped/1-DDT backfilled substrate was monitored 
more closely and imaged periodically in aspirin solution to assess growth of crystals 
on this template. 
 
3.2.2 AFM analysis. 
 
Contact mode imaging was employed throughout, using a ThermoMicroscopes 
Explorer AFM (Veeco, Bicester, Oxon, U.K.). V-shaped silicon nitride cantilevers  
(200Pm length) with integrated pyramidal tips (Nanoprobes, Veeco, Santa Barbara, 
CA) were used. Both topography and deflection images were acquired in all 
experiments. Deflection images emphasize areas of rapid topography changes, such 
as steps, but do not give any information about the relative heights of features on the 
surface. 
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3.2.3 SEM analysis. 
 
All samples were initially gold coated for four minutes using a Balzers SCD 030 
Sputter Coater (Balzers Union Limited, Liechtenstein), operated at 0.1mbar with a 
sputtering current of 30mA. A Philips 505 SEM (Philips Electron Optics, Eindhoven, 
Netherlands) was used to image all samples under a range of magnification settings 
at a voltage of 23KeV, with a spot size of 50nm. 
 
3.3 Results and Discussion 
 
The images in Figure 3. 4 show the surface of bare gold after incubation in 0.015M 
aspirin solution for 3 days, 9 days, and 8 weeks. There are large features present on 
this surface after 3 days and 9 days, indicated by arrows on images a) and b), which 
may be clusters of aspirin crystals. However, after 8 weeks of incubation in aspirin 
solution, there are no crystalline features visible on the surface. Therefore the 
features present after 3 and 9 days must be due to debris on the surface. The debris 
may be clumps of gold which not have annealed properly to the mica, or may be 
deposits of impurities present in the aspirin solution. The globular features apparent 
in image c) are due to annealing of gold into spherical grains rather than in a layer, as 
shown in images a) and b). Therefore the clean gold surface, without any SAM 
attached, does not promote nucleation of aspirin crystals. Figure 3. 5 displays images  
of 1-DDT SAM covered gold after 3 days, 9 days, and 8 weeks of incubation in 
aspirin solution. Throughout this time period, the gold retains its characteristic 
appearance of pits and islands, without the formation of any crystals on the surface. 
Note that the monolayers are approximately 2 nm in height [206, 226, 230] and 
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hence are not visible at this resolution using AFM. Even after 8 weeks there is no 
discernible crystallization on this surface. 
Figure 3. 6 shows the features on the surface of the 11-MUA SAM covered 
gold during incubation. After only 2 days the appearance of crystals on the surface is  
evident. These continue to develop and grow until, after 8 weeks, crystals with 
distinct faces reside on the SAM covered surface. One of these can be observed in 
the upper left-hand side of image c), indicated by an arrow. 
The images shown in Figure 3. 7 depict the 11-MUD SAM covered gold 
surface during incubation. Again the surface features remain consistent with that of 
bare gold throughout the incubation period, and hence crystallization does not occur 
on this surface. The globular features observed in images b) and c) are again due to 
the annealing of gold in spherical grains. The presence of such features does not 
impede the formation of SAMs on the surface [219], and therefore will not influence 
the nucleation of crystals.  
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Figure 3. 4 AFM topography images of the control, bare gold, after incubation in 
0.015M aspirin solution for a) 3 days, b) 9 days, and c) 8 weeks. Both a) and b) are 
10 µm x 10 µm images whereas c) is a 5 µm x 5 µm image. The arrows indicate 
clumps of gold, or impurities from the aspirin solution which have deposited on the 
surface. 
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Figure 3. 5 AFM topography images of 1-DDT SAM-covered gold after incubation 
in 0.015M aspirin solution for a) 3 days, b) 9 days, and c) 8 weeks. Both a) and b) are 
10 µm x 10 µm images whereas c) is a 5 µm x 5 µm image. 
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Figure 3. 6 AFM topography images of 11-MUA SAM-covered gold after 
incubation in 0.015M aspirin solution for a) 2 days, b) 7 days, and c) 8 weeks. Both 
a) and b) are 10 µm x 10 µm images whereas c) is a 5 µm x 5 µm image. The arrow 
indicates a crystal with distinct faces which has grown on the SAM-covered surface. 
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Figure 3. 7 AFM topography images of 11-MUD SAM-covered gold after 
incubation in 0.015M aspirin solution for a) 1 day, b) 9 days, and c) 8 weeks. Both a) 
and b) are 10 µm x 10 µm images whereas c) is a 5 µm x 5 µm image. 
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From these data we can conclude that of the four substrates investigated, only 
the 11-MUA SAM-covered gold surface promotes aspirin nucleation and subsequent 
crystal growth. This is clearly due to molecular recognition between the aspirin 
molecules and the chemical functionality of the surface. In the crystal structure of 
aspirin the molecules dimerize, and are linked together via a pair of hydrogen bonds 
between their carboxyl groups [172]. Figure 3. 8 illustrates the orientation of aspirin 
molecules in a hydrogen-bonded dimer. A similar type of bonding could occur 
between aspirin molecules and the carboxyl-terminated MUA SAMs, allowing 
aspirin molecules to attach to the surface. Given that the pKa values for aspirin and 
11-MUA are 3.5 [241, 242] and 6.5 [243] respectively, and the measured pH of the 
aspirin solution is 2, both SAM and aspirin molecule would be protonated. This 
would therefore increase the strength of the bonding between these components, and 
hence the stability of the resulting complex. If bonding does occur in this manner, we 
can assume that aspirin molecules attach to the SAM individually, and not as a 
dimer. Successive aspirin molecules must then attach to the initial aspirin molecule 
and/or the juxtaposed SAM molecules.  
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Figure 3. 8 Structure of a hydrogen-bonded aspirin dimer in the crystalline state. 
Hydrogen bonds are represented by dashed red lines. Adapted from [172]. 
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Molecules bind progressively to form a stable nucleus and continue to grow to form 
microscopically visible crystals. The process by which these crystals grow on the 
surface is described by the Deposition, Diffusion, and Aggregation (DDA) model 
[244-247], and is illustrated in Figure 3. 9. This model proposes that atoms or 
molecules (adatoms) deposit onto the surface (Figure 3. 9 a) and diffuse across it 
until they reside in a site immediately next to another adatom (b) or cluster (c). When 
two adatoms occupy neighbouring sites, they and the clusters to which they belong 
bind irreversibly. These clusters can continue to diffuse across the surface (illustrated 
in d) and e)), but their rate of diffusion is inversely proportional to their size.  
As previously mentioned, SAMs on gold pack with densities approaching 
those of crystalline solids [206, 209-211], and thus this process could be considered 
epitaxial growth. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 -  - 106
Chapter 3 
 
e) 
c) 
d) 
b) 
a) 
 
 
Figure 3. 9 Diagrammatic illustration of the Deposition, Diffusion, and Aggregation 
(DDA) model for growth on surfaces. In a) an adatom adsorbs (deposits) onto the 
surface. It then diffuses across the surface until it meets another adatom, b), or 
cluster, c). When two adatoms occupy neighbouring sites, they and the clusters to 
which they belong bind irreversibly. These clusters can continue to diffuse across the 
surface, shown in d) and e). Adapted from [244].   
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In order to investigate nucleation and the initial stages of aspirin crystal growth, we 
require a substrate upon which aspirin crystals will nucleate in predetermined areas. 
In order to create such templates for nucleation and growth, we patterned 11-MUA 
and 1-DDT SAMs on gold using microcontact printing with a PDMS stamp cast 
from a microchip. SEM images of areas of the PDMS stamp are shown in Figure 3. 
10 and Figure 3. 11. The stamp consists of two main areas, one with linear features 
composed of raised and lowered domains, and one with almost square raised 
features. The dimensions of both sets of features are illustrated in Figure 3. 11 b) and 
d). The almost square features are 14.1 µm x 12.7 µm, and are separated by 7.3 µm 
channels horizontally and 4.1 µm vertically.  The raised components of the linear 
features are 13.6 µm x 5.5 µm, and are separated by 7.3 µm channels horizontally 
and 8.2 µm vertically.    
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Figure 3. 10 SEM images of the surface features of the PDMS stamp used to pattern 
gold templates. Image a) shows the repeating almost square features consisting of a 
C shaped element and a dot. This image is taken at magnification x 573. Image b) 
illustrates the linear features on the surface which have both raised and lowered 
components. This image is taken at magnification x 287.   
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Figure 3. 11 Higher magnification SEM images of the surface features of the PDMS 
stamp used to pattern gold templates. Image a) shows the almost square features at 
magnification x 2300. b) shows the dimensions of the raised features of this area of 
the stamp, and the width of the channels between them. Image c) shows the linear 
features of the stamp at magnification x 1150. d) shows the dimensions of the raised 
and lowered features in this area of the stamp. 
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The templates were prepared by stamping 1-DDT onto the gold surface, and 
incubating in 11-MUA solution to fill the unstamped regions of the gold (template 
A), or by stamping 11-MUA onto the surface and incubating in 1-DDT solution 
(template B). The templates were incubated in 0.015M aspirin solution and AFM 
images of the resulting surfaces are shown in Figure 3. 12 and Figure 3. 13.  As can 
be seen in Figure 3. 12, crystallization is apparent all over template A. It may appear 
from these images that 1-DDT SAM does in fact promote aspirin crystal nucleation, 
in direct contrast to our earlier findings (Figure 3. 5). However the images of the 
template B, shown in Figure 3. 13, display tabular crystals, approximately 300 nm in 
height, in patterned formations across the surface. These images indicate that 
crystallization occurs only in areas of the 11-MUA SAM, and suggest that the 
features apparent in Figure 3. 12 are due to the fact that, when 1-DDT was stamped 
onto the gold surface, a complete monolayer was not formed in all the stamped areas. 
Therefore when the template was incubated in 11-MUA solution, this SAM filled not 
only the channels around the stamped areas, but also the gaps within the stamped 
areas. This shows that discrete areas of 11-MUA SAM are sufficient to promote 
aspirin crystal nucleation. 
SEM images, Figure 3. 14, corroborate these findings, showing that after four 
weeks of incubation the crystals on the template surface still remain almost 
rectangular in shape, and reside in discrete areas.  
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Figure 3. 12 AFM topography images of template A after incubation in 0.015M 
aspirin solution for a) 1 day, and b) 6 days. Both a) and b) are 50 µm x 50 µm 
images. 
 
 
 
 
 
 
 -  - 112
Chapter 3 
a) 
5 µm 
5 µm 
5 µm 
 
 
 
 
 
 
 
b)  
 
 
 
 
 
 
 c) 
 
 
 
 
 
 
Figure 3. 13 AFM topography images of template B after incubation in 0.015M 
aspirin solution for a) 1 day, and b) 6 days. Image c) is a higher resolution image of 
the bottom right area of image b). Both a) and b) are 50 µm x 50 µm images, whereas  
c) is a 20 µm x 20 µm image. 
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a) 
 
 
 
 
 
 
 
 
 
 
 b) 
 
 
 
 
 
 
 
 
 
Figure 3. 14 SEM images of template B after incubation in 0.015M aspirin solution 
for 4 weeks. Image a) shows the template surface at magnification x 1010, and image 
b) at magnification x 2020. 
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From the AFM images of template B shown in Figure 3. 13, it is clear that patterning 
the surface in this manner promotes the growth of highly oriented tabular crystals. In 
Figure 3. 13 c) the dimensions of the crystallizing areas are approximately 4.6 µm x 
1.9 µm, and the distance between these areas  is approximately 2.5 µm. We do not 
know which of the two characteristic areas of the PDMS stamp will have contacted 
this area of template B. However, the dimensions of the crystals and channels do not 
mirror the dimensions of either area of the stamp. It is apparent that more than one 
crystal nucleates within each stamped area, unlike the studies reported by Aizenberg 
et al. [188, 234] where only one calcite crystal nucleated in each nucleating region of 
the patterned SAM surface, which varied in size from 15 µm to 50 µm. These 
researchers stated that the number of crystals which nucleate within each nucleating 
region depends linearly upon its area. Therefore, the parameters of the stamp used for 
our experiments need to be optimized in order to create patterns which promote 
nucleation of only one aspirin crystal per nucleating site, and thus mimic more 
precisely the surface features of the stamp.  
Nevertheless, template B, where the gold surface is stamped with 11-MUA 
and backfilled with 1-DDT, promotes the growth of highly oriented tabular crystals. 
This template, therefore, allows nucleation to occur at specific sites. The periodic 
pattern of crystals on the surface reflects the influence of mass transport [234]. Again 
the growth of crystals on the surface follows the DDA model (Figure 3. 9). However, 
we suspect that the flux of aspirin molecules to the specific nucleation sites increases  
as the crystals begin to grow. Mass transport of aspirin molecules to the growing 
crystals depletes the concentration of aspirin in the vicinity, thus locally 
undersaturating the solution. This sets up local diffusion gradients and elevates the 
transport of aspirin molecules to the nucleating sites. A positive feedback process is 
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induced which perpetuates the growth of crystals at nucleation sites, and produces 
non-nucleating zones surrounding the growing crystals where the aspirin 
concentration is depleted [234]. The channels or distances between the crystals on 
the surface represent the non-nucleating zones.  
The fact that the orientation of crystals grown on template B (Figure 3. 13) is  
uniform implies that the interfacial structure of the SAM is governing the orientation 
of the incipient crystals. As suggested earlier in the chapter, aspirin molecules may 
attach to the MUA SAM via hydrogen bonding between carboxyl groups of aspirin 
and SAM molecules. Figure 3. 15 shows the crystal structure of aspirin projected 
along the b-axis, and displays the functional groups present on the (001) and (100) 
faces. From this diagram it is evident that carboxyl groups project from the (100) 
face. Hence we assume that this face attaches to the SAM surface via hydrogen 
bonding during these experiments. The crystal habit of aspirin obtained during these 
experiments is shown in Figure 3. 16. The Miller indices are shown on each of the 
crystal faces.  
Techniques such as chemical force microscopy [166, 248-251] or X-ray 
diffraction could be used in the future to identify which surface groups protrude from 
the crystal faces, and hence which face is binding to the SAM surface. Chemical 
force microscopy is a modification of conventional AFM. In this technique, probe 
tips are functionalized with SAMs to enhance the chemical sensitivity of the AFM. 
During raster scanning it is possible to detect interactions between the functionalized 
tip and the sample surface, thus allowing chemical inhomogenities of the surface to 
be identified. 
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Figure 3. 15 Aspirin crystal structure viewed along the b-axis projection. The 
horizontal and almost vertical lines indicate the position of the (001) and (100) faces  
respectively. Adapted from [165]. 
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Figure 3. 16 A diagrammatic illustration of the habit of aspirin crystals grown on 
template B, which consisted of 11-MUA SAM stamped regions surrounded by 1-
DDT backfilled areas. The crystals attached to the 11-MUA SAM by hydrogen 
bonding through the terminating carboxyl groups of the SAM and the carboxyl 
groups projecting from the (100) faces. The respective Miller indices are shown on 
each of the faces. 
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These experiments were repeated using template B, periodically imaging the surface 
in an attempt to observe nucleation occurring on the surface. Figure 3. 17 shows the 
results of these experiments. Image a) is taken 7 days after addition of aspirin 
solution and displays the characteristic aspirin crystal on the template surface. Image 
b) shows the same area after 74 minutes, and an island of aspirin is clearly visible on 
the crystal surface. Throughout the sequence this structure continues to grow across 
the face of the crystal, in both [100] and [001] directions. In images a) to c) growth in 
the [001] direction is predominant, with an average growth rate of 29.2 nm/min, 
compared with 8.0 nm/min in the [100] direction. However, the island grows 
uniformly in the [100] direction during this period. After this time, growth in the 
[001] direction ceases, but growth in both positive and negative [100] directions 
rapidly increases. The growth is no longer uniform, and the rates of growth of the 
different regions of the island range from 23.5 nm/min to 37.6 nm/min. The type of 
nucleation observed here is known as secondary nucleation, due to the fact that it 
occurs on a crystal of the same composition as the crystallizing solute [7]. The 
heights of the crystal and growing nucleus are 474 nm and 151 nm respectively. 
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Figure 3. 17 AFM images of a single aspirin crystal growing and facilitating 
secondary nucleation on the surface of template B. This sequence of images  is taken 
after incubation in 0.015M aspirin solution for 7 days. In image a) time t = 0, b) t = 
74 mins, c) t = 139 mins, d) t = 186 mins, e) t = 212 mins, and f) t = 257 mins. The 
imaged area was moved slightly between a) and b) to centralize the crystal apparent 
on the surface. All are 23 µm x 23 µm deflection images. 
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These findings show that during secondary nucleation, growth in the [001] direction 
is initially dominant. The progressive decrease in growth rate in the [001] direction is  
concurrent with an increase in the growth rate in the [100] direction. Applying these 
growth mechanisms to the early stages of growth of the original crystal on the SAM 
surface, may aid in the explanation of the observed tabular crystal habit.  
These images also illustrate the growth of the original crystal, bound to the 
SAM surface. Growth is negligible in the [100] direction throughout this period. 
However growth in the [001] direction is observed in images c) to f), and the growth 
rate is calculated as 18.1 nm/min.  
This technique, therefore, enables us to direct and pattern crystallization of 
aspirin, as previously illustrated with glycine [231] and calcite [188, 205, 234] 
crystals. However, we have also utilized this technique to the monitor growth rates of 
these patterned crystals, as well as observe secondary nucleation upon them. The 
specific habit attained by all of the crystals patterned on to these templates is also 
indicative of the potential uses of this technique in pharmaceutical crystal growth. Of 
the problems encountered throughout the crystallization of pharmaceutical 
components, highlighted in Chapter 1, the occurrence of polymorphic and chiral 
drugs are prominent, as they present both economic and health issues. Polymorphic 
forms of a drug can have very diverse physical properties, which can result in 
diverging solubility and bioavailability of the drug products. The kinetic mechanisms  
underlying polymorphism are largely unknown and crystallization often results in the 
formation of more than one polymorph.  
More than half of all marketed drugs are chiral and exist in at least two 
symmetrical enantiomer forms [75]. Currently crystallization is the most efficient 
method of separation of enantiomers, but in most cases this results in either crystals 
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of both enantiomers, or crystals containing proportions of each enantiomer. 
Difficulties in separation make the development of a single enantiomeric drug 
compound economically impractical. Consequently drugs are often administered as a 
mixture of enantiomers, even if the two enantiomers exhibit different 
pharmacological activity profiles [28]. The most well-known and tragic example of 
such a drug is thalidomide. During the 1960s thalidomide was administered to 
pregnant women to relieve morning sickness. The R-enantiomer of the drug has a 
sedative effect whereas the S-enantiomer is highly teratogenic, causing deformities in 
unborn children. 
The ability to control and dictate crystallization of a particular polymorph or 
enantiomer of a drug is an aspiration of those involved in drug design and delivery. 
Here we illustrate a technique which enables crystallization of a particular habit of 
aspirin. In principle these experiments could be adapted and exploited to direct 
nucleation of particular polymorphs or enantiomers of drugs, or indeed to search for 
unknown polymorphs, and may thus provide critical information to the 
pharmaceutical industry.  
In order to fully scrutinize the mechanisms taking place during nucleation and 
the fundamental stages of aspirin crystal growth, the preparation of templates with 
smaller nucleation areas is imperative. In addition, more precise determination of the 
location of these areas  is necessary. The preparation of PDMS stamps is relatively 
easy and inexpensive, so the creation of stamps with smaller features would be a 
simple task. As mentioned earlier in the chapter, microcontact printing allows the 
production of features as small as 200 nm, and can therefore be utilized to produce 
smaller nucleating areas. Chemical force microscopy has previously been used to 
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differentiate the locations of SAMs on a patterned surface and thus could be used in a 
similar manner here [248-251].  
 Although the lattice of SAMs bearing different functional groups are similar,  
the structure, chemical nature, and co-ordination number of their terminal groups 
vary [205]. Thus the application of a wider range of SAMs, including those with 
terminal groups akin to the aspirin molecule, may enable directed growth or selective 
attachment of aspirin crystal faces on the SAM surface.  These experiments could 
also be employed to control resulting crystal habit, size, and overall morphology of 
this and other drug crystals.  
 This technique enables the fabrication of a large number of nucleation sites in 
controlled microenvironments on the same surface. It should hence allow us to study 
the influence of crystallization parameters such as supersaturation, solvent, pH and 
temperature, on crystal growth and polymorphism. 
 
3.4 Conclusion 
 
The control, design, and promotion of crystal growth are greatly desired objectives of 
crystal engineers and the pharmaceutical industry alike. In order to achieve this goal 
more information is required on all aspects of the crystal growth procedure. In the 
previous chapter we investigated the growth on the face of an aspirin crystal at two 
supersaturations. Here we have focused on the nucleation and promotion of aspirin 
crystal growth. Methods previously used to promote crystal growth employed 
synthetic surfaces, such as Langmuir monolayers and functionalized polymer 
surfaces. The drawbacks of these surfaces lie in their lack of homogeneity, and as a 
result, the control of crystal growth on such surfaces is problematic. In recent years 
 -  - 123
Chapter 3 
SAMS have come to the fore as surfaces upon which crystallization can not only be 
promoted, but can also be directed and patterned in predetermined locations.  
In this chapter we have assessed the aspirin binding capabilities of three 
SAMs chemisorbed on gold. Of the three SAMs investigated, only the carboxyl-
terminated 11-MUA SAM allowed aspirin crystals to nucleate on its surface. We 
assume that aspirin molecules bind to the SAM via hydrogen bonding between the 
two carboxyl groups, in a manner similar to that of aspirin molecules dimerizing in 
the crystal structure.  
 Further investigation is required to precisely determine the mechanism of 
crystal formation on the SAM surface. However, nanostructure growth on surfaces is  
postulated to occur via the Deposition, Diffusion, and Aggregation (DDA) model. 
This model suggests that atoms or molecules (adatoms) deposit onto the surface and 
diffuse across it until they reside in a site next to another adatom or cluster. Here they 
bind irreversibly and the resulting cluster of molecules can continue to diffuse across 
the surface. SAMS have similar densities to crystalline solids, and hence this process 
could be considered epitaxial growth. 
Microcontact printing facilitated the patterning of gold substrates with 11-
MUA and 1-DDT SAMs, and has allowed us to create templates comprising aspirin-
binding and non-binding regions. Incubation of these templates in aspirin solution 
resulted in the patterned formation of tabular unidirectional aspirin crystals. 
However, the dimensions of the crystals and channels did not mirror the dimensions 
of the stamp features and more than one crystal nucleated within each stamped area. 
Therefore the parameters of the stamp used for our experiments need to be optimized 
in order to create patterns which promote nucleation of only one aspirin crystal per 
nucleating site. 
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Nevertheless, the observation that this template promoted the growth of 
highly oriented crystals implies that it allowed nucleation to occur at specific sites. 
The periodic pattern of crystals formed on the surface reflects the influence of mass 
transport. Again the growth of crystals on the surface followed the DDA model. 
However, we suspect that the flux of aspirin molecules to the specific nucleation 
sites increased as the crystals began to grow. Mass transport of aspirin molecules to 
the growing crystals therefore depleted the concentration of aspirin in the vicinity, 
thus locally undersaturating the solution. This set up local diffusion gradients and 
elevated the transport of aspirin molecules to the nucleating sites. A positive 
feedback process was thus induced, which perpetuated the growth of crystals at 
nucleation sites, and produced non-nucleating zones surrounding the growing 
crystals where the aspirin concentration was depleted [234]. The channels or 
distances between the crystals on the surface represented the non-nucleating zones.  
  The face of the crystal which bound to the SAM was (100), and the resulting 
crystals formed on the SAM had a tabular habit bounded by the faces {001}, {011}, 
and {110}. Techniques such as chemical force microscopy, time of flight secondary 
ion mass spectroscopy (TOF-SIMS), and imaging X-ray photoelectron spectroscopy 
(XPS), would further prove the location of the 11-MUA and 1-DDT SAMs within 
the templates, and would also identify the surface groups on the protruding crystal 
faces. These techniques could, thus, verify our findings. 
These templates have also permitted us to observe the secondary nucleation 
and growth of a cluster of aspirin molecules on the surface of another aspirin crystal. 
The observation that growth of the nucleus in the [001] direction was initially 
dominant but was then curtailed, whilst growth in the [100] direction increased, may 
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aid in the explanation of the tabular habit of the crystals grown on the underlying 
SAM.  
This technique, in conjunction with AFM, also allowed visualization of the 
growth of a crystal bound to the SAM surface. Only growth in the [001] direction 
was observed, with the growth rate calculated as 18.1 nm/min.  
 In order to further investigate the mechanisms of nucleation of these crystals, 
the preparation of templates with smaller nucleation areas is imperative. In addition, 
the location of aspirin-binding regions must be more precisely known. These criteria 
can be met by microcontact printing and chemical force microscopy respectively. 
 In addition, the application of a wider range of SAMs, including those with 
terminal groups akin to the aspirin molecule, may be used. These may prove to direct 
the growth or attachment of specific aspirin crystal faces on the SAM surface.  These 
experiments could also be employed to control the resulting crystal habit, size, and 
overall morphology of this and other drug crystals. They may also provide a surface 
upon which nucleation and growth can be monitored under differing crystallization 
parameters. Thus the effect of such factors as supersaturation, pH, solvent, and 
temperature can all be quantified. 
The methods described here can be adapted to investigate the nucleation and 
fundamental stages of growth of drug crystals to provide much needed information to 
the pharmaceutical industry. Such knowledge may assist in predicting the outcomes 
of crystallization, controlling polymorphism, directing nucleation of polymorphs or 
enantiomers, or searching for unknown polymorphs. These techniques may thus aid 
in preventing the formation of unwanted morphologies of drugs.  
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Chapter 
4 
 
The effects of additives on the morphology and growth 
on the (001) face of paracetamol crystals. 
 
It is well known that the presence of impurities can dramatically affect the 
nucleation, morphology, and chemical properties of crystals. Although literature is 
replete with examples of impurity or additive-induced modifications of crystals, few 
have probed the interaction of these compounds with distinct growing faces. In this 
chapter we utilize AFM and SEM to investigate the influence of two structurally 
related additives of paracetamol on its crystal morphology. We also probe, in situ,  
the effects of these additives on the morphology and growth rate of steps on the (001) 
face of the crystal. This, in conjunction with further studies, may establish the 
specific mechanisms of inhibition of these additives on each face of paracetamol, and 
provide a means of overcoming the poor compaction behaviour of paracetamol. 
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4.1 Introduction 
 
4.1.1 The effects of impurities on crystal nucleation and growth. 
 
Chapter 1 highlighted the need to develop crystallization studies which investigate 
how factors such as solvent, supersaturation, temperature, and impurities influence 
the bulk and surface properties of crystalline materials. Such information may enable 
a greater degree of control over crystallization, and may facilitate the manufacture of 
crystals with a particular processing behaviour. In this chapter, we focus upon the 
effects of impurities. 
  It has long been recognized that the presence of trace amounts of impurities 
can have substantial effects on the kinetics of crystal nucleation, growth morphology 
and dissolution [49, 50, 56, 58]. Mullin [4] stated that the suppression of nucleation 
may result from changes in the equilibrium solubility or the solution structure, or by 
physical or chemical adsorption of the impurity on homogeneous or heterogeneous  
nuclei. During growth, impurities can adsorb onto the crystal surfaces, changing the 
relative surface free energies of the faces and blocking the active growth sites. Some 
impurities can suppress growth entirely, some may enhance growth, whilst others 
may produce a selective effect, acting to varying degrees on each crystallographic 
surface, and consequently modifying the crystal habit [4]. 
 The classic model of Cabrera and Vermilyea [252] proposes that impurities 
can adsorb onto terraces or steps of growing crystals, and become almost immobile. 
Impurities which have adsorbed onto a terrace cannot be passed by a straight 
growing step, because impurities act as local pinning points. Therefore, these 
impurities serve as a fence to growing steps. Consequently, growing steps must 
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bend in order to squeeze through the impurity fence and, as a result, the velocity of 
the steps is reduced compared to that of straight steps growing in the absence of 
impurities.   
 
4.1.2 Impurities in pharmaceutical compounds. 
 
Impurities may be additives that are introduced for specific purposes, such as habit 
modification or to control crystal size, or may be impurities that result from the 
synthesis or degradation of the desired end product. If the solubility of an impurity or 
additive is close to that of the product, its removal during the purification process 
may be difficult. Impurities or additives have the potential to modify the solubility of 
the primary solute and thus affect the crystallization process. One specific 
application of additives in the crystallization process is in transdermal delivery. 
Additives, such as the polymers polyvinyl pyrrolidone (PVP) [25, 62] and 
hydroxypropyl methylcellulose (HPMC) [25, 253-256], are used as nucleation 
inhibitors to allow the supersaturation of a drug to be enhanced without inducing 
crystallization. Hence, the concentration of the drug is increased, as is the subsequent 
permeation of the drug through the skin [25, 253-257]. 
Structurally related compounds are common impurities in pharmaceutical 
components. These compounds become incorporated with varying efficiencies, and 
can, hence, influence the nucleation and subsequent crystal growth rate of the solute. 
As the distinct faces of crystals are influenced to different degrees, due to their 
contrasting molecular structure, morphological changes are often observed, 
sometimes at concentrations as low as several parts per million [96]. The presence of 
structurally related compounds has been shown to distinctly alter the habit of 
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pharmaceutical excipients, such as adipic acid [34, 51, 53, 54, 57] and Į-lactose 
monohydrate [39].  
It has been suggested that growth of drug crystals in the presence of low 
concentrations of additives can provide a means of controlling water content, crystal 
energy and order, dissolution rate, and possibly bioavailability [19]. 
Literature is replete with references to the additive-induced effects on 
crystalline drug compounds [34, 39, 51, 53, 54, 57, 258-260]. Of these studies, only a 
limited number are sufficiently quantitative to provide adequate insight into the 
specific mechanisms  involved. For pharmaceutical technology, understanding of 
these mechanisms may help to control the quality and purity of raw crystalline 
substances and, consequently, to improve the manufacture and performance of the 
final dosage forms [96]. 
 
4.1.3 Paracetamol and its structurally related additives. 
  
Paracetamol, also known as p-hydroxyacetanilide or acetaminophen, was first 
launched as a drug in 1956 and has now grown to be the most widely accepted 
antipyretic and analgesic in the world, used by over 30 million people in the U. K. 
every year [261]. 
 Two crystalline polymorphs of paracetamol have been reported, although 
evidence has been published which suggests that a third polymorph could exist [262]. 
The crystal structures of the two known forms of paracetamol are monoclinic [263-
270] and orthorhombic [262, 267, 270-273]. The monoclinic form is the 
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thermodynamically stable polymorph at room temperature and, hence, is the 
commercially used form of paracetamol.  
A particular problem with the monoclinic form of paracetamol is that it 
displays poor compaction behaviour, that is, it resists compression into tablets [274-
276]. It has been suggested that a modification of the structure or defect density of 
paracetamol crystals may produce more readily compressible structures [274]. 
Currently, there is considerable interest in modifying the properties of paracetamol 
using different crystallization techniques or additives in order to improve the 
compaction behaviour of the crystals [272, 274-280]. 
There are six known structurally related additives of paracetamol which have 
been observed to inhibit the nucleation and growth rates of paracetamol crystals to 
varying degrees [19-23, 29, 37, 59, 96, 281]. These are acetanilide, p-
acetoxyacetanilide (PAA), orthocetamol, methylparaben, p-acetoxybenzoic acid 
(PABA), and metacetamol. The molecular structures of paracetamol and its 
structurally related additives are illustrated in Figure 4. 1.  
Of these additives, the effects of PAA, (a suggested prodrug of paracetamol) 
[282, 283], on paracetamol crystallization have been the most extensively studied 
[19-23, 29, 59, 96, 281]. The effects of PAA on the morphology [23, 29, 59], 
nucleation [22, 23, 59], dissolution, in situ growth [96], melting point, enthalpy and 
entropy of fusion, uptake of water [19], and defect content [59] of paracetamol have 
all been investigated. On the contrary, the influence of the remaining additives on 
only the morphology [23] and nucleation [22, 23] of paracetamol crystals has been 
reported. 
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Figure 4. 1 The molecular structures of paracetamol and the structurally related 
additives which are known to inhibit its growth. 
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A primary feature of the paracetamol crystal structure is hydrogen bonding. This 
bonding leads to the formation of hydrogen bonded chains of molecules, packed in a 
herring bone conformation within the crystal structure. The molecular structure of a 
paracetamol crystal on the (001) face is shown in Figure 4. 2. The molecules form 
corrugated hydrogen bonded sheets which stack in the [010] direction. The 
consecutive stacks are bound by van der Waals interactions [281]. Any disruption to 
this bonding motif will lead to a change in the corresponding crystal growth rate and 
hence lead to a modification of the crystal habit [23]. There are two hydrogen 
bonding donors within the paracetamol molecule, N-H and O-H, and one hydrogen 
bond acceptor, C=O. The degree of hydrogen bonding which occurs within the 
paracetamol crystal has been quantified as 8.31 kcal mol-1 [23]. This corresponds to 
approximately 30% of the total lattice energy. Thus, any additive which disrupts the 
hydrogen bonding network within the crystal has the potential to significantly alter 
its morphology. 
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Figure 4. 2 Diagrammatic representation of the molecular packing of paracetamol on 
the (001) face of the crystal. Both [010] and [100] directions are shown. The 
molecules adopt a herring bone arrangement, where the molecules within each 
layer are held together by hydrogen bonds, indicated by dashed red lines. Adapted 
from [281]. 
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It has been proposed that structurally related additives may influence the 
nucleation and crystal growth of paracetamol in three principal ways [23]. Additives 
may: 
i) Block adsorption of solute molecules and therefore induce 
morphological changes.  
ii)  Dock onto the surface and become incorporated into the crystal 
lattice. An effective measure of the docking ability of additives is  
given by the segregation coefficient (SC). The SC is defined as the 
ratio of the mole fraction of additive in the crystals, to that in the 
crystallizing solution. Thus, additives that are incorporated as readily 
as paracetamol itself have an SC value of 1, whereas those not 
incorporated at all have an SC value of 0. 
iii)  Disrupt the emerging nucleus and thus inhibit the nucleation process.  
Each of these interactions depends upon the molecular similarity of the additive to 
paracetamol, both energetically and sterically. Although these interactions are 
interrelated, it is convenient to consider each separately [23]. The blocking, docking, 
and disrupting behaviours of the six additives which inhibit paracetamol growth have 
been extensively studied by Hendriksen et al. [23]. However, these studies have been 
conducted on entire crystals. We, therefore, wish to supplement this information by 
performing AFM studies on the in situ growth on the (001) face of paracetamol 
crystals, in the presence and absence of additive molecules. For these initial studies, 
two of the lesser studied additives have been selected, namely acetanilide and 
metacetamol. The blocking, docking, and disrupting activities of these two additives 
are described in the following sections. 
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4.1.4 Blocking activity of acetanilide and metacetamol. 
 
Blocking is the ability of an adsorbed additive molecule to hinder the subsequent 
adsorption of further layers of host molecules. As the additive molecules block 
different faces of the crystal to differing degrees, the growth rates of some faces will 
be dramatically altered, whilst others will remain unchanged. Consequently, the 
morphology of the resulting paracetamol crystals may be altered.  
Acetanilide caused appreciable morphological changes, despite its relatively 
low level of uptake into paracetamol crystals, as indicated by the SC value of 0.11. It 
was therefore considered a potent blocking molecule [23].  
Metacetamol also caused a high degree of morphological change, inducing a 
large shift in the aspect ratio. The aspect ratio is defined as the ratio of distances 
between the centre of the crystal and the furthest and nearest faces [89].  However, 
its uptake level was much higher than that of acetanilide, at SC = 0.25, and was thus 
considered to be a less effective blocker [23]. The reasons proposed for the observed 
morphological effects of these additives are discussed below. 
In order to successfully block the adsorption of a host molecule in a 
subsequent crystalline layer, a blocking molecule must present a conformation 
sterically and energetically different from that of paracetamol. If we consider a face 
or faces in which paracetamol molecules are oriented with their acetamido groups 
positioned inwards (away from the crystal-solution interface), we can discuss the 
potential blocking effects of these additives. 
 Acetanilide has no group in the p-position (Figure 4. 1), so no steric 
hindrance is present. However, it does not possess a proton donor to contribute to the 
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existing hydrogen bonding network, and hence it strongly blocks further addition of 
paracetamol molecules [23].   
 Similarly, metacetamol presents no great steric hindrance. It possesses an OH 
group in the m-position, allowing the hydrogen bonding network to be largely 
preserved, although distorted. As a result, metacetamol appears to be a less effective 
blocker than acetanilide [23]. 
 
4.1.5 Docking activity of acetanilide and metacetamol. 
 
Docking is the ability of a molecule in solution to be adsorbed onto the growing 
crystal surface in an orientation which will allow its inclusion into the crystal lattice. 
A molecule which successfully docks onto a crystal face may not block the arrival of 
further paracetamol molecules. If it does block effectively, the level of incorporation 
of this molecule into the crystal lattice will be less than that of a poor blocker. The 
level of incorporation of an additive is a reasonable measure of its docking ability, 
provided that its blocking ability is taken into consideration [23].  
Using these criteria, metacetamol was judged to be a strongly docking 
molecule, due to its high level of incorporation (SC = 0.25) and only moderate 
blocking activity. Metacetamol contains an acetamido group identical to that of 
paracetamol, which may aid in its successful docking.  
Acetanilide too contains an acetamido group identical to paracetamol. Its SC 
value was 0.11 and, as already mentioned, it is thought to be an excellent blocker of 
the growth of subsequent layers of paracetamol. It is therefore presumed that its 
moderate level of incorporation may be due to good docking on the crystal surface, 
coupled with the effective blocking of further crystal growth [23]. On the basis of 
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molecular similarity, acetanilide and metacetamol were regarded as equally efficient 
dockers. 
 
4.1.6 Disrupting activity of acetanilide and metacetamol. 
 
Disruption is the ability of an incorporated additive molecule to reduce the stability 
of an emerging nucleus. Thus, the nucleation size critical for growth increases, 
inhibiting the nucleation process. The incorporated molecule generates this effect by 
a combination of steric and energetic disruptions of the hydrogen bonding network.   
Experimentally, acetanilide and metacetamol were found to be only 
moderately disruptive [23]. The authors of these studies did not comment upon the 
disruptive activities of acetanilide and metacetamol. However, we propose that the 
disruptive ability of acetanilide is greater than that of metacetamol for the following 
reasons. The acetanilide molecule has no proton donor which can contribute to the 
hydrogen bonding network, and displayed this degree of disruption at a relatively 
low level of incorporation (SC = 0.11). Conversely, the m-OH group of metacetamol 
acts as a proton donor, allowing the formation of a preserved but distorted network of 
hydrogen bonds, and creates only a small steric disruption. 
   
 As described in the preceding sections, acetanilide is an effective blocker of 
the adsorption of paracetamol molecules during crystallization, is a strong docker, 
and is also moderately disruptive. Metacetamol is a less competent blocker than 
acetanilide, but its docking and disrupting abilities are equal to those of acetanilide. 
 As the growth studies performed in this chapter will be carried out on the 
faces of complete crystals, the disruptive effects of the additives cannot be 
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quantified. In addition, the AFM is unable to monitor the incorporation of additive 
molecules into the growing crystals and, hence, the docking activities of the additives  
cannot be further investigated through these experiments. 
 However, this method should enable the blocking activities of the additives to 
be both visualized and quantified. We envisage that growth in the presence of 
molecules which efficiently block adsorption of paracetamol onto the (001) face of 
the crystal should result in a change in morphology of growing steps, and should 
reduce the growth rate of steps, with respect to those grown in the absence of any 
additive. If these predictions prove to be accurate, similar experiments can be 
conducted to establish the blocking activity of each of the six additives on this and 
the other faces of paracetamol crystals. These data could be applied to the 
modification of paracetamol crystals, in order to optimize their compaction 
behaviour. Furthermore, AFM can be added to the series of techniques used to reveal 
the degree of inhibition induced by additives on specific faces of crystals.  
 
4.1.7 Aims of chapter. 
 
The influence of acetanilide and metacetamol on the morphology and growth of 
entire paracetamol crystals has previously been studied. However, there have been no 
investigations into the effects of these additives on the growth of individual faces of 
paracetamol crystals. In this chapter, we utilize both AFM and SEM to characterize 
the morphology of pure paracetamol crystals and those crystallized in the presence of 
an additive. In addition, we employ AFM to visualize and quantify the effects of 
these additives on growth on the most prominent, (001), face of paracetamol crystals. 
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4.2 Methods and Materials 
 
4.2.1 Preparation of paracetamol crystals grown in the presence and absence of an 
inhibitor. 
 
All crystals were prepared using a modified version of the cooling method described 
by Hendriksen et al. [23]. Pure paracetamol crystals were prepared by dissolving 
2.674g of paracetamol (99%, Sigma Aldrich, Dorset, U.K.) in 200ml of HPLC grade 
water, which had been filtered once. This solution was heated to approximately 40ºC, 
with a stirring rate of 238 rpm, until all of the solute had dissolved. It was then 
transferred to a refrigerator and maintained at 5ºC. The solubility of paracetamol at 
5ºC is 8.21g/l [284]. The supersaturation (ı) of the crystallization media was 
calculated using Equation 2.1 from Chapter 2: 
ı = ln (c/c0)      Equation 2.1 
where c and c0 are the actual and saturated solution concentrations respectively. The 
ı value of the crystallization media was calculated as 0.49. The crystals formed in 
solution over a period of four to five days, after which they were filtered, air-dried, 
and stored in a desiccator. Crystals containing additives were prepared in the same 
manner as described above, with an additive concentration equivalent to 4 mol%, 
with respect to paracetamol. This additive level was chosen as it has been previously 
used to investigate the effect of these compounds on the crystallization of 
paracetamol [23]. Thus, 0.096g of acetanilide (97%, Sigma Aldrich, Dorset, U.K.) or 
0.107g of metacetamol (97%, Sigma Aldrich, Dorset, U.K.) were added to the 
solution prior to heating. Again, crystals formed over a period of four to five days, 
and were subsequently filtered, air-dried, and stored in a desiccator. The morphology 
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and surface features of these crystals were examined using SEM and AFM. Crystals 
were immobilized on AFM sample stubs using Tempfix (Agar, Stansted, U. K.) prior 
to examination. 
 
4.2.2 Preparation of solutions for growth studies. 
 
Growth solutions, without any additive present, were prepared by dissolving 0.192g 
of paracetamol (99%, Sigma Aldrich, Dorset, U.K.) in 10 ml HPLC grade water,  
which had been filtered once. These solutions were heated to approximately 40ºC, 
with a stirring rate of 238 rpm, until all of the solute had dissolved. They were then 
allowed to cool to room temperature, before being placed in the AFM liquid cell with 
a paracetamol crystal sample. Growth solutions containing an additive were prepared 
in the same manner as described for pure paracetamol solutions. Solutions containing 
additive were prepared with a concentration equivalent to 4 mol%, with respect to 
paracetamol. In the case of the acetanilide-containing solution, 0.007g of acetanilide 
were added to the solution prior to heating, whereas 0.008g of metacetamol were 
added to its respective solution. All growth solutions were prepared immediately 
prior to each experiment. The ı value of paracetamol in each solution was expressed 
using Equation 2.1. 
The saturated concentration or solubility of paracetamol (mol %) was 
calculated using the following equation [24, 27, 29, 285]: 
ln c0 = 12200/T + 49.69 ln T  330.4   Equation 4.1 
where T is the absolute temperature in Kelvin. The temperature in all experiments 
was approximately 25ºC (298K). Using Equation 4.1, the solubility of paracetamol at 
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this temperature was calculated as 0.095 mol dm-3, which correlates well with 
measured values [284-286]. 
 Hence, using Equation 2.1, the supersaturation of paracetamol, ı, in the 
solutions used for the growth experiments was calculated as 0.29. It should be noted 
that structurally related compounds are known to increase the solubility of 
paracetamol [19, 22, 287]. However, the degree to which acetanilide and 
metacetamol affect the solubility of paracetamol is yet to be determined, and hence 
the solubility of paracetamol in the growth solutions is taken to be that of a pure 
solution. 
Prior to each experiment, paracetamol crystals were immobilized on AFM 
sample stubs, and then onto a suitable liquid cell using Tempfix (Agar, Stansted, U. 
K.). In each growth experiment, approximately 2.5 ml of the respective solution was  
placed in the liquid cell. Each sample was imaged continuously using AFM, after 
addition of the growth medium, to assess the growth rate in each solution, and to 
establish the extent of inhibition induced by acetanilide and metacetamol. 
 
 
4.2.3 AFM analysis. 
 
Contact mode imaging was employed throughout, using a ThermoMicroscopes 
Explorer AFM (Veeco, Bicester, Oxon, U.K.). V-shaped silicon nitride cantilevers  
(200µm length) with integrated pyramidal tips (Nanoprobes, Veeco, Santa Barbara, 
CA) were used. Both topography and deflection images were acquired in all 
experiments. 
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4.2.4 SEM analysis. 
 
All samples were initially gold coated for two minutes using a Balzers SCD 030 
Sputter Coater (Balzers Union Limited, Liechtenstein), operated at 0.1mbar with a 
sputtering current of 30mA. A Philips 505 SEM (Philips Electron Optics, Eindhoven, 
Netherlands) was used to image all samples under a range of magnification settings 
at a voltage of 23KeV, with a spot size of 50 nm. 
 
4.3 Results and Discussion 
 
4.3.1 Morphology of crystals grown in the presence and absence of the additives  
acetanilide and metacetamol. 
 
The SEM images of paracetamol crystals, Figure 4. 3, illustrate the habit of the pure 
paracetamol crystals. The tabular morphology attained by these crystals is consistent 
with that of paracetamol crystals grown at ı values greater then 0.15 [24, 29, 37, 59, 
281], here ı = 0.49. A schematic diagram of the morphology of paracetamol crystals 
grown at ı > 0.15 is given in Figure 4. 4. 
  
Figure 4. 5 shows AFM images of the surface of a paracetamol crystal. These 
images show steps ranging in height from 1 nm to 21 nm. The small, single 
molecular steps, which were previously found to be 10 Å in height [37], are curved 
in appearance, whereas the larger, multi-molecular steps have straight edges.  
 
 - 143 - 
Chapter 4 
a) 
b) 
 
Figure 4. 3 SEM images of paracetamol crystals showing their tabular habit. Both 
images are at magnification x 16.4. 
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Figure 4. 4 Diagrammatic representation of the morphology of paracetamol crystals 
grown at supersaturation values greater than 0.15. Adapted from [24]. 
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Figure 4. 5 10 µm x 10 µm AFM images of the surface of a paracetamol crystal 
acquired in air. Image a) illustrates the appearance of both small,  curved steps (black 
arrow) and larger, straight-edged steps (white arrow) on the surface of the crystal. 
Image b) highlights the small steps visible on the surface. Both a) and b) are 
deflection images. 
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Figure 4. 6 shows SEM images of paracetamol crystals grown in the presence of 4 
mol% acetanilide. Hereafter, these crystals shall be referred to as PA crystals. It is 
evident from these images that the habit of the PA crystals is comparable with that of 
paracetamol crystals, however, the PA crystals are smaller than paracetamol crystals. 
The AFM images shown in Figure 4. 7 reveal the surface features of the PA crystals. 
These images  portray steps which appear to have thin, branched terraces, rather than 
having curved or straight edges, as seen for pure paracetamol crystals (Figure 4. 5). 
The steps, which are approximately 20 nm in height, may adopt this branched 
appearance due to the pinning of steps by the acetanilide molecules. Pinning 
occurs when additives adsorb onto step or terrace regions of the growing crystal and 
impede the progression of growing steps. These steps must bend in order to squeeze 
through the impurity fence, and hence acquire a convoluted appearance. A large 
number of holes, indicative of defects, are also present in the surface.  
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a) 
b) 
 
Figure 4. 6 SEM images of paracetamol crystals grown in the presence of 4 mol% 
acetanilide. Image a) is at magnification x 17.2, and b) is at magnification x 34.4. 
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Figure 4. 7 10 µm x 10 µm AFM topographical images of the surface of a 
paracetamol crystal grown in the presence of 4 mol% acetanilide.  
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SEM images of paracetamol crystals grown in the presence of 4 mol% metacetamol 
are shown in Figure 4. 8. Hereafter, these crystals shall be referred to as PM crystals. 
Clearly, PM crystals attain a columnar habit, distinctly different from the tabular 
morphology observed with both paracetamol and PA crystals. From these data it is 
evident that the aspect ratio of the paracetamol crystal is more significantly affected 
by the addition of metacetamol to the crystallization medium than by acetanilide. 
These data are consistent with previous findings which calculated aspect ratios of 
paracetamol crystals grown in the absence of any additive as 1.2, whereas those 
grown in the presence of 4 mol% of metacetamol or acetanilide had aspect ratios of 
7.33 and 2.84 respectively [23]. 
Figure 4. 9 shows AFM images of the surface of a PM crystal. Image a) 
depicts steps of approximately 15 nm in height interspersed with holes in the surface. 
A defect is also evident in the centre of the image. Figure 4. 9b) illustrates the 
cavities formed in the surface as a result of the crystallization in the presence of 4 
mol% of metacetamol. The cavities are up to 65 nm in depth. It is clear from these 
images that metacetamol considerably increases the defect density of the (001) face 
of paracetamol crystals. These data suggest that the crystal lattice is significantly 
disrupted by metacetamol molecules during growth. 
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a) 
b) 
 
Figure 4. 8 SEM images of paracetamol crystals grown in the presence of 4 mol% 
metacetamol. Image a) is at magnification x 12.1, and b) is at magnification x 16.4. 
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Figure 4. 9 AFM topographical images of the surface of a paracetamol crystal grown 
in the presence of 4 mol% metacetamol. a) is a 5 µm x 5 µm image, b) is a 10 µm x 
10 µm image. 
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4.3.2 Growth on the (001) face of a paracetamol crystal in solutions of pure 
paracetamol, and those containing acetanilide or metacetamol. 
 
The sequence of images in Figure 4. 10 illustrate the growth of steps on the (001) 
face of a paracetamol crystal during incubation in a pure solution, where ı = 0.29. 
The steps range from 95 nm to 588 nm in height, and hence are macrosteps. The 
steps are curved in appearance, indicating that they are growing via the dislocation 
mechanism. This mechanism of growth is described in Chapter 2, and illustrated 
Figure 2. 1. In summary, a dislocation occurs as a result of stresses on the crystal 
during growth. These stresses induce sections of the crystal to become misaligned 
with respect to their neighbouring areas [1, 98]. As a result, a ledge is formed onto 
which molecules can absorb and continue growth. However, as the ledge is of non-
uniform height, growth occurs in a spiral pattern around the dislocation, and the 
growth mechanism is often referred to as screw dislocation [98, 103]. The features 
which arise from growth around such a dislocation are growth hillocks.  
These data are consistent with previous studies which have shown that all of 
the major faces of paracetamol ({110}, {001}, and {-201}) grow via a dislocation 
mechanism [27]. The rate of growth of the observed steps ranges from 26.4 nm/s to 
76.2 nm/s, and decreases with increasing step height. The steps are observed to grow 
in the [-100] direction. 
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Figure 4. 10 A sequence of 10 µm x 10 µm AFM images of the (001) face of a 
paracetamol crystal during incubation in paracetamol solution of supersaturation 
0.29. In image a) time t = 0 secs, b) t = 60 secs, c) t = 118 secs, d) t = 176 secs, e) t = 
234 secs, and f) t = 292 secs. All images are deflection images. 
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The images shown in Figure 4. 11 display the (001) face of a paracetamol crystal 
during incubation in paracetamol/4 mol% acetanilide solution. The supersaturation of 
the solution is 0.29, with respect to paracetamol. From these images it is clear that 
dissolution is occurring on the face. Prior to incubation in paracetamol/4 mol% 
acetanilide solution, the surface of the crystal exhibited features comparable to those 
shown in Figure 4. 5. However, after 11½ minutes of incubation, holes emerged in 
the surface. One such hole is highlighted by an arrow in Figure 4. 11a), and its 
dissolution is followed by an arrow in subsequent images. These holes may originate 
from defects in the crystal surface. The steps, which range from 13 nm to 45 nm in 
height, are observed to dissolve at rates between 1.3 nm/s and 2.7 nm/s, in the [100] 
direction. The dissolution rate of the steps decreases with increasing step height. The 
holes or clefts in the surface are also observed to deepen over time, indicating that 
dissolution is taking place towards the crystal core as well as laterally.  
As previously mentioned, the presence of additive molecules increases the 
solubility of paracetamol, which may induce the dissolution demonstrated here. 
However, we cannot assume that dissolution is ubiquitous over the crystal, as the 
remaining faces may be influenced to different degrees by the additive molecules. 
Further studies must be undertaken to evaluate the affect of such levels of acetanilide 
on the other faces of paracetamol crystals. These studies should allow a more precise 
determination of the extent to which acetanilide inhibits paracetamol crystal growth. 
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Figure 4. 11 A sequence of 10 µm x 10 µm AFM images of the (001) face of a 
paracetamol crystal during incubation in paracetamol/4 mol% acetanilide solution. 
The supersaturation of the solution is 0.29, with respect to paracetamol. In image a) 
time t = 0 secs, b) t = 146 secs, c) t = 290 secs, d) t = 436 secs, e) t = 582 secs, and f) 
t = 728 secs. All images are deflection images. 
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Figure 4. 12 shows a sequence of AFM images of the (001) face of a paracetamol 
crystal during incubation in paracetamol/4 mol% metacetamol solution. The 
supersaturation of the solution is again 0.29, with respect to paracetamol. A black 
and a white arrow follow the movement of two steps on the surface. From these 
images, it is clear that steps are growing in the [-100] direction. The steps range from 
4 nm to 21 nm in height, and their calculated growth rates range from 19.0 nm/s to 
37.8 nm/s, with no relation between step height and growth rate. 
 From the AFM images alone, it is evident that the progression of steps is 
hindered by metacetamol molecules. Those images showing growth during 
incubation in pure paracetamol solution, Figure 4. 10, illustrate that in such an 
environment, the face grows via the dislocation mechanisms of macrosteps. 
However, the images shown in Figure 4. 12 portray significantly smaller steps which 
are pointed in appearance, implying that pinning may be taking place. As 
previously stated, pinning occurs when additives adsorb onto step or terrace regions  
of the growing crystal, and thus, the steps must bend in order to squeeze through the 
impurity fence. Here, the steps acquire a pointed appearance. These characteristic 
pointed, and thus pinned, steps have been observed using AFM in other crystal-
additive systems [138, 139, 288, 289].   
The presence of metacetamol molecules not only alters the morphology of the 
growing steps, it also reduces their growth rates from an average of 49.5 nm/s to 27.1 
nm/s in the [-100] direction. These data are also consistent with previous AFM 
studies on additive effects on growth interfaces, which show a considerable 
retardation in step velocity in the presence of additive molecules [138, 139, 288, 
289]. It is evident, therefore, that metacetamol induces considerable inhibition of 
growth on the (001) face of paracetamol at this level (4 mol%).  
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Figure 4. 2 illustrates the molecular structure of paracetamol on the (001) face 
of the crystal. From this diagram, it is clear that the groups protruding from the 
surface in the direction of growth, [-100], are OH and NHCOCH3. Both of these 
groups allow the perpetuation of the hydrogen bonding network within the crystal, 
via attachment of molecules to the OH and CO groups. The only difference between 
paracetamol and metacetamol is the p- and m-position of their OH group, 
respectively. Hence, metacetamol could readily attach to the protruding OH and CO 
groups of the crystal surface via its CO group, which is equivalent to that of 
paracetamol, and its OH group, which resides juxtaposed to that of paracetamol. The 
former case would allow the hydrogen bonding network to be fully preserved, 
whereas the latter would cause it to be slightly distorted. It appears that metacetamol 
molecules could attach to the (001) face of paracetamol crystals and induce the 
degree of inhibition detected here. 
Again, we cannot assume that the same degree of inhibition would be 
observed on the other faces of the crystal, and hence further studies are required to 
assess the metacetamol-induced inhibition on the remaining faces. These studies may 
reveal the mechanisms by which metacetamol modifies the habit of paracetamol 
from tabular to columnar (Figure 4. 3 and Figure 4. 8 respectively).  
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i) 
 
ii) 
1 µm 
[-100] 
[010] 
b) c) 
e) f) 
a) 
d) 
Figure 4. 12 i) A sequence of 10 µm x 10 µm AFM images of the (001) face of a 
paracetamol crystal during incubation in paracetamol/4 mol% metacetamol solution. 
The supersaturation of the solution is 0.29, with respect to paracetamol. In image a) 
time t = 0 secs, b) t = 90 secs, c) t = 182 secs, d) t = 272 secs, e) t = 364 secs, and f) t 
= 454 secs. ii)  is a 4.8 µm x 4.8 µm image showing a portion of image i) d) at higher 
magnification, to highlight the pointed steps. All images are deflection images. 
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4.4 Conclusion 
 
The use of AFM and SEM has permitted the investigation of the effects of the 
additives, acetanilide and metacetamol, on the morphology and the growth on the 
(001) face of paracetamol crystals. SEM images showed the characteristic tabular 
habit of pure paracetamol crystals was only moderately altered by the presence of 
acetanilide, but the crystals adopted a columnar habit when grown in the presence of 
metacetamol.  
On a microscopic level, AFM revealed that the surface features of pure 
paracetamol crystals were steps ranging from 1 nm to 21 nm in height. On the 
contrary, crystals grown with acetanilide possessed thin, branched steps of 
approximately 20 nm in height. We suspect that the branched appearance of the steps 
is due to the adsorption of acetanilide molecules onto terraces or steps during growth, 
causing pinning and bending of the growing steps. Crystals grown in the presence of 
metacetamol also displayed different surface features to those of pure paracetamol. 
The presence of metacetamol during growth resulted in steps of approximately 15 
nm in height interspersed with holes, and also induced the formation of defects in the 
crystal surface. These data suggest that the crystal lattice, and hence the hydrogen 
bonding network, were considerably disrupted by metacetamol during growth. 
Growth on the (001) face of paracetamol crystals in the presence and absence 
of acetanilide or metacetamol was monitored via AFM. In the absence of any 
additive, growth was observed to occur by a dislocation mechanism. Growing steps 
ranged from 95 nm to 588 nm in height. The rate of growth of the steps ranged from 
26.4 nm/s to 76.2 nm/s, and decreased with increasing step height. All steps were 
observed to grow in the [-100] direction. 
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In the presence of acetanilide, holes emerged in the surface after 11½ minutes 
of incubation. These holes may have originated from defects in the crystal surface. 
Steps, ranging from 13 nm to 45 nm in height, emanated from these holes and 
dissolved at rates between 1.3 nm/s and 2.7 nm/s, in the [100] direction. The 
dissolution rate of the steps decreased with increasing step height. The holes or clefts 
in the surface were also observed to deepen over time, indicating that dissolution was 
occurring into the crystal core as well as laterally.  
The presence of additives is known to increase the solubility of paracetamol, 
which may have induced such dissolution. However, we cannot assume that 
dissolution was ubiquitous over the crystal, as each of the faces may have been 
influenced to different degrees by the additive molecules, and some may have grown 
under these conditions. Nonetheless, the presence of acetanilide in the growth 
medium caused dissolution in the [100] direction, whereas a pure paracetamol 
solution of the same ı facilitated growth of macrosteps in the [-100] direction.  
The presence of metacetamol resulted in the growth of steps, of 4 nm to 21 
nm in height, at rates of 19.0 nm/s to 37.8 nm/s in the [-100] direction. The steps 
were pointed in appearance and significantly smaller than those observed in the 
absence of metacetamol, suggesting that the additive molecules pinned the steps. The 
average growth rates in the absence and presence of metacetamol were 49.5 nm/s and 
27.1 nm/s respectively. Hence, metacetamol dramatically altered not only the 
morphology, but also the rate of the growing steps. AFM enabled the observation of 
the effects of metacetamol on the growing interface on a micrometre scale. However, 
we could not establish, at this resolution, whether additive adsorption occurred at 
step edges or on terraces, as both generate the formation of pointed, pinned steps 
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[138, 139]. Nonetheless, pinning of steps and reduction in growth rates were 
observed, in accordance with the Cabrera and Vermilyea model. 
The functional groups which protrude from the (001) face, in the [-100] 
direction, are NHCOCH3 and OH. These groups may enable attachment of 
metacetamol molecules via their CO group, which is equivalent to that of 
paracetamol, or their OH group, which is located juxtaposed to that of paracetamol. 
In either case, the hydrogen bonding network of the crystal would be largely 
preserved. Hence, metacetamol may bind with relative ease to this face and induce 
the degree of inhibition observed. 
We suggest that further similar experiments should be carried out using each 
of the structurally related additives, not only on the (001) face, but on all other faces  
of the crystal. These investigations would help to achieve a ranking order of the 
inhibitory effects of the additives on each of the crystal faces. Particular attention 
should be paid to the inhibitory activities on the {110} faces. These are considered to 
be morphologically the most influential, because their growth rates and mechanisms 
change with increasing ı,  altering the habit of the crystal from columnar to tabular 
[24, 29, 37, 59].   
Once the degree of inhibition of these additives has been established for each 
face of paracetamol, they could, individually or as a mixture, be employed to control 
the habit of paracetamol crystals, their chemical properties, and perhaps their 
problematic compaction behaviour.  
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Chapter 
5 
 
Determination of the mechanisms of anion exchange in 
Co-ordination Polymers. 
 
Co-ordination polymers are currently attracting extensive interest due to the vast 
scope of potential applications for their supramolecular structures. Many applications 
rely on the ion exchange capabilities of these compounds. Considerable debate 
surrounds the mechanism by which ion exchange occurs in co-ordination polymers. 
Here we investigate the process by which the anion exchange and subsequent 
structural transformations of the crystalline co-ordination polymers {[Ag(4,4-
bipy)]BF4}f and {[Ag(4,4-bipy)]NO3}f occur. The experiments described in the 
following chapter have been the subject of a publication in Crystal Engineering 
Communications [290], and a further manuscript has been submitted to the Journal 
of Microscopy [291]. 
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5.1    Introduction 
 
5.1.1 The design and assembly of co-ordination polymers. 
 
Polymeric compounds generated via the interaction between metal cations and 
organic ligands have led to the emergence of a wide variety of fascinating one-, two-, 
and three-dimensional structures. Commonly referred to as co-ordination polymers, 
this class of compounds has been termed living polymers due to their ability to 
grow and shorten, rearrange their interaction patterns, exchange components, 
undergo annealing, healing and adaptation processes [292].  
These materials self-assemble from their elementary components of organic 
molecules and transition metal ion salts (see, for example, references [293-298]). The 
metal-anion complexes within the salt dissociate, allowing the metal ions to form a 
polymeric framework with the organic molecules, and the anions to become 
incorporated into the pores of the framework as molecular or ionic guests depending 
on the framework charge [293]. Thus, the intrinsic structure of the framework is held 
together by co-ordination bonds, and is dictated by the bonding geometry of the 
metal linker, the functionality and denticity of the organic ligand [299, 300], and 
nature of the anions [293, 299, 301, 302]. Extended anionic, cationic, and neutral 
frameworks can be produced, depending on the constituent building blocks of the co-
ordination polymers. The design of co-ordination polymers takes into account factors 
such as the co-ordination nature of the metal ion, the structural characteristics of the 
polydentate organic ligand, the metal-ligand ratio, and the possible anion influence. 
A subtle alteration in any of these factors can lead to new extended network 
structures. Consequently, a great variety of supramolecular architectures have been 
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ingeniously constructed [294, 295, 297, 298, 303-305]. Theoretically, there are a vast 
number of porous frameworks of varying size, structure, dimension and pore size, 
and hence function which may be produced by exploiting the binding characteristics 
of both the metal ions and the organic molecules which constitute co-ordination 
polymers. Indeed the production of tailor-made compounds with desired structure, 
pore size, or function may soon be an attainable goal as the level of research 
dedicated to these compounds continues to increase. 
 
5.1.2 Ion exchange properties of co-ordination polymers and their potential uses. 
 
An exciting, yet little explored area of these supramolecular compounds, is the 
ability of these rigid porous frameworks to exchange the ions within their pores with 
ions from solution, without destruction of their framework [293, 301, 305-312]. This 
phenomenon induces the interconversion of a framework containing host ions, to a 
framework containing solution ions. Ion exchange frequently involves a structural 
transformation occurring in the crystalline state [298, 301, 302, 304, 306]. For 
example, anionic species within polycationic hosts may be involved in interactions 
with metal centres or organic ligands, and in some cases can play an important role 
in supporting the overall framework of the polymer [300, 313]. Removal of such 
anions would induce the collapse of the polymer framework. However, anions often 
interact only weakly with the framework, and hence their removal or exchange does  
not disrupt the integrity of the framework. This observation has recently led 
researchers to use co-ordination polymers as ion exchange materials [293, 298, 301-
304, 314-316]. It has been shown that anions freely located in the co-ordination 
polymer framework can be completely replaced when the solid co-ordination 
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polymer is treated with an aqueous  solution containing other anionic species [293, 
298, 301-304, 307, 316]. Spectroscopic methods of analysis and X-ray powder 
diffraction (XRPD) show that the exchange is fast (occurs within a few hours), 
complete and often reversible in various types of co-ordination polymers [290, 293, 
298, 301-304, 307, 308, 312, 314-317]. 
It has been postulated that cationic frameworks capable of anion exchange 
may be utilised in the removal and recovery of inorganic and organic anions such as, 
MoO4
2-, CN-, HS-, and C6H5O
- from industrial wastewater [293]. Neutral frameworks 
may also prove to be extremely useful in the removal and recovery of aromatic 
compounds and halogenated hydrocarbons from industrial processes [293].  
The ion exchange capabilities of these compounds have led to an extensive 
list of potential uses for co-ordination polymers. These include reversible solvent 
inclusion [305, 318-323], molecular sieving [298, 318-321], catalysts for specific 
reactions [309, 312, 318, 324-327], drug and chemical delivery [298], molecular 
recognition, chemical sensor technologies [302, 304], in optoelectronic [328, 329], 
magnetic [330], microporous [313, 331], and biomimetic materials [298]. 
 
5.1.3 Is the mechanism of ion exchange a solid-state or solvent-mediated process?  
 
The mechanisms by which this ion exchange process occurs are currently the subject 
of considerable debate. There are two main hypotheses regarding the ion exchange 
mechanisms of these compounds.  One hypothesis suggests that the exchange is a 
solid-state process [293, 317], namely that, when in a solution of anions, the host 
anions migrate out of the crystalline solid through the channels between layers. 
Concurrently, the anions from solution move into the crystalline complex [293, 298, 
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301]. It has been postulated that the facility with which the ion exchange occurs, 
coupled with the fact that the crystal morphology is retained throughout the exchange 
process, is evidence that the anions diffuse into the framework without any 
dissolution/recrystallization of the material or destruction of the host network [293]. 
However, as already mentioned, many anion exchange processes require a dramatic 
structural reorganization from the initial phase to the resulting phase [298, 301, 302, 
304, 306], which is not consistent with a solid-state mechanism. 
The alternative hypothesis suggests that the process occurs via a solvent-
mediated recrystallization process [332], involving the dissolution of one crystalline 
phase and subsequent precipitation of another. Such processes have been illustrated 
in inorganic crystals [333-336], and followed using AFM [333, 335, 336]. Previous 
reports on anion exchange show that, although crystals retain their shape and size, 
they lose their crystallinity rapidly during the exchange process [293, 301, 314, 315]. 
This would indicate the occurrence of significant restructuring within the crystal and 
would, hence, support this hypothesis. However, the apparent insolubility of co-
ordination polymers in water [304, 314] would tend to contradict this theory. In order 
to assess which of the proposed hypotheses is correct, we have used AFM to 
investigate, in situ, the processes by which anion exchange occurs in the co-
ordination polymers {[Ag(4,4-bipy)]BF4}f and {[Ag(4,4-bipy)]NO3}f.  
 
5.1.4 Structures of {[Ag(4,4-bipy)]BF4}f and {[Ag(4,4-bipy)]NO3}f.   
 
AgI [293, 295, 298, 299, 301, 302, 304, 310, 314] and 4,4-bipyridine (4,4-bipy) 
[293, 299, 305, 314, 316, 337, 338] are common building blocks of co-ordination 
polymers. The structure of the 4,4-bipyridine ligand is shown in Figure 5. 1. The co-
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ordination sphere of AgI is very flexible and can adopt co-ordination numbers from 
two to six, and varying geometries from linear to tetrahedral, trigonal,  pyramidal and 
octahedral [339].  
N N
 
Figure 5. 1 Structure of the 4,4-bipyridine ligand. 
 
 
Similarly, (4,4-bipy) is known to yield diamond-like, hexagonal, square grid, and 
ladder structures [293]. The crystal structures of both {[Ag(4,4-bipy)]NO3}f (Figure 
5. 2) [299, 314, 315] and the two isomers of {[Ag(4,4-bipy)]BF4}f (Figure 5. 3 and 
Figure 5. 4) [299, 340] have been elucidated, and reveal the presence of linear 
polymeric chains in all three structures.  
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Figure 5. 2 Illustration of the packing of polymeric chains within the crystal 
structure of {[Ag(4,4-bipy)]NO3}f, where two consecutive layers of chains are 
depicted in black and red. The filled purple circles represent the silver ions within the 
chains [341]. 
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Figure 5. 3 Illustrations of the alignment of single stacks of polymeric chains within 
isomer B (a) and isomer A (b) of {[Ag(4,4-bipy)]BF4}f. The silver ions are shown 
as filled purple circles [341]. 
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Figure 5. 4 Arrangement of the stacks of polymeric chains in the crystal structures of 
isomer B (a) and isomer A (b) of {[Ag(4,4-bipy)]BF4}f. Again the silver ions are 
shown as filled purple circles [341]. 
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Despite the very similar structure of the single polymeric chains, the spatial 
arrangement of these chains within each polymer and, hence, the overall three-
dimensional structures of the polymers are considerably different. In {[Ag(4,4-
bipy)]NO3}f and isomer A of {[Ag(4,4-bipy)]BF4}f, the chains are orthogonal, that 
is, they are stacked in a criss-cross pattern (Figure 5. 2 and Figure 5. 4b). In isomer B 
of  {[Ag(4,4-bipy)]BF4}f the chains stack in parallel layers (Figure 5. 4a), whereas  
in the isomer A the neighbouring stacks are inclined at 74.2o angle (Figure 5. 4b) 
[340]. In {[Ag(4,4-bipy)]NO3}f the Ag-(4,4-bipy) chains are cross-linked through 
Ag-Ag bonds (2.977 Å) to form a three-dimensional porous framework with large 
rectangular channels of dimension 23 x 6 Å [293]. The T-shaped co-ordination of 
silver leaves an open co-ordination site pointing towards the centre of the channels, 
where the nitrate guests form very weak interactions with silver (Ag-O bond length is 
2.78 Å) [293, 314]. NO3
- anions reside in the pores of the hatched {[Ag(4,4-
bipy)]NO3}f complex. {[Ag(4,4-bipy)]BF4}f chains are bound together by only 
aromatic interchain interactions [315]. BF4
- anions are located in the space between 
stacks in both forms of the complex {[Ag(4,4-bipy)]BF4}f. Anions in crystalline 
complexes of {[Ag(4,4-bipy)]X}f are effectively non-co-ordinating and, therefore, 
available for exchange. 
 
5.1.5 Reversible anion exchange properties of {[Ag(4,4-bipy)]BF4}f and 
{[Ag(4,4-bipy)]NO3}f. 
 
Evaluation of the ion exchange properties of {[Ag(4,4-bipy)]NO3}f has revealed 
that the NO3
- ions residing in the channels of the complex can be reversibly 
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exchanged with PF6
-, BF4
-, SO4
2-, and MoO4
2- without destruction of the framework 
[293, 314]. Experiments using single crystals of {[Ag(4,4-bipy)]BF4}f and 
{[Ag(4,4-bipy)]NO3}f immersed in aqueous solutions of anions have shown that the 
crystals do not change size or shape upon exchange, but quickly loose optical 
transparency and the single crystal integrity [290, 293, 314]. This may indicate that 
significant restructuring has occurred. In each instance, ion exchange occurs simply 
and reversibly via incubation of the crystalline polymer in an aqueous solution of 
anions. These findings have been confirmed by infrared spectroscopy [290, 293, 
314], elemental microanalysis [293, 314], XRPD [290, 293, 314], optical microscopy 
[293, 314], transmission electron microscopy (TEM) [290], and 1H nuclear magnetic 
resonance (NMR) [290]. These techniques collectively illustrate that the ion 
exchange process results in a pure crystalline phase of the new co-ordination 
polymer. The apparent loss of crystallinity observed during the ion exchange process 
may imply that the mechanism follows that of the solvent-mediated hypothesis.  
The assumption that co-ordination polymer compounds are insoluble [304, 
314], appears to be untrue for {[Ag(4,4-bipy)]NO3}f and {[Ag(4,4-bipy)]BF4}f. 
Recent studies using electroconductance measurements, atomic absorption 
spectrophotometry, and AFM (illustrated later in this chapter) show polymers 
{[Ag(4,4-bipy)]NO3}f and {[Ag(4,4-bipy)]BF4}f have water solubility values of 
0.84 mmol/L and 0.82 mmol/L respectively [290]. The albeit low solubility values of 
these two polymers may prove to be enough to facilitate the proposed solvent-
mediated mechanism. 
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5.1.6 Aims of chapter. 
 
There have been no previous detailed microscopic investigations of the crystal phase 
transformations during ion exchange reactions of these types of systems. In order to 
address the discrepancies in the current ion exchange theories, and assess which of 
the proposed hypotheses is correct, here we use AFM to investigate, in situ, the 
processes by which anion exchange and the subsequent structural transformations 
occur in the co-ordination polymers {[Ag(4,4-bipy)]NO3}f and {[Ag(4,4-
bipy)]BF4}f. 
 
5.2    Methods and Materials 
 
All reagents (Aldrich) were used as received. The co-ordination polymers were 
prepared by the literature methods [299, 314, 342]. Crystals were immobilized on 
AFM sample stubs, and then to a suitable liquid cell using Tempfix (Agar, Stansted, 
U. K.). {[Ag(4,4-bipy)]BF4}f crystals were imaged in HPLC grade water to 
investigate their apparent insolubility. The anion exchange process was investigated 
by imaging {[Ag(4,4-bipy)]BF4}f crystals in 3M NaNO3 solution, and imaging 
{[Ag(4,4-bipy)]NO3}f crystals in 1M NaBF4 solution. It was found that solutions of 
NaBF4 of concentration greater than 1M induced the formation of salt crystals 
throughout the AFM liquid cell, on the scanner, and tip, thus preventing imaging. In 
all experiments HPLC grade water was used as a solvent. In each case, 
approximately 2.5 ml of the respective solution was placed in the liquid cell. 
 
 - 174 - 
Chapter 5 
5.2.1 AFM analysis. 
  
Contact mode imaging was employed throughout, using a ThermoMicroscopes 
Explorer AFM (Veeco, Bicester, Oxon, U.K.). V-shaped silicon nitride cantilevers  
(200µm length) with integrated pyramidal tips (Nanoprobes, Veeco, Santa Barbara, 
CA) were used. Both topography and deflection images were acquired in all 
experiments. Deflection images emphasize areas of rapid topography changes, such 
as steps, but do not give any information about relative heights of features on the 
surface. 
 
5.2.2 SEM analysis. 
 
{[Ag(4,4-bipy)]NO3}f and {[Ag(4,4-bipy)]BF4}f crystals were also imaged using 
SEM. After incubation in 3M NaNO3 and 1M NaBF4 solution for 24 hours 
respectively, {[Ag(4,4-bipy)]BF4}f and {[Ag(4,4-bipy)]NO3}f were imaged using 
SEM. All samples were initially gold coated for four minutes using a Balzers SCD 
030 Sputter Coater (Balzers Union Limited, Liechtenstein), operated at 0.1mbar with 
a sputtering current of 30mA. A Philips 505 SEM (Philips Electron Optics, 
Eindhoven, Netherlands) was used to image all samples under a range of 
magnification settings at a voltage of 23KeV, with a spot size of 50 nm. 
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5.3    Results and Discussion 
 
5.3.1 AFM and SEM data for {[Ag(4,4-bipy)]BF4}f and {[Ag(4,4-bipy)]NO3}f 
crystals in air and water. 
 
The topographical features of {[Ag(4,4-bipy)]BF4}f crystal revealed by AFM are 
shown in Figure 5. 5. These AFM images reveal long, narrow, finger-like processes 
on the surface, which may reflect the underlying parallel chains of isomer B within 
the crystal structure. The average height of these features is 87 nm. SEM images, 
Figure 5. 6, confirm the presence of finger-like features on the surface of these 
crystals, but also display regions  which appear disordered or amorphous in nature. 
These regions may correspond to the ends of vertical finger-like features, or may 
indeed correspond to areas of isomer A within the crystal.  
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a) 
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Figure 5. 5 10 µm x 10 µm AFM topographical images of the surface of a {[Ag(4,4-
bipy)]BF4}f crystal, acquired in air. 
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b) 
a)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. 6 SEM images of the surface of a {[Ag(4,4-bipy)]BF4}f crystal. Image a) 
is at magnification x 2200, and b) is the lower central area of image a) at 
magnification x 8800. 
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AFM images of  {[Ag(4,4-bipy)]NO3}f crystal in Figure 5. 7 illustrate much larger 
features than those present on {[Ag(4,4-bipy)]BF4}f crystals, with an average 
height of 1835 nm. The features are almost triangular in shape which, again, may 
reflect the underlying hatched pattern of the chains within the crystal. We do note 
that some of the triangular features apparent in these images may be artefacts 
induced by the AFM tip imaging itself when scanning large surface features. 
However SEM data, Figure 5. 8, confirm the presence of much larger, triangular 
topographical features on the surface of {[Ag(4,4-bipy)]NO3}f crystals. 
The sequence of images  in Figure 5. 9 show the surface of a {[Ag(4,4-
bipy)]BF4}f crystal during incubation in water. It is evident that immediately after 
exposure the surface features of the crystal have changed as a result of dissolution. 
The progressive dissolution of steps is apparent throughout the sequence of images, 
and hence dispels the widely accepted presumption that these co-ordination polymers 
are insoluble [304, 314]. Dissolution of one step is indicated on each image by an 
arrow. 
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Figure 5. 7 10 µm x 10 µm AFM images of the surface of a {[Ag(4,4-bipy)]NO3}f 
crystal, acquired in air. Both a) and b) are topography images which have been left-
shaded to allow the features to be more easily visualized. 
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b) 
a)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. 8 SEM images of the surface of a {[Ag(4,4-bipy)]NO3}f crystal. Image a) 
is at magnification x 549, and b) is at magnification x 2200. 
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d) c) 
b) a) 
 
 
Figure 5. 9 10 µm x 10 µm AFM topographical images of the surface of a {[Ag(4,4-
bipy)]BF4}f crystal during incubation in water. Image a) shows the surface at time t 
= 0, immediately after addition of water, b) after 5 min 34 s,  c) after 9 min 19 s, and 
d) after 13 min 13 s. Dissolution one particular step is followed on each image with 
an arrow. 
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5.3.2 Anion exchange. 
 
The images shown in Figure 5. 10 depict the surface changes of a {[Ag(4,4-
bipy)]BF4}f crystal during incubation in 3M NaNO3 solution. Immediately after 
addition of NaNO3 solution, the surface topography has changed in a manner 
indicating that dissolution is  occurring. After only 30 minutes, new features begin to 
emerge on the surface. The features appear triangular in shape, analogous with those 
found in AFM and SEM images of {[Ag(4,4-bipy)]NO3}f crystals. Within one hour 
of the addition of NaNO3 solution the triangular features dominate this area of the 
surface, and the surface is comparable to that of the {[Ag(4,4-bipy)]NO3}f crystal 
in air,  Figure 5. 10 e). These images clearly show that the anion exchange process 
which the {[Ag(4,4-bipy)]BF4}f crystal undergoes in the presence of  NaNO3 
solution, occurs via the initial dissolution of {[Ag(4,4-bipy)]BF4}f, followed by 
subsequent recrystallization of {[Ag(4,4-bipy)]NO3}f onto the crystal surface. AFM 
data show that the reaction was complete within 12 hours, which correlates well with 
previous findings [290, 293, 314]. Prior to the addition of NaNO3 solution the 
average height of the surface features is 158 nm, but immediately after addition of 
NaNO3 solution this increases to 308 nm, to 437 nm after 30 minutes, and to 518 nm 
after 3 hours. The progressive enlargement of surface features may, in part, be due to 
the recrystallization of {[Ag(4,4-bipy)]NO3}f on the surface, but may also be as a 
result of dissolution. The latter would allow clefts in the crystal to become deeper, 
and thus provide the solution with access to the successive crystalline layers. These 
observations are typical for solvent-mediated transformations [141, 333, 335].  
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e) 
c) b) 
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Figure 5. 10 10 µm x 10 µm AFM images of the surface of a {[Ag(4,4-bipy)]BF4}f 
crystal before and during incubation in 3M NaNO3 solution. Image a) shows the 
surface of the crystal in air prior to the addition of NaNO3 solution, b) at time t = 0, 
immediately after addition of NaNO3 solution, c) t = 30 min, and d) t = 60 min. 
Image e) is a comparative 10 µm x 10 µm AFM image of the surface of a {[Ag(4,4-
bipy)]NO3}f crystal in air. All are topography images which have been left-shaded 
to allow the features to be more easily visualized. 
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This process allows dissolution and recrystallization to occur deeper into the crystal 
core, resulting in a self-perpetuating (autocatalytic) transformation from {[Ag(4,4-
bipy)]BF4}f to {[Ag(4,4-bipy)]NO3}f. These findings aid the explanation of TEM 
and XRPD data [290] which show that upon anion exchange of {[Ag(4,4-
bipy)]BF4}f to {[Ag(4,4-bipy)]NO3}f or {[Ag(4,4-bipy)]NO3}f to {[Ag(4,4-
bipy)]BF4}f, crystals X retained their shape but became a mass of microcrystals of 
pure crystal Y.  
The conditions required and the mechanisms operating during autocatalysis 
have been extensively studied [343, 344]. A typical autocatalytic process involves a 
new phase growing on the surface of a parent phase which acts as a sink because it 
lies within the diffusion distance. This may indeed be the mechanism of dissolution-
recrystallization observed during the ion exchange process of these co-ordination 
polymers. 
The solvent-mediated transformations of organic crystalline solids are well 
documented [345-347], and are essentially rearrangements of hydrogen bonds, 
dipole-dipole, van der Waals and/or other non-covalent interactions. We suggest that 
the structural reorganization observed in these co-ordination polymers is initiated by 
the depolymerization (dissolution) of the initial polymer from the crystal surface. 
Once in the solution, anion exchange occurs, and a new polymeric phase is formed. 
This new phase precipitates on the surface of the initial crystal. This process 
proceeds via autocatalysis, facilitated by emerging clefts and fundamental defects in 
the crystal. This results in a self-perpetuating cascade of dissolution and 
recrystallization throughout the crystal. 
SEM images of {[Ag(4,4-bipy)]BF4}f crystals after incubation in NaNO3 
solution for 24 hours, Figure 5. 11, also support previous TEM data. Here it is 
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evident that the crystal retains its shape, but loses its integrity as it becomes a mass of 
microcrystals of {[Ag(4,4-bipy)]NO3}f. In addition, these SEM images show that 
only certain areas of the crystals have converted to microcrystalline {[Ag(4,4-
bipy)]NO3}f, while other regions retain the characteristic finger-like features 
observed on the surface of {[Ag(4,4-bipy)]BF4}f crystals (Figure 5. 6). From these 
images it appears that the crystal may have been removed from 3M NaNO3 solution 
before the growth of the new phase had spread across the entire crystal. This would, 
however, contradict previous findings in which the process has been shown to be 
complete within 12 hours [290, 293, 314]. One plausible explanation for this is that 
during anion exchange, recrystallization occurs on the crystal, followed by growth of 
the phase across the surface in a manner analogous to that of two-dimensional 
nucleation [141, 145].  
Alternatively, the geographical location of the differing phases may be due to 
the different isomers of {[Ag(4,4-bipy)]BF4}f crystal. The proportion of each 
isomer in these crystals is unknown, and hence the location of each isomer within the 
crystal structure is unknown. However it is easy to rationalize that one of the isomers 
may dissolve faster than the other, or allow recrystallization to occur with greater 
ease or more compatibility. For example, isomer A has a hatched structure, 
comparable to that of {[Ag(4,4-bipy)]NO3}f and hence may allow the 
dissolution/recrystallization process to occur with greater ease because it does not 
need to undergo such a pronounced structural change. In addition, the structure of 
isomer A may facilitate the recrystallization of {[Ag(4,4-bipy)]NO3}f, by allowing 
an almost epitaxial growth of the new phase to occur, similar to that observed by 
Booth et al. [335]. Organic crystals are commonly used for such a purpose, and act 
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as nucleation promoters and crystallizing aids in the manufacturing of polymers 
whose properties require a specific degree of crystallinity [13]. 
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Figure 5. 11 SEM images of {[Ag(4,4-bipy)]BF4}f crystals after incubation in 3M 
NaNO3 solution for 24 hours. Image a) i)  shows a crystal, at magnification x 274, 
which has retained its shape but almost entirely become a mass of microcrystals. 
These microcrystals are shown at magnification x 1100 in image a) ii). Image b) i)  
also shows a crystal at magnification x 274. Only approximately half of this crystal 
has converted to microcrystals, whereas the other half retains the original {[Ag(4,4-
bipy)]BF4}f surface structure. The boundary between the two halves is shown in 
image b) ii) at magnification x 549. 
Chapter 5 
Further investigations are necessary to fully assess the proportion of each isomer in 
{[Ag(4,4-bipy)]BF4}f crystals, and their effect on this ion exchange process.  
The AFM image sequence shown in Figure 5. 12 follows the surface changes  
on a {[Ag(4,4-bipy)]NO3}f crystal during incubation in 1M NaBF4 solution. This is 
the reverse process of that visualized in Figure 5. 10. At time t = 0 the height of the 
apex of the triangular feature is 1194 nm. After 1 hour, the height of the feature 
decreases to 847 nm and a cleft is emerging at its point, indicating dissolution is 
taking place. At t = 1½ hours the height of the feature is 894 nm and depth of the 
cleft is 275 nm, suggesting that dissolution is occurring on and around the feature. 
Dissolution continues and after 2 hours the height of the feature is 1141 nm and the 
cleft, which has almost divided the feature into two distinct areas, has a depth of 730 
nm. Recrystallization is observed after 2½ hours during this process, which is later 
than in the {[Ag(4,4-bipy)]BF4}f to {[Ag(4,4-bipy)]NO3}f process. This is 
probably due to the relative solubilities of the two polymers, as discussed later in the 
chapter. The new phase continues to recrystallize and grow across the surface and the 
entire process is again complete within 12 hours.  
These images clearly illustrate the dissolution and recrystallization processes 
which constitute the anion exchange mechanisms, and the emergence of clefts which 
perpetuate the autocatalytic process. 
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Figure 5. 12 Images a) to f) are 10 µm x 10 µm AFM images of the surface of a 
{[Ag(4,4-bipy)]NO3}f crystal during incubation in 1M NaBF4 solution. In image a) 
time t = 0, b) t = 1 hr, c) t = 2 hrs, d) t = 2½ hrs, e) t = 3 hrs, and f) t = 4½ hrs. All are 
topography images which have been left-shaded to allow the features to be more 
easily visualized. 
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SEM images, Figure 5. 13, of {[Ag(4,4-bipy)]NO3}f crystal after incubation in 1M 
NaBF4 for 24 hours demonstrate the presence of microcrystals which remained 
within the boundary of the initial {[Ag(4,4-bipy)]NO3}f crystal. These findings 
reiterate those of previous TEM and XRPD data [290]. Unlike the {[Ag(4,4-
bipy)]BF4}f crystals, after incubation in NaNO3 solution (Figure 5. 11) these crystals 
had completely converted from {[Ag(4,4-bipy)]NO3}f  to {[Ag(4,4-bipy)]BF4}f 
microcrystals.    
The kinetics of solvent-mediated processes are dependent upon the 
dissolution and growth rates of the corresponding phases [332]. However, the driving 
force for the process is invariably the difference in solubility of a metastable initial 
phase (more soluble) and a stable new phase (less soluble) [332]. These principles 
are applicable to the anion exchange process of these co-ordination polymers. 
The solubility values for {[Ag(4,4-bipy)]BF4}f and {[Ag(4,4-bipy)]NO3}f 
in 3M NaNO3 are 0.06 mmol L
-1 and 0.02 mmol L-1 respectively [290]. Hence solid 
{[Ag(4,4-bipy)]BF4}f is the metastable phase in 3M NaNO3, and will therefore 
dissolve. As it dissolves the solution becomes progressively more saturated with Ag+ 
ions and bipyridyl molecules. When the saturation reaches a critical value, the 
monomeric components reassemble to form the more stable {[Ag(4,4-bipy)]NO3}f 
phase, which then recrystallizes on the surface of the crystal. This process 
undersaturates the solution and induces further dissolution of {[Ag(4,4-bipy)]BF4}f. 
During the solvent-mediated transformations of the sparingly soluble solids, the 
solution is always saturated with respect to the metastable phase and supersaturated 
in respect of the stable phase [332]. 
The solubility values for these polymers in 1M NaBF4 are unknown. 
However, the values are known for 3M NaBF4, they are 0.13 mmol L
-1 and 0.57 
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mmol L-1 for {[Ag(4,4-bipy)]BF4}f and {[Ag(4,4-bipy)]NO3}f respectively [290]. 
Clearly the solubility of the polymers would be greater in 1M NaBF4, but from these 
values it is evident that, in NaBF4 solution, {[Ag(4,4-bipy)]NO3}f is the metastable 
phase whereas {[Ag(4,4-bipy)]BF4}f is the stable phase. Therefore a similar 
scenario to that described above can be envisaged for the transformation of 
{[Ag(4,4-bipy)]NO3}f to {[Ag(4,4-bipy)]BF4}f in NaBF4 solution.  
In general it can be assumed that, when {[Ag(4,4-bipy)]X}f is immersed in 
a solution containing an excess of anion Y, it can be regarded as a metastable phase 
and, therefore, undergoes a transformation into the new stable phase {[Ag(4,4-
bipy)]Y}f.  
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Figure 5. 13 SEM images of a {[Ag(4,4-bipy)]NO3}f crystal after incubation in 1M 
NaBF4 solution for 24 hours. The magnification used in each image is a) x 131, b) x 
526, c) x 2100, and d) x 4200. 
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5.4    Conclusion 
 
AFM has proven to be an essential tool in elucidating the true mechanism by which 
the reversible anion exchange process of the co-ordination polymers {[Ag(4,4-
bipy)]BF4}f and {[Ag(4,4-bipy)]NO3}f occurs. AFM data has confirmed the 
solubility of these co-ordination polymers and verified that the anion exchange 
process is indeed solvent-mediated, involving the dissolution of one crystalline phase 
and subsequent recrystallization of another, as illustrated in Figure 5. 14. As the 
crystal dissolves, clefts form within the crystal allowing the solution to access layers 
beneath the crystal surface. We suggest that the structural reorganization observed in 
these co-ordination polymers is initiated by the depolymerization (dissolution) of the 
initial polymer from the crystal surface. Once in the solution phase, anion exchange 
occurs, and a new polymeric phase is formed. This new phase precipitates on the 
surface of the initial crystal. This process proceeds via autocatalysis, facilitated by 
emerging clefts and fundamental defects in the crystal. This results in a self-
perpetuating cascade of dissolution and recrystallization throughout the crystal. This 
data supports previous findings which speculated that the solvent-mediated process 
was the true one [290].  
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Figure 5. 14 Schematic diagram illustrating the mechanism by which ion exchange, 
and consequent structural conversion occurs in the co-ordination polymers 
{[Ag(4,4-bipy)]BF4}f and {[Ag(4,4-bipy)]NO3}f. In a) {[Ag(4,4-bipy)]BF4}f is 
in a solution of nitrate ions, b) shows the dissolution of the top layer of the 
{[Ag(4,4-bipy)]BF4}f crystal in the nitrate solution. This is followed by the 
recrystallization of the polymeric layer, with weakly bound nitrate ions, onto the 
initial crystal, as displayed in c).  
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SEM data support and consolidate the AFM data, showing the appearance of 
microcrystals which retain the shape of the initial crystal, after each co-ordination 
polymer crystal had been incubated in their respective solution of ions. In addition, 
these SEM data also highlight the possible effect of the two isomers of {[Ag(4,4-
bipy)]BF4}f on the anion exchange process. Further studies are imperative in order 
to assess the impact of these isomers on the potential applications of {[Ag(4,4-
bipy)]BF4}f. 
These findings reiterate the ability of such interconversion processes to 
produce pure crystalline states of other compounds, which may be difficult to 
produce by other means [297]. These characteristics may prove to be very desirable 
to crystal engineers, whose ultimate aim is the rational design and control of crystal 
structures as well as the fine-tuning of their structure by modifying the constituent 
components [317, 348-350].     
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Chapter 
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General Conclusions 
 
 
 
 
AFM has been extensively used to investigate the growth of a plethora of crystalline 
compounds. However, to date, it has not been used to probe the growth dynamics of 
any pharmaceutical drug crystal. In Chapter 1, the parameters which affect drug 
crystal growth, and their subsequent effects on processing, were comprehensively 
discussed. One of the parameters highlighted was supersaturation. Supersaturation 
(ı) is known to have profound effects on both the morphology and, at the molecular 
level,  the growth mechanisms of crystals. In Chapter 2, we utilized AFM to assess 
the mechanisms and kinetics of growth on the (001) face of aspirin crystals at two 
levels of supersaturation. We used AFM to directly visualize, in situ, the mechanisms  
of growth which occurred on the (001) face of aspirin crystals at ı = 0.31 and ı =  
0.36. AFM also allowed the acquisition of kinetic information at each ı.  
At both ı values, the mechanism of growth observed was consistent with that 
of the dislocation mechanism. Other growth modes, such as 2-dimensional or 3-
dimensional nucleation, were not observed. However, it is thought that 3D nucleation 
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is unique to macromolecular protein and virus crystals. At ı = 0.31, the step heights 
ranged from 1 nm to 85 nm. The rate of growth of steps ranged from 4.6 nm/s to 10.8 
nm/s, and showed no correlation between step height and growth rate. All steps were 
observed to grow in the [100] direction. 
 At ı = 0.36, the steps growing in the [100] direction varied in height from 1 
nm to 315 nm, and grew at rates ranging from 17.4 nm/s to 34.5 nm/s. Again there 
was no relation between step height and growth rate. The average growth rate of 
steps in the [100] direction at ı = 0.31 and ı = 0.36 was calculated as 7.2 nm/s and 
25.7 nm/s respectively. Therefore, at ı = 0.36, the growth rate of the steps was a 
factor of 3.6 times higher than at ı = 0.31, irrespective of the larger macrosteps 
observed at ı = 0.36.  
At ı = 0.36, growth was also initiated in the [010] direction, with steps 
ranging in height from 1 nm to 365 nm. In this direction, the growth rates ranged 
from 6.0 nm/s to 17.0 nm/s, with no relation between step height and growth rate. 
Thus, the growth rates of steps in the [100] and [010] directions were anisotropic. It 
is probable that the step anisotropy arises due to the difference in molecular structure 
of the steps advancing in different crystallographic directions. 
These data may suggest that growth on the (001) face of aspirin crystals 
occurs solely via the dislocation mechanism at all values of ı. However, as  
dissolution was observed at ı d 0.15, and at ı  0.48 microcrystals were visible in 
the growth medium, the range of ı values over which growth on the surface occurs is  
narrow. Hence, the two ı values investigated in this chapter were moderate to high. 
As the dislocation mechanism is the most energetically favourable at low ı, we 
assume that at ı values lower than those studied here, growth would again progress 
via the dislocation mechanism. It is therefore necessary to conduct similar 
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experiments on the (001) crystal face at higher ı to assess whether 2D or 3D 
nucleation occur at any level of ı.  
The (001) face is the most prominent, and therefore the slowest growing, face 
of the crystal. It would, hence, be of great interest to carry out such experiments on 
the remaining faces of the crystal, as the faster growing faces may employ other 
modes of growth at these levels of ı.  
 
The control, design, and promotion of crystal growth are greatly desired objectives of 
crystal engineers and the pharmaceutical industry alike. In order to achieve this goal 
more information is required on all aspects of the crystal growth procedure. In 
Chapter 3, we focused on the nucleation and promotion of aspirin crystal growth. In 
recent years, SAMs have come to the fore as surfaces upon which crystallization can 
not only be promoted, but can also be directed and patterned in predetermined 
locations.  
We assessed the aspirin binding capabilities of three SAMs chemisorbed on 
gold. Of the three SAMs investigated, only the carboxyl-terminated 11-MUA SAM 
allowed aspirin crystals to nucleate on its surface. We assume that aspirin molecules  
bind to the SAM via hydrogen bonding between the two carboxyl groups, in a 
manner similar to that of aspirin molecules dimerizing in the crystal structure. 
Further investigation is required to precisely determine the mechanism of crystal 
formation on the SAM surface. However, nanostructure growth on surfaces is 
postulated to occur via the Deposition, Diffusion, and Aggregation (DDA) model. 
Microcontact printing facilitated the patterning of gold substrates with 11-
MUA and 1-DDT SAMs, and allowed us to create templates comprising aspirin-
binding and non-binding regions. Incubation of these templates in aspirin solution 
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resulted in the patterned formation of tabular unidirectional aspirin crystals. The face 
of the crystal which bound to the SAM was (100), and the resulting crystals formed 
on the SAM had a tabular habit bounded by the faces {001}, {011}, and {110}. 
However, the dimensions of the crystals and channels did not mirror the dimensions 
of the stamp features, and more than one crystal nucleated within each stamped area. 
Therefore the parameters of the stamp used for our experiments need to be optimized 
in order to create patterns which promote nucleation of only one aspirin crystal per 
nucleating site. 
Nevertheless, the observation that this template promoted the growth of 
highly oriented crystals implies that it allowed nucleation to occur at specific sites. 
Again the growth of crystals on the surface followed the DDA model. 
This method, in conjunction with AFM, allowed visualization of the growth 
of a crystal bound to the SAM surface. Only growth in the [001] direction was  
observed, with the growth rate calculated as 18.1 nm/min. These templates also 
permitted the observation of the secondary nucleation and growth of a cluster of 
aspirin molecules on the surface of another aspirin crystal. Initially, growth in the 
[001] direction was predominant, with an average growth rate of 29.2 nm/min, 
compared with 8.0 nm/min in the [100] direction. After approximately 140 minutes, 
growth in the [001] direction ceased, but growth in the [100] direction rapidly 
increased, with rates ranging from 23.5 nm/min to 37.6 nm/min.  
The observation that growth in the [001] direction was initially dominant but 
was then curtailed, whilst growth in the [100] direction increased may aid in the 
explanation of the tabular habit of the crystals grown on the underlying SAM.  
These experiments could be employed to control the resulting crystal 
morphology and size of this and other drug crystals. SAMs may also provide a 
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surface upon which nucleation and growth can be monitored under differing 
crystallization parameters. Such knowledge may assist in predicting the outcomes of 
crystallization, controlling polymorphism, directing nucleation of polymorphs or 
enantiomers, and searching for unknown polymorphs.  
 
It is well known that the presence of impurities can dramatically affect the 
nucleation, morphology, and chemical properties of crystals. Although literature is 
replete with examples of impurity or additive-induced modifications of crystals, few 
have probed the interaction of these compounds with distinct growing faces. In 
Chapter 4, we utilized AFM and SEM to investigate the influence of two structurally 
related additives of paracetamol, namely acetanilide and metacetamol, on its crystal 
morphology. We also probed, in situ, the effects of these additives on the 
morphology and growth rate of steps on the (001) face of the crystal.  
SEM images showed the characteristic tabular habit of pure paracetamol 
crystals was only moderately altered by the presence of acetanilide, but the crystals 
adopted a columnar habit when grown in the presence of metacetamol.  
On a microscopic level, AFM revealed that the surface features of pure 
paracetamol crystals were steps ranging from 1 nm to 21 nm in height. On the 
contrary, crystals grown with acetanilide possessed thin, branched terraces of 
approximately 20 nm in height. We suspect that the branched appearance of the steps 
is due to the adsorption of acetanilide molecules onto terraces or steps during growth, 
causing pinning and bending of the growing steps. 
The presence of metacetamol during growth resulted in steps of 
approximately 15 nm in height interspersed with holes, and also induced the 
formation of defects in the crystal surface. These data suggest that the crystal lattice, 
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and hence the hydrogen bonding network, were considerably disrupted by 
metacetamol during growth. 
Growth on the (001) face of paracetamol crystals in the presence and absence 
of acetanilide or metacetamol was monitored via AFM. In the absence of any 
additive, growth was observed to occur by a dislocation mechanism. Growing steps 
ranged from 95 nm to 588 nm in height. The rate of growth of the steps ranged from 
26.4 nm/s to 76.2 nm/s, and decreased with increasing step height. All steps were 
observed to grow in the [-100] direction. 
In the presence of acetanilide, holes, which may have originated from defects, 
emerged in the surface during incubation. Steps, ranging from 13 nm to 45 nm in 
height, emanated from these holes and dissolved at rates between 1.3 nm/s and 2.7 
nm/s, in the [100] direction. The dissolution rate of the steps decreased with 
increasing step height. The holes or clefts in the surface were also observed to 
deepen over time, indicating that dissolution was occurring into the crystal core as  
well as laterally. The presence of additives is known to increase the solubility of 
paracetamol, which may have induced such dissolution.  
The presence of metacetamol in the growth medium resulted in the growth of 
steps, of 4 nm to 21 nm in height, at rates of 19.0 nm/s to 37.8 nm/s in the [-100] 
direction. The steps were pointed in appearance and significantly smaller than those 
observed in the absence of metacetamol, suggesting that the additive molecules  
pinned the steps. The average growth rates in the absence and presence of 
metacetamol were 49.5 nm/s and 27.1 nm/s respectively. Hence, metacetamol 
dramatically altered not only the morphology, but also the rate of the growing steps. 
AFM enabled the observation of the effects of metacetamol on the growing 
interface on a micrometre scale. However, we could not establish, at this resolution, 
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whether additive adsorption occurred at step edges or on terraces, as both generate 
the formation of pointed, pinned steps. Nonetheless, the observed pinning of steps 
and reduction in growth rates are in accordance with the Cabrera and Vermilyea 
model. 
The functional groups which protrude from the (001) face, in the [-100] 
direction, are NHCOCH3 and OH. These groups may facilitate the attachment of 
metacetamol molecules via their CO group, which is equivalent to that of 
paracetamol, or their OH group, which is located juxtaposed to that of paracetamol. 
In either case, the hydrogen bonding network of the crystal would be largely 
preserved. Hence, metacetamol may bind with relative ease to this face and induce 
the degree of inhibition observed. 
We suggest that further similar experiments should be carried out using each 
of the six known structurally related additives of paracetamol, not only on its (001) 
face, but on all other faces of the crystal. Particular attention should be paid to the 
inhibitory activities on the {110} faces. These are considered to be morphologically 
the most influential, because their growth rates and mechanisms change with 
increasing ı, altering the habit of the crystal from columnar to tabular. 
Once the degree of inhibition of these additives has been established for each 
face of paracetamol, they could be employed to control the chemical properties of 
crystalline paracetamol and, perhaps, its problematic compaction behaviour.  
 
Finally, we wished to assess the capabilities of AFM in following the structural 
transformations of crystals. Thus, in Chapter 5, we used AFM to determine the 
process by which the anion exchange, and the subsequent structural transformations, 
of the crystalline co-ordination polymers {[Ag(4,4-bipy)]BF4}f and {[Ag(4,4-
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bipy)]NO3}f occur. Many of the applications of co-ordination polymers rely on the 
ion exchange capabilities of these compounds. Currently, there has been considerable 
debate over whether the anion exchange process is solid-state or solvent-mediated. 
AFM data confirmed the solubility of the aforementioned co-ordination 
polymers and verified that the anion exchange process is indeed solvent-mediated, 
involving the dissolution of one crystalline phase and subsequent recrystallization of 
another. As the crystal dissolves, clefts form within the crystal allowing the solution 
to access layers beneath the crystal surface. We suggest that the structural 
reorganization observed in these co-ordination polymers is initiated by the 
dissolution of the initial polymer from the crystal surface. Once in the solution phase, 
anion exchange occurs, and a new polymeric phase is formed. This new phase 
precipitates on the surface of the initial crystal. This process proceeds via 
autocatalysis, facilitated by emerging clefts and fundamental defects in the crystal. 
This results in a self-perpetuating cascade of dissolution and recrystallization 
throughout the crystal. 
 
The results presented here reiterate the capability of AFM to monitor dynamic 
events, such as in situ growth, dissolution, and structural transformation on crystal 
faces, at the nanoscale. It has also proven its capacity to deduce the mechanisms and 
rates of growth of drug crystals, as a function of crystallization parameters. These 
studies emphasize the fact that AFM can provide essential fundamental information 
on the growth of drug compounds to the pharmaceutical industry. Such knowledge 
may facilitate the optimization of crystallization parameters of these compounds, and 
may assist in preventing the production of unwanted or unstable pharmaceutical 
compounds. 
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